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ABSTRACT
The chronic metabolic e ffects of an increased consumption of galactose as 
lactose hydrolysate syrup (LHS) in man and the influence of the sex of the consumer 
and the menstrual cycle on peroral galactose tolerance were investigated. Chronic 
metabolic e ffects of dietary galactose were studied in rats and guinea-pigs.
Inclusion of LHS in the diet of human volunteers fo r 10 weeks so tha t 6-7% of 
the energy intake was supplied by carbohydrate in the syrup did not increase fasting 
serum galactose levels or influence the tolerance of an acute peroral galactose load. 
Fasting serum glucose, insulin and to ta l cholesterol levels and normal live r function 
were not altered. There was an increase in fasting serum trig lycerides which was 
greater in males than females but was not o f c lin ica l importance and could not be 
a ttribu ted  to an increased consumption of galactose as LHS per se.
There was no sex difference in acute peroral galactose tolerance. Female 
subjects showed a consistently lower tolerance during the secretory or early pre- 
mentrual phase of the ovulatory menstrual cycle than during the menstrual or pre­
ovulatory phase. D ifferences in renal galactose excretion or in the rate of liquid 
gastric emptying were not involved.
Consumption o f diets containing 20 or 30% of the metabolisable energy as 
galactose fo r 10 weeks caused cataract development in rats but not in guinea-pigs. 
Fasting plasma galactose and albumin concentrations were not altered in e ither 
species. Fasting plasma glucose levels were increased in rats fed galactose at the 
higher level o f intake. Chronic galactose consumption did not a ffe c t the hepatic or 
erythrocyte galactokinase a c tiv ity  in rats or guinea-pigs, but reduced the hepatic 
a c tiv ity  of UDP-galactose-4-epimerase in rats when fed at 20% of the metabolisable 
d ietary energy. Changes in the a c tiv ity  o f galactokinase or UDP-galactose-4- 
epimerase in the red blood cells of rats or guinea-pigs did not re fle c t changes in the ir 
a c tiv ity  in the live r. An influence o f d ie ta ry galactose on water uptake and urine 
production was described in rats. Fasting plasma sodium and potassium levels were 
not altered.
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CHAPTER 1 
INTRODUCTION
1.1 Historical Background
Galactose was f irs t acknowledged as being d iffe ren t from  glucose by Pasteur 
in 1856. Dubrunfaut, in reports of th is period, noted that the acid hydrolysis o f m ilk  
sugar resulted in the form ation of a readily crysta llizable product which, like 
giucose, was fermentable but which had a stronger dextroro tary power than the 
usual form of giucose. I t  was Pasteur who suggested that this sugar was not another 
form  of glucose but was a d iffe ren t moiety which he named lactose. The term  
lactose la ter became used to describe m ilk sugar and was found to contain both 
giucose and the newly discovered m oiety which was renamed galactose (Tanret, 
1902). The early analytical methods available fo r galactose lacked sp e c ific ity  and 
accuracy and i t  was not un til the development o f enzymic methods tha t the in vivo 
absorption, metabolism and excretion of d ietary galactose became understood.
1.2 Structure
Galactose is the epimer o f glucose; tha t is, i t  has the same chem ical 
configuration as glucose, C ^ H ^ O ^ , but d iffe rs  stereochem ically a t the 
position. In glucose the hydroxyl group is in the equatorial position and in 
galactose i t  is in the axial position (Figure 1).
OH
HO OH
oh
HO
QH
OH
OHH
D-Glucose
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OH
OH
OH OH
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Figure 1. Molecular diagrams of Glucose, Galactose and Lactose
1.3 Occurrence
Galactose occurs in the oligosaccharides lactose, raffinose and melibiose. 
The cerebrosides and gangliosides o f brain and nervous tissue are principally 
galactosides (Kalckar, 1965) and fo r this reason galactose is sometimes referred to 
as cerebrose or brain sugar. The major dietary source of galactose is lactose, a 
disaccharide in which galactose is joined by a 61-4 linkage to the of glucose 
(Figure 1).
Lactose is a unique constituent of m ilk and is synthesised from  blood glucose 
in the epithe lia l cells of the lactating mammary gland. The lactose concentration 
o f mammalian m ilk varies according to species (Jones, 1976). Human m ilk contains 
7.8g lactose/lOOml and cows m ilk 4.7g/100ml (Paul and Southgate, 1978). Lactose 
is a major carbohydrate in the diet of suckling infants but in adulthood only a 
lim ited  number o f races consume m ilk.
During 1984 the galactose intake from  lactose in liquid m ilk  in the United 
Kingdom was estimated as being 6.9g/capita/day (Household Food Consumption and 
Expenditure Survey, 1986). However, in recent years a new dietary source o f 
galactose has resulted from  the development o f a lactose hydrolysate syrup fo r use 
as a sweetner in food manufacture (Harju and Kreula, 1980; Eustace, 1982). As the 
use o f this syrup becomes more widespread an increase in the per capita galactose 
consumption is like ly .
1.4 Digestion
Galactose is p rim arily  ingested in the form  of lactose. P rio r to absorption, 
lactose is hydrolysed to glucose and galactose by the enzyme lactase which is one 
o f three 6-galactosidases found in the small in testine (Dahlqvist, 1984). I t  is a 
membrane-bound enzyme located in the brush border o f the mucosal ep ithe lia l cells 
(Newcomer and M cG ill, 1984) and exerting greatest a c tiv ity  in the d ista l duodenum 
and jejunum (Newcomer and M cG ill, 1966).
In many human races the a c tiv ity  of lactase decreases a fte r weaning (Paige 
e t al., 1979) and is often only 5 to 10% of its  pre-weaning level by the age of six 
years (Newcomer and M cG ill, 1984). This condition is termed primary adult lactase 
deficiency or lactase non-persistence and is the physiological "norm" fo r the 
m ajority  of the world's adult population w ith  the exception o f Caucasians 
(Kretchmer et al., 1971; Rosenweig, 1971; Johnson, Kretchm er and Simoons, 1974). 
Current evidence suggests that the decline in lactase a c tiv ity  is determined by an 
autosomal recessive gene and is not influenced by the amount of lactose consumed 
(F latz, 1983; Newcomer and M cG ill, 1984). Individuals diagnosed as lactase non- 
persistent vary greatly in the ir tolerance of lactose (Newcomer and M cG ill, 1984) 
and do not necessarily abstain from  m ilk consumption. Symptoms o f lactose 
intolerance only become apparent follow ing the ingestion o f a lactose load which 
exceeds the hydro lytic capacity of the lactase present in the small intestine 
(Newcomer and M cG ill, 1984). The osmotic e ffe c t o f undigested lactose draws 
water into the lumen of the intestine. In the ileum and colon, lactose in terferes 
w ith  water absorption and in the colon i t  is fermented by the natura lly occurring 
in testinal flo ra  to la c tic  acid and carbon dioxide. The increase in flu id  load, ac id ity  
and gas production causes bloating, fla tu lence and, in some individuals, abdominal 
pain and diarrhoea (Hulbert, 1981).
Reduced lactase a c tiv ity  is also apparent in transient or secondary lactase 
deficiency due to in jury to the small in testina l mucosa (Dahlqvist, 1978) and in the 
extrem ely rare condition o f congenital lactase deficiency (Dahlqvist, 1984; 
Newcommer and M cG ill, 1984).
1.5 Absorption
In lactase-persistent man, the hydrolysis o f lactose by lactase is not thought 
to l im it  the absorption o f e ither glucose or galactose (McMichael, Webb and 
Dawson, 1967; McMichael, 1972). Perfusion studies in man have shown th a t the
absorption rates of the giucose and fructose from  sucrose and maltose solutions are 
the same as (Gray and Ingelfinger, 1966; McMichael et al., 1967) or greater than 
those a fte r the monosaccharides are given alone (Macdonald and Turner, 1968; 
Cook, 1973). A specific hydrolase related transport system has been postulated fo r 
glucose absorption (Crane et al., 1970; Ramaswamy £ t al., 1974) but the existence 
of a sim ilar transfer mechanism for galactose absorption is unlikely since the 
absorption of glucose and galactose from  lactose is slower than from  a m ixture of 
the monosaccharides in man (Gray and Santiago, 1966).
The absorption of glucose and galactose against a concentration gradient has 
been demonstrated using everted sacs o f golden hamster intestine (Wilson and 
Wiseman, 1954). This suggests an involvement of a process other than simple 
diffusion and subsequent work has established the existence o f both an active and a 
passive route fo r hexose absorption |n  vivo (Debnam, 1982). Sodium ions appear to 
be necessary for the active process (Csaky and Thale, 1960; Csaky and Z o llico ffe r, 
1960; Debnam, 1982). Crane (1960) postulated a mechanism fo r the active transport 
o f glucose and galactose which involved a sodium dependent carrie r, shared by both 
monosaccharides, in the brush border of the in testina l mucosa. In teraction between 
the carrie r and a localized sodium pump was thought to allow the monosaccharide 
to be active ly concentrated w ith in  the cell. This mechanism continues to be 
supported by experimental evidence although i t  is now believed tha t there may be 
more than one such carrie r (McMichael, 1973; Debnam and Levine, 1976). The 
recognition o f a rare congenital condition o f glucose-galactose malabsorption in 
which the absorptive defect is confined to glucose and galactose fu rthe r supports 
this concept (Elas et al., 1970; Wimberley, Harries and Burges, 1974; Huges and 
Senior, 1975).
Early quantita tive data on monosaccharide absorption in rats showed tha t 
galactose and glucose were absorbed from  the small in testine at a faster ra te than 
were other monosaccharides and that galactose was absorbed at a s ligh tly  faste r
rate than glucose (Cori, 1925). Jejunal perfusion studies in man using a double­
lumen tube technique confirmed these results (Groen, 1937; Cook, 1977) and 
established absorption coe ffic ien t ratios fo r galactose, glucose and fructose as 
being 122, 100 and 67 respectively (Groen, 1937). However, such data is of lim ited  
use unless the e ffects of concentration changes on absorption are known. Since the 
carrie r sites fo r glucose and galactose absorption can become saturated, as can the 
active sites on enzymes, i t  is possible to apply the Michaelis-Menten equation to 
monosaccharide absorption data. Jejunal perfusion studies in man have shown the 
maximum rate of absorption (Vmax) fo r glucose and galactose to be 
0.73g/30 cm /m inute and 1.0g/30cm/minute respectively (Holdsworth and Dawson, 
1964). The concentration of monosaccharide required in the lumen of the intestine 
fo r the rate o f absorption to reach ha lf its  maximum value (km) was found to be 
4.0g/100ml for glucose and 5.9g/100ml fo r galactose. These data suggest that the 
carrie r has the greatest a ff in ity  fo r glucose, although galactose can be absorbed at 
a faster rate than glucose in man; they are, therefore, in accordance w ith  the 
results o f Groen (1937) and Cook (1977).
The ingestion o f an equimolar solution o f galactose and glucose m ight be 
expected to result in a mutual inh ib ition of the ir absorption since both 
monosaccharides share the same in testina l transport system. M ichaelis-Menten 
kinetics predict tha t galactose absorption would be inhibited by 30% and glucose 
absorption by 21% fo llow ing consumption of an equimolar m ixture in man (Finch 
and H ird, 1960). However, human jejuna! perfusion studies have shown galactose 
absorption to be inhib ited by 29% in the presence of glucose, but glucose absorption 
to be unaffected by galactose (Holdsworth and Dawson, 1964). I t  is possible tha t 
these figures re fle c t d iffe ren t sites of maximum absorption. Infusion o f glucose and 
galactose m ixtures into the whole intestine o f calves has shown tha t glucose is 
absorbed rapidly in the proxim al intestine whereas galactose absorption occurs 
most e ffic ie n tly  in the d istal portion (Coombe and Smith, 1973). In te rp re ta tion  o f
quantita tive data obtained using perfusion techniques of a specific in testinal area 
is like ly  to be lim ited.
• Consumption o f osmotically active solutions are known to slow gastric 
emptying, possibly due to the excitation o f duodenal osmoreceptors (Hunt, 1961). 
Studies in man have shown that glucose is slightly more e ffec tive  per mole at 
slowing gastric emptying than galactose and it  is thought that this is due to a 
physical difference which reduces the true osmotic potentia l of galactose (Elias et 
al., 1968). However, when glucose and galactose are consumed simultaneously the 
e ffe c t on gastric emptying is the same as that seen when galactose is ingested 
alone (Elias et al., 1968). In lactase-persistent man lactose has the same e ffe c t on 
gastric emptying as does a glucose and galactose m ixture (Mallinson, 1968), thus 
providing further evidence that the absorption rate o f glucose and galactose is not 
lim ited  by lactose hydrolysis in these individuals.
1.6 Tissue Uptake
Once absorbed in to the blood, galactose can be excreted in the urine (see 
la ter) or taken up into body tissues, prim arily  the live r. The live r receives more 
than 90% of absorbed galactose and glucose d irec tly  via the porta l vein (M cIntyre, 
Turner and Holdsworth, 1970) and studies in dogs have shown tha t galactose is 
rapidly cleared from  the porta l c ircu la tion. Although galactose may not be 
completely assimilated during the f irs t passage more than 90% o f galactose 
consumed is eventually taken up into the live r (Goresky, Bach and Nadeau, 1973).
The rate o f galactose transport into isolated ra t hepatocytes has been found 
to obey M ichaelis-Menten kinetics and to be inhibited by glucose (Craik and E llio t, 
1980). I t, therefore, seems like ly  that the mechanism o f galactose transport across 
the live r cell membrane is s im ilar to tha t described fo r in testina l galactose 
absorption and tha t galactose and glucose are transported into the hepatocytes via 
a single system.
Norm ally the maximum rate of galactose uptake by the human live r is less 
than 2.8mmol/m inute (Waldstein et al., 1960; Tygstrup, 1966) and saturation o f 
hepatic uptake occurs at a serum galactose concentration of 4.16mmol/L 
(Waldstein et al., 1960). Hepatic galactose uptake appears to be s ign ificantly 
smaller in females and to decrease w ith  age (Tygstrup, 1964).
1.7 Metabolism
The fate o f d ietary galactose is discussed in this tex t and so only the 
catabolic pathways of galactose metabolism w ill be considered.
1.7.1 Major Catabolic Pathway fo r Galactose
The major catabolic route fo r galactose metabolism in normal man is the 
Le lo ir Pathway (Figure 2); so named a fte r Le lo ir who, in 1951, f irs t  described the 
inter-conversion o f uridinediphospho-glucose (UDP-gluc) and uridinediphospho- 
galactose (UDP-gal). I t  is a four stage metabolic pathway which is p rim arily  
located in the cytosolic fraction  o f hepatocytes and results in the overall 
conversion o f galactose to glucose-l-phosphate (g luc-l-P ) (Herman and Zakim , 
1968; Cohn and Segal, 1973).
In this pathway D-galactose is in it ia lly  phosphorylated at carbon atom 1 to 
form  galactose-l-phosphate (ga l-l-P ). Phosphorylation is mediated by the enzyme 
galactokinase and requires the presence o f magnesium chloride and adenosine 
triphosphate (ATP) (Sherman and Alder, 1963). Galactokinase is subject to both 
substrate and product inh ib ition and, in this way, is believed to regulate the 
form ation o f g a l-l-P , a po ten tia lly  tox ic  m etabolite (Cohn and Segal, 1973). Gal- 
l - P  uridyltransferase then catalyses the reaction of g a l-l-P  w ith  UDP-gluc to form  
glucose-l-phosphate (g luc-l-P ) and UDP-gal. The UDP-gal so formed can serve as a 
donor of galactose in the synthesis o f lactose and some glycoproteins, g lycolip ids 
and mucopolysaccharides or be converted in to UDP-gluc in stage 3 o f the Le lo ir 
Pathway. The enzyme UDP-gal-4-epimerase mediates the inversion o f the hydroxyl
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group on carbon atom 4 in the hexose ring and is an im portant enzyme in the 
endogenous synthesis o f galactose from  glucose. I t  has been shown to have an 
absolute requirement for the oxidised form  of nicotinamide adenine dinucleotide 
(NAD+) and to be inhibited by the reduced form (NADH) (Maxwell, 1957; Cohn and 
Segal, 1969). UDP-glucose is required fo r glycogen synthesis (Gitzelman and 
Hanson, 1980). The fina l stage in this pathway is the conversion of UDP-gluc to 
g luc-l-P  and involves the enzyme UDP-gluc pyrophosphorylase.Gluc-l -  P can 
then be fu rther metabolised via the G lyco lytic  Pathway and the Pentose Phosphate 
Pathway or be released from  the live r as glucose.
Since changes in galactokinase a c tiv ity  have been reported to closely paralle l 
changes in galactose u tiliza tion  i t  has been suggested tha t the in it ia l 
phosphorylation o f galactose is rate lim iting  (Cuatrecasas and Segal, 1965). 
However, data available from  live r perfusion studies appear conflic ting . Although 
several workers support the hypothesis that the galactokinase step is ra te  lim itin g  
(Keiding, Johnson and Winkler, 1976) others favour a regulatory role of UDP-gal-4- 
epimerase (Berman et al., 1978; Rogers and Segal, 1981).
1.7.2 Minor Catabolic Pathways fo r Galactose
The congenital absence of e ither one of the f irs t two enzymes in the Le lo ir 
Pathway results in c lin ica l galactosaemia and w ill be discussed la te r in this chapter 
(1.12). Despite this enzyme deficiency, certa in patients w ith  c lin ica l galactosaemia 
have been found to metabolise appreciable quantities of galactose (Komrower et 
al., 1956). This suggests the existence o f a lternative pathways fo r galactose 
metabolism and has led to the elucidation of several minor pathways in man. The 
Isselbacher Pathway is one such pathway and is an alternative route fo r the 
conversion o f ga l-l-P  to UDP-gal (Figure 2). I t  involves the enzyme UDP-gal 
pyrophosphorylase and requires uridine triphosphate (UTP); its  development is 
believed to increase the a b ility  of older patients w ith  c lin ica l galactosaemia to 
metabolise galactose (Isselbacher, 1957).
1 1
Several workers have reported that some Caucasian c lin ica lly  galactosaemic 
individuals are able to oxidise carbon 1 of intravenously administered galactose to 
carbon dioxide (Segal, B la ir and Topper, 1962; Segal, B la ir and Roth, 1965; Segal 
and Cuatrecasas, 1968). A d irect oxidative pathway for galactose in the live r has 
been postulated (Cuatrecasas and Segal, 1966a) and is shown in Figure 3. In this 
pathway galactose is oxidised to galactonate which is then oxidised and 
decarboxylated to xylulose and can be metabolised via the Pentose Phosphate 
Pathway. Galactose dehydrogenase is the f irs t enzyme in this oxidative pathway. I t  
is principa lly located in the soluble fraction  o f hepatocytes and has been 
demonstrated in human tissue (Cuatrecasas and Segal, 1966b), however, i t  is not 
known i f  a specific enzyme is involved (Beutler, 1967; Beutler and Morrison, 1967; 
Ray and Bhaduri, 1975). Although the metabolism o f galactonic acid to xylulose has 
been described in ra t live r slices jn  v itro  (Cuatrecasas and Segal, 1966a) i t  has not 
yet been described in man. Galactonic acid appears to be rapid ly cleared by the 
human kidney (Segal and Cuatrecasas, 1968) and has been identified  in the urine o f 
both normal and c lin ica lly  galactosaemic subjects a fte r ingestion o f a 60g 
galactose load (Bergren, Ng and Donnell, 1972).
Galactose can be reduced by a non-specific aldose reductase (Figure 3) to 
form  the sugar alcohol, ga lactito l (Hayman and Kinoshita, 1965). G a lac tito l has 
been isolated from  body tissues and urine o f patients w ith  c lin ica l galactosaemia 
(Wells, P ittm an and Egan, 1964; Wells, P ittm an and Wells, 1965; Roe et al., 1973) 
and from  the tissue o f rats fed a high galactose d ie t (Van Heyningen, 1959; Quan- 
Ma and Wells, 1965). There is no evidence tha t ga lac tito l is fu rthe r metabolised in 
mammals and when administered intravenously to normal man has been shown to be 
excreted unchanged in the urine (Weinstein and Segal, 1968). Accum ulation o f 
ga lac tito l in the lens is believed to be involved in cataract form ation (K inoshita, 
1974).
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Galactose
The conversion o f ga l-l-P  to gal-6-P by phosphoglucomutase has been 
demonstrated in patients w ith  a deficiency o f ga l-l-P  uridyltransferase (Inouye, 
Schneider and Hsia, 1964).
These minor metabolic pathways fo r galactose are unlikely to be of 
significance in normal man but may allow a residual ab ility  for metabolism in 
patients w ith c lin ica l galactosaemia. They are, however, unable to compensate fo r 
loss o f enzyme a c tiv ity  in the Le lo ir Pathway and the ab ility  of such patients to 
metabolise galactose remains impaired (Rennert, 1977).
1.7.3 Extra-Hepatic Galactose Metabolism
Although the live r is the major site o f galactose uptake and metabolism 
evidence exists for an extra-hepatic involvement. Studies in dogs have reported 
tha t only 50-62% of an intravenous galactose load is recovered in the urine 
follow ing complete hepatectomy (Bollman, Mann and Power, 1935). I t  is unlikely 
tha t galactose was metabolised to glucose in these animals since there was l i t t le  
change in the prevailing hypoglycaemia. The presence o f galactose metabolising 
enzymes has since been established in the kidney o f the ra t (Cuatrecasas and Segal, 
1965; B erto li and Segal, 1966a, Cohn and Segal, 1969) and man (Shin-Buehring et 
al., 1981) when studied in v itro  and in human erythrocytes (Puck and H ill, 1967; H ill 
and Puck, 1970; H ill, 1971). A review o f galactose metabolism in these tissues is 
provided by McNamara and Segal (1972) and Ng (1971). More recently a localised 
involvement o f free galactose in the biosynthesis o f glycoconjugates in human 
gastric mucosa has been described (Kopacz-Jodczyk, Zw ierz and Galasinski, 
1984a,b).
The extent o f this extra-hepatic galactose metabolism m vivo in man is 
unknown. K ine tic  data available suggest that, at least in erythrocytes, i t  is unlike ly 
to  be o f any quantita tive importance when compared to metabolism in the liv e r 
(Keiding, 1985).
1.8 Excretion
Galactose can be detected in the urine when plasma concentrations are as 
low as 0.5 m mol/L (Tengstrom, 1968). However, at plasma concentrations below 
2.77 m mol/L galactosuria is insignificant when compared to its hepatic metabolism 
(Tygstrup, 1961). Urinary galactose excretion becomes increasingly im portant as 
blood galactose levels rise above 4.44 m mol/L (Stenstam, 1946). A sex difference in 
renal galactose excretion is possible since early studies have detected galactose in 
the urine of male, but not female, subjects following ingestion of a 30g galactose 
load (Rowe, 1924).
Galactose has been shown to compete w ith glucose fo r a common tubular 
reabsorption mechanism in man (Tengstrom, 1968).
1.9 Acute Metabolic Response to Galactose
1.9.1 Serum Galactose
The normal fasting serum galactose level in man is below 0.24 m m ol/L 
(Rommel, Bernt and Schmitz, 1968). This concentration increases a fte r galactose 
adm inistration although the size of the increase varies considerably between 
individuals. Such a variation has been described a fte r both a standard peroral 
galactose test meal (Stenstam, 1946) and a body weight re lated peroral load (Roe 
and Schwartzman, 1932; W illiams, Phillips and Macdonald, 1983). D ifferences in 
the rate o f galactose absorption do not appear to be involved since a large 
scattering of serum galactose concentrations between individuals has also been 
seen a fte r intravenous galactose infusions (Bohmer, Torok and Rommel, 1978).
The maximum blood galactose concentration, the tim e taken fo r this to be 
reached and the duration o f the galactosaemia fo r an individual subject have a ll 
been found to increase w ith  the quantity o f galactose consumed (Stenstam, 1946). 
This response d iffe rs  from  tha t reported fo llow ing ingestion o f glucose over a 
comparable dose range where the maximum blood concentration was consistently
seen a fte r approximately 30 minutes and where there was no significant difference 
in the resulting maximum blood level (Macdonald, Keyser and Pacy, 1978).
1.9.2 Serum Glucose
Several studies have described a moderate increase in blood glucose levels 
following peroral galactose in man (Stenstam, 1946; Dormandy, Leak and Grant, 
1959; Ganda et al., 1979; W illiams et al., 1983). This increase occurred 20 to 30 
minutes a fte r galactose ingestion and was not related in magnitude to the quantity 
o f galactose given (Stenstam, 1946). Intravenous galactose infusion has also been 
found to result in hyperglycaemia (Segal and Blair, 1961; Royle et al., 1978; E lia et 
al., 1979; Ganda et al., 1979). The hepatic conversion of galactose to glucose is 
believed to produce this response (Royle et al., 1978). Studies in normal subjects 
have shown that 30 minutes a fte r the intravenous in jection of ^C - l-g a la c to s e  five  
elevenths o f the administered dose is in the body glucose pool (Segal and B la ir, 
1961), thus demonstrating the e ffic iency w ith  which the live r converts galactose to 
glucose. Intravenous galactose infusion has been found to produce a greater rise in 
blood glucose levels in fasted subjects than in subjects in the fed state, however, 
the maximum glycaemia recorded was the same in both groups (Royle e t al., 1978). 
Post-operative hyperglycaemia does not surpress the rise in serum glucose 
produced by intravenous galactose (Elia et al., 1979). The factors involved in 
hepatic glucose release a fte r galactose adm inistration are, therefore, unclear 
although the prevailing serum insulin concentration is thought to be im portant (Elia 
et al., 1979).
Blood glucose levels have occasionally been reported to fa ll in normal 
subjects fo llow ing galactose in jection (Stenstam, 1946; Dormandy e t al., 1959) 
possibly due to a greater sensitiv ity to insulin release.
1.9.3 Serum Insulin
Peroral galactose has been found to produce a slight increase in serum insulin 
levels in man (Shima et al., 1972; Ross and Dupre, 1978; Ganda £ t  al., 1979;
Morgan, Wright and Marks, 1979; W illiams at al., 1983). However, data available 
from  intravenous galactose infusion studies in man appear conflic ting; although a 
slight increase in serum insulin concentrations has been reported by some workers 
(Morse et al., 1960; Rommel et al., 1969; Ganda et al., 1979) no such rise was 
reported by others (Kvam, 1964; Morgan et al., 1979). I t  is of in terest that 
intravenous galactose produced an increase in plasma insulin levels in fasted 
subjects; but not in fed volunteers in whom the rise in blood glucose concentration 
was less (Royle et al., 1978). Galactose is not metabolised by the islets of 
Langerhans (Ja rre tt and Keen, 1968) and studies using in v itro  preparations o f ra t 
pancreas have shown i t  to be non-insulinogenic per se (Grodsky e t al., 1963; 
Sussman, Vaughan and Timmer, 1966; Malaise, Malaise-Lagae and W right, 1967). I t, 
therefore, seems possible that the small rise in the blood insulin concentration seen 
a fte r galactose adm inistration is, at least in part, secondary to its  conversion to 
glucose. This hypothesis is supported by the work o f Goetz, Maney and Greenburgh 
(1967) which demonstrated an increased insulin output when galactose was infused 
into the hepatic arte ry o f dogs but not when galactose was infused in to the 
pancreatic artery. Furthermore, i t  has been shown tha t peroral galactose does not 
result in increased insulin levels in patients w ith  c lin ica l galactosaemia, in whom 
the conversion of galactose to glucose is negligible (Samols and Dormandy, 1963; 
Gitzelman and Ilig , 1969).
In normal subjects peroral galactose has been shown to in it ia te  the release o f 
gastric inh ib itory polypeptide (GIP) (Ross and Dupre, 1978; Morgan et al., 1979) and 
to produce a rise in serum GIP levels sim ilar in size to that seen a fte r glucose 
ingestion (Ganda et al., 1979). GIP is believed to be an im portant in testina l 
mediator of insulin release (Brown et al., 1975; C rockett et al., 1976; Fujim oto e t 
al., 1978) and i t  is like ly  tha t the modest increment in blood insulin levels seen 
a fte r galactose adm inistration is due to the conversion o f galactose to glucose and 
to the action o f this monosaccharide together w ith  tha t o f GIP on the pancreatic 
8 -is le t cells. Since GIP has been shown to be re la tive ly  in e ffe c tive  in
*  peroral galactose fa iled  to produce an insulin response. ,
stim ulating insulin release except in the presence of m ild to moderate 
hyperglycaemia (Brown et al., 1975) i t  has been postulated that the small rise in 
blood glucose concentrations produced by galactose in vivo makes the 6-is le t cells 
receptive to the increase in GIP levels (Morgan et al., 1979).
1.9.4 Other Acute Metabolic E ffects of Galactose
An increase in the plasma concentration of lactate and pyruvate has been 
observed follow ing intravenous galactose adm inistration in fasted man (Royle et 
al., 1978; E lia et al., 1979). No such rise in blood lactate levels was reported in 
subjects in the fed state (Royle et al., 1978). This suggests that there is an 
increased glucose uptake or hepatic glycolysis, and hence conversion o f galactose 
to pyruvate and lactate, when fasting and a greater metabolism o f galactose to 
glycogen or lipids when fed. In contrast, a fa ll in the serum lacta te  concentration 
was seen when glucose was ingested by fasting man and no sign ificant change 
occurred in serum pyruvate levels (Macdonald et al., 1978).
The respiratory quotient (RQ) is defined as the ra tio  o f carbon dioxide 
expired to oxygen consumed over a given tim e period. I t  has been found to increase 
faster in man a fte r galactose ingestion than a fte r glucose consumption, thus 
suggesting tha t galactose is oxidised or converted to fa t more readily than is 
glucose (Deul, 1936). Recent work has shown the RQ to remain elevated fo r longer 
when glucose is the carbohydrate ingested (Macdonald and Russell, 1983). 
Experimental data from  rats (Cori, 1926) and dogs (Deul et al., 1933) has shown 
that in the adult animal glycogen synthesis occurs less readily from  galactose than 
from  glucose or fructose. However, extrapolation of these results to man is lim ite d  
since both species are known to have a lower tolerance o f galactose (Cori and Cori, 
1934; Harding, Grant and G laister, 1934). O ther acute metabolic e ffects  o f peroral 
galactose in man include a rise in serum uric acid concentrations (Macdonald e t al., 
1978).
1.10 Factors Affecting the Acute Metabolic Response to Galactose
1.10.1 Glucose
The influence of glucose adm inistration on the acute metabolic effects 
associated w ith  a peroral galactose load was f irs t described by Folin and Berglund 
(1922). They found that the addition of lOOg of glucose to a lOOg galactose test 
meal markedly reduced the resulting galactosuria in man. This e ffe c t has since 
been produced using lesser quantities of glucose in dogs (Bodansky, 1923) and in 
man (Harding and Grant, 1933; Carpenter, 1937). In normal man the simultaneous 
ingestion of glucose w ith  galactose has been found to reduce the subsequent rise in 
blood galactose levels (Stenstam, 1946) to an extent proportional to the quantity of 
glucose consumed (W illiams et al., 1983). A sim ilar e ffe c t was also observed when 
lactose was given to normal subjects (Williams et al., 1983) and when an equimolar 
solution of the individual monosaccharides was given to lactose in to lerant subjects 
(W illiams and Macdonald, 1982a). Simultaneous fructose ingestion did not a ffe c t 
the serum galactose response to peroral galactose (Stenstam, 1946; W illiams et al.,
1983).
Several hypotheses have been put forward to explain this e ffe c t. O rig ina lly i t  
was believed tha t a decrease in galactose absorption occurred when a m ixture  o f 
glucose and galactose was consumed and tha t this could account fo r the 
hypogalactosaemic e ffe c t o f glucose (Cori and Cori, 1928; Deul, 1936). However, 
when intravenous glucose was given simultaneously to a peroral galactose test meal 
the serum galactose response was sign ifican tly  reduced (Stenstam, 1946; Morgan e t 
al., 1979; W illiams et al., 1983). Com petition between glucose and galactose fo r 
the same in testinal transport system does not, therefore, appear to be involved. 
Neither does an increased urinary galactose excretion since a decrease in 
galactosuria has been described in man fo llow ing the simultaneous adm in istra tion 
o f galactose and glucose (Harding and Grant, 1933; Carpenter, 1937; W illiam s et
I t  is possible that the hyperglycaemia caused by peroral or intravenous 
glucose adm inistration reduces serum galactose levels either via a delay in gastric 
emptying or via its stim ulation of insulin release (Morgan et al., 1979). A reduced 
rate o f gastric emptying is unlikely to be the cause since increasing quantities of 
glucose in an oral glucose plus galactose test meal were reflected in the serum 
insulin levels in man (Williams et al., 1983). This suggests that glucose absorption, 
and hence gastric emptying, was not reduced by an increase in the glucose content 
of the test meal.
Infusion of exogenous insulin has been reported to inh ib it the absorption of 
galactose from  the intestine o f rabbits (Beyreiss, M uller and Strack, 1964). I f
insulin s im ilarly a ffects galactose absorption in man i t  is possible tha t the
simultaneous peroral or intravenous adm inistration o f glucose may, via its  
stim ulation o f insulin relase, reduce the blood galactose levels subsequent to 
peroral galactose.
I t  is o f in terest to note that Stenstam (1946) described a decrease in 
galactosaemia and galactosuria in an individual when simultaneously given 
galactose intravenously and glucose perorally. Although no other subjects were 
investigated this result appears to suggest tha t glucose reduces the blood galactose 
response to peroral galactose via an e ffe c t at the post-absorptive stage. I t  may be 
that the hypoglactosaemic e ffe c t o f glucose in man is due to the ensuing insulin 
release increasing the rate of galactose clearance from  the blood. Experim ental 
data from  animals have shown exogenous insulin to increase galactose uptake by 
peripheral tissues (Levine et al., 1950; Wick and Dury, 1953; Kvam, 1964). In
contrast subcutaenous insulin fa iled to a lte r the blood galactose clearance in
rabbits fo llow ing in traperitoneal galactose adm inistration (Roe and Schwartzmann, 
1932) and an intravenous insulin in jection did not a ffe c t the serum galactose 
response to peroral galactose in man (W illiams et al., 1983). I t  is possible tha t this 
was due to s ign ifican tly  reduced serum glucose levels, induced by insulin infusion, 
in te rfe ring  w ith  galactose clearance (W illiam s et al., 1983). Exogenous glucagon is
known to be insulinogenic (Samols, M arri and Marks, 1965) and, when injected 
intravenously together w ith  galactose, reduced the galactosaemia produced by 
intravenous galactose in man (Benedetti, 1970). I t  is like ly that elevated blood 
glucose and insulin concentrations occurred simultaneously in these volunteers and 
it  seems reasonable to assume that an increase in both parameters is necessary fo r 
a reduction to occur in the blood galactose response to galactose adm inistration.
I t  is currently thought that the hypoglactosaemic e ffe c t of peroral or 
intravenous glucose in man involves an improvement in hepatic galactose 
metabolism (Williams et al., 1983). This is supported by the observation tha t 
glucose has l i t t le  or no e ffe c t on blood galactose levels where there is severe 
diffuse hepatic in jury (Stenstam, 1946). W illiams et al. (1983) postulated tha t the 
hyperglycaemia subsequent to glucose adm inistration increases the hepatic 
synthesis of UDP-gluc, an essential cofactor in the Le lo ir Pathway of galactose 
metabolism, thereby increasing the rate o f galactose metabolism in the live r. The 
prevailing insulinaemia was then suggested to increase the uptake o f galactose in to 
the live r since su ffic ien t UDP-gluc would be available to metabolise the extra load.
The ava ilab ility  o f a suitable animal model would allow this hypothesis to be 
investigated fu rther. Glucose does not appear to reduce the serum galactose 
response to peroral galactose in the ra t (Newstead, 1979; W illiams and Owens,
1984). However, a hypoglactosaemic e ffe c t o f peroral glucose has been reported in 
the guinea-pig (W illiams and Owens, 1984).
1.10.2 Insulin
Although insulin is not essential fo r a normal blood galactose response to 
peroral galactose (Roe and Schwartzmann, 1932; Banjeree and Divakaran, 1957) 
intravenous or subcutaneous insulin infusion increases the volume—of galactose 
d istribution in eviscerated and nephrectomized dogs (Levine et al., 1950; Goldstein 
et al., 1953), rabbits (Wick and Dury, 1953) and rats (Lotspeich and Wheeler, 1962;
Kvam, 1964). Since the eviscerated animals used in these studies were w ithout 
liver, intestinal tra c t and kidneys i t  is assumed that the galactose administered was 
unable to be metabolised in vivo. The increased uptake of both galactose and 
glucose by in v itro  preparations of ra t diaphragm muscle has been demonstrated in 
the presence of insulin (Kono and Colowick, 1961). In v itro  studies by Vega and 
Kono (1978) suggested that insulin increased the galactose uptake by ra t epididymal 
fa t cells; this was contradictory to earlier findings (Ball and Cooper, 1960; Pozza 
and Ghidoni, 1962; Kuo and D ill, 1969).
1.10.3 Alcohol
In normal man ethanol ingestion increases the blood galactose response to 
both peroral and intravenous galactose (Stenstam, 1946; Salaspuro and Kesaniemi, 
1973); the resulting galactosuria is also increased (Stenstam, 1946). This e ffe c t was 
seen a fte r ingestion o f as l i t t le  as 2ml o f alcohol and appeared to be dose related. 
In vivo studies in man have shown a decreased oxidation of ^C - l-g a la c to s e  to 
carbon dioxide when ethanol is consumed im m ediately prior to an infusion o f radio- 
labelled galactose (Segal and B la ir, 1961). I t  is believed that oxidation of alcohol in 
the live r increases the NADH /N AD+ ra tio  which then inhib its UDP-gal-4- 
epimerase, thus reducing hepatic galactose metabolism and uptake (Isselbacher and 
Krane, 1961).
1.10.4 Age
Galactose serves as a major energy source in the neonate and its  metabolism 
in the newborn mammal is known to d iffe r from  tha t of the adult (Walker, 1968). In 
man comparison o f the clearance rates o f intravenous galactose in newborn infants 
and adults appears confusing. Although some studies described a slower rate of 
galactose disappearance from  the blood of neonates than adults fo llow ing a body- 
weight related, intravenous load (Cornblath, Wybregt and Baens, 1963; Donnell et 
al., 1967) others showed a faste r rate of clearance in the newborn (H je lm  and
Sjolin, 1966). A positive association has been reported between the half life  of 
galactose in the blood stream a fte r an intravenous galactose load and age up to 15 
years (Relander, 1968), thus suggesting that the rate of galactose clearance from  
the blood decreases throughout childhood. No differences have been found in the 
resulting galactosuria w ith age (Donnell et al., 1967). I t  has been postulated that 
the age-dependence found in the blood galactose clearance rate may not accurately 
re fle c t a change in the rate of galactose u tiliza tion  jn  vivo. Decreases in basal 
metabolic rate, re la tive  live r weight and hepatic blood flow  through life  m ight be 
involved (Vink, 1959).
Intravenous infusion of Ig  of galactose/kg o f body weight has been shown to 
produce a greater rise in blood glucose levels in newborn infants than in older 
children or adults (Donnell et al., 1967). This difference was also seen a fte r peroral 
galactose adm inistration (Haworth and Ford, 1963) and may indicate an increased 
a b ility  of the human neonate to convert galactose to glucose. I t  has also been 
shown that the in tac t erythrocytes o f newborn infants produce carbon dioxide from  
■^C-l-galactose at a markedly higher rate than do adult erythrocytes (Donnell e t 
al., 1967), thus suggesting a greater ab ility  of neonatal erythrocytes to oxidise 
galactose. The demonstrated elevation of galactokinase a c tiv ity  in erythrocytes of 
in fants fu rther substantiates this hypothesis (Ng, Donnell and Bergren, 1965; 
Donnell et al., 1967), although i t  is not known i f  the ac tiv ities  o f galactose 
metabolising enzymes in red cells are indicative of the enzymic a c tiv ity  in other 
tissues.
Segal, Roth and B e rto li (1963) showed that the live r of newborn rats has a 
greater ab ility  fo r galactose u tiliza tion  and oxidation to carbon dioxide than has 
the live r o f older animals. In the ra t the heaptic ac tiv ities  o f galactokinase, gal-1- 
P uridyltransferase and UDP-gal-4-epimerase have a ll been found to peak during 
the neonatal period (Cuatrecasas and Segal, 1965; B e rto li and Segal, 1966; Cohn 
and Segal, 1969). No such change in galactokinase a c tiv ity  has been found in 
guinea-pig livers (Walker, Khan and Eaton, 1966). In man the enzymes required fo r
galactose metabolism have been identified in foetal livers (Shin-Buehring et al.,
1981); fu ll term  neonates were not investigated.
More recently a role of galactose as a regulator of hepatic glycogen synthesis 
in the newborn mammal has been postulated. In neonatal dogs incorporation of 
galactose into glycogen in the live r was greater than fo r glucose (Kliegman et al., 
1981; Kliegman, M iettinen and Morton, 1983) and it  is possible tha t galactose is 
p re ferentia lly  u tilized to increase hepatic glycogen deposition in the neonate 
(Sparks et al., 1975).
1.10.5 L ive r Function
Since galactose is predominantly metabolised in the live r, tests based on 
hepatic galactose metabolism have been used to investigate live r function. 
Stenstam (1946) reported an abnormally high rise in blood galactose levels and a 
prolonged galactosaemia follow ing either peroral or intravenous galactose loading 
in about 75% o f patients w ith hepatitis or hepatic cirrhosis. Galactosuria did not 
appear to be a reliable indicator of live r disease.
Tests based on intravenous galactose infusions abolish absorptive e ffects  and
are, therefore, considered to be o f greatest use. Their application as a diagnostic
and prognostic aid fo r the evaluation o f live r function has been fu lly  described
(Tengstrom, 1966; Henderson, Kutner and Bain, 1982; Lindskov, 1982). The in vivo 
14oxidation of C -l-ga lactose to carbon dioxide has been found to decrease in 
patients w ith  cirrhosis (Preisig, Grimm and Bricher, 1979). This reduction in carbon 
dioxide production was corre lated w ith  a fa ll in the galactose e lim ina tion capacity 
from  the blood and suggests tha t the greater galactosaemia seen a fte r galactose 
adm inistration in patients w ith  diffuse hepatic in jury is due, a t least in part, to an 
im pairment o f hepatic galactose metabolism.
1.10.6 Endocrine Influences
Patients w ith  hyperthyroid conditions have been reported to show a greater
than normal rise in blood galactose levels and abnormally high levels of galactose 
in the urine following peroral galactose adm inistration (Stenstam, 1946). In some of 
these patients a normal galactosaemia was seen a fte r an intravenous galactose 
load, suggesting that the abnormal blood galactose response to peroral galactose 
was due to a rapid absorption from  the intestine; in others an im pairment of 
galactose metabolism due to hepatic in jury has been postulated (Stenstam, 1946). A 
normal blood galactose response to peroral galactose has been shown to be restored 
subsequent to thyroidectom y (Althousen and Wever, 1937).
Patients w ith a hyperfunctioning p itu ita ry  gland and patients w ith  a lowered 
functional a c tiv ity  of the ovary or adrenal gland have also been found to excrete 
abnormally high levels of galactose in the urine a fte r galactose ingestion (Rowe, 
1935). Since adrenal insufficiency is associated w ith  a decrease in cortiso l 
secretion the adm inistration of cortisol m ight be expected to reduce the 
galactosaemia produced by peroral galactose _in vivo. Although such a decrease was 
observed in fasting subjects follow ing the intramuscular in jection o f 300mg of 
cortisone (Hein-Sekula and Siedek, 1953) i t  was not seen in the la te r study o f 
Papper, Saxon and A lpe rt (1957) in which a 200mg dose was given intravenously. 
Blood cortisone levels were not documented in either o f these studies. 
Furthermore, m v itro  investigations have described an inhib ition o f galactose 
metabolism to carbon dioxide, fa tty  acid and glycogen in the presence o f cortiso l 
(Plager, Matsui and Ariyoshi, 1969).
Following galactose ingestion galactose can be detected in the urine of 
healthy adult male volunteers irrespective o f age, whereas the peroral galactose 
dose required to produce galactosuria in females appears to vary w ith  sexual 
m atu rity  (Rowe, 1924). In the female menstruation, pregnancy and removal o f the 
ovaries have a ll been reported to reduce the peroral galactose load required to 
produce galactosuria (Rowe, 1935). An influence of female sex hormones on the 
blood galactose response to galactose, therefore, seems possible and is fu rthe r 
investigated la te r in th is thesis.
1.11 Chronic Metabolic Response to Galactose
L itt le  data is available on the chronic metabolic effects associated w ith  an 
increased consumption of galactose by normal man. Studies in baboons described a 
s ignificant increase in fasting serum galactose levels following consumption of a 
diet containing approximately 80% by weight of an equal m ixture of galactose and 
glucose over a ten week period (Williams and Macdonald, 1982b). S ignificantly 
elevated serum trig lyceride  levels were seen in female animals only. This is of 
interest since the baboon is considered to be a good model of lip id metabolism fo r 
extrapolation to man (Kritchevsky, Shapiro and Werthessen, 1962; Gresham and 
Howard, 1969) and, like man, can develop atherosclerosis in its natural environment 
(M cG ill et al., 1960).
An increased consumption o f carbohydrate has been shown to produce a 
transient increase in fasting serum trig lyceride concentrations in man (Antonis and 
Bersohn, 1961). However, hypertriglyceridaem ia in response to d ietary 
carbohydrate has been found to be o f greater magnitude in males (Beveridge, 
Jagannathan and Connell, 1964) and to vary w ith  the type o f carbohydrate 
consumed (Anderson et al., 1963; Macdonald and Braithw aite, 1964; Hodges and 
Krehl, 1965; Macdonald, 1965a).
The influence of d ietary carbohydrate on fasting serum to ta l cholesterol 
levels in man is believed to be small when compared to tha t o f d ie tary lipids 
(Anderson, Grande and Keys, 1973).
An increased risk o f atherosclerotic coronary heart disease has been 
associated w ith  elevated fasting serum concentrations o f trig lycerides (Crowley, 
1971; Carlson and Bo ttige r, 1972) and to ta l cholesterol (Kannel et al., 1961; Kagan 
et al., 1962). Epidemiological evidence has described a positive corre lation between 
m ilk consumption and ischaemic heart disease (Segall, 1977) and has suggested tha t 
lactose may be involved (Segall, 1980). Since lactose is hydrolysed to glucose and
galactose in vivo an investigation of the e ffe c t of an increased consumption of 
lactose hydrolysate syrup on fasting serum trig lyceride and to ta l cholesterol levels 
in man seems pertinent.
1.12 Inborn Errors of Galactose Metabolism
Galactose in the urine and elevated blood galactose levels are key 
biochemical abnormalities in disorders o f galactose metabolism. The term  "c lin ica l 
galactosaemia" or "galactosaemia" is frequently used to describe the symptoms 
associated w ith  galactose ingestion in patients w ith  a congenital abnormality in its  
metabolism. Two d istinct autosomal-recessive forms of c lin ica l galactosaemia are 
now recognised in man and result from a deficiency o f either galactokinase or gal- 
l-P  uridyltransferase (Rennert, 1977). Both can be successfully treated by the 
early elim ination o f galactose and lactose from  the d ie t (C loth ier and Davidson, 
1983).
1.12.1 Classical or G a l-l-P  uridyltransferase Deficiency Galactosaemia
Although the in it ia l phosphorylation o f galactose occurs in patients w ith  
classical galactosaemia fu rther metabolism is prevented due to an almost to ta l 
deficiency o f ga l-l-P  uridyltransferase (Kalckar, Anderson and Isselbacher, 1956). 
Adm inistra tion of galactose to such patients causes a marked accumulation o f gal-
l-P  in the erythrocytes (Schwartz et al., 1956; Anderson, Kalckar and Isselbacher, 
1957) and various body tissues (Schwartz, 1960). Elevated tissue levels o f ga l-l-P  
inh ib it gluc-6-P dehydrogenase, phosphoglucomutase, UDP-gluc pyrophosphorylase 
and UDP-gal-4-epimerase (Schwartz, 1975; G itzelman and Hansen, 1980) and result 
in a diminished synthesis of glycoproteins and glycolipids (Schwartz, 1975). I t  is this 
derangement o f carbohydrate and glycolip id metabolism which is thought to 
account fo r the mental retardation o f untreated classical galactosaemia due to an 
impaired synthesis o f 5-hydroxy-tryptam ine receptors in the brain (Schwartz, 
1975). A fu tile  cycle o f phosphorylation and dephosphorylation o f galactose is
believed to cause a decline in concentrations of ATP, phosphocreatinine and 
diphosphoglyceric acid in the live r and red blood cells of these patients (Schwartz, 
1975; Rennert, 1977).
Infants w ith classical galactosaemia appear normal at b irth  but develop 
symptoms of vom iting, diarrhoea, jaundice and fa ilure to thrive soon a fte r m ilk 
consumption. I f  m ilk feedings are continued live r malfunction, hepato- 
splenomegaly, cataract formation, mental retardation and eventual death can 
result (Gitzelman and Hansen, 1980). The incidence of ga l-l-P  uridyltransferase 
deficiency is d iff ic u lt  to determine due to the existence o f many variant forms of 
the disorder. Estimates have put the prevalence of homozygous enzyme deficiency 
at about 1 in 62,000 births (Beutler, 1973; Levy and Hammersen, 1978).
Variants of ga l-l-P  uridyltransferase deficiency include the Duarte, Los 
Angeles, Rennes, Indiana, West Germany, Chicago and Negro forms (Beutler et al., 
1965; Beutler and Baluda, 1966; Woon, Tock and Wong, 1980; Kliegman and Sparks,
1985). The most frequently detected abnormality on neonatal screening tests is the 
compound heterozygous state of classical galactosaemia w ith  the Duarte variant 
(Levy and Hammersen, 1978).
1.12.2 Galactokinase Deficiency Galactosaemia
A deficiency o f galactokinase results in galactosaemia since ingested 
galactose remains unphosphorylated. The only im portant c lin ica l m anifestation in 
these patients is believed to be the development o f cataracts during the f irs t  
decade of life  (Gitzelman, 1967; Beutler et al., 1973). However, mental re ta rdation 
has recently been reported in two galactokinase defic ien t brothers (Segal, Rutman 
and F rim pter, 1979). Data on the occurrence of galactokinase deficiency appear 
fragm entary; although Mayes and Guthrie (1968) found the incidence o f 
homozygosity to be in the order o f 1 in 46,000 persons a more extensive 
investigation suggests a much lower occurrence (Levy and Hammersen, 1978). The 
d ifference in the d ivers ity  and severity o f symptoms of classical and galactokinase
defic ient galactosaemia is thought to re fle c t the high tox ic ity  o f ga l-l-P  to man 
(Schwartz, 1975).
1.12.3 UDP-qal-4-epimerase Deficiency Galactosaemia
Deficiency o f UDP-gal-4-epimerase was f irs t described in human 
erythrocytes by Gitzelmann (1972). Case studies described in the lite ra tu re  suggest 
that the defect is confined to the red and white blood cells and is not associated 
w ith  any significant c lin ica l manifestation (Gitzelmann and Steinmann, 1973; 
Oyanagi et al., 1981). However, the existence of an extremely rare generalized 
form  of epimerase deficiency has been identified  in which the c lin ica l presentation 
appears indistinguishable from that o f classical galactosaemia (Garibaldi et al., 
1983). UDP-gal-4-epimerase deficiency is estimated to occur in about 1 per 40,000 
births (Gitzelmann and Steinmann, 1973).
1.13 Galactose T oxicity
The potentia lly hazardous nature of galactose and its  metabolites to man is 
thus demonstrated in c lin ica l galactosaemia. Galactose to x ic ity , pa rticu la rly  
cataract form ation, has been widely studied in animals fed a high galactose diet.
1.13.1 Galactose Induced Cataract in Animals
Galactose, glucose and xylose can a ll cause cataract in animals (Van 
Heyningen, 1959; Lerman, 1965; Bunce, 1979). Xylose is poorly absorbed and is not 
a cause o f cataract in man (Obazawa, Merola and Kinoshita, 1974). Both galactose 
and glucose have been shown to be active ly absorbed from  the in testine (Debnam,
1982), however, glucose-induced ca taract is only seen in patients w ith  diabetes 
m ellitus (Van Heyningen, 1959). Unlike blood glucose levels, blood galactose levels 
are not controlled by insulin (Roe and Schwartzmann, 1932; Banjeree and 
Divakaran, 1957) and the galactosaemia produced by galactose ingestion is dose 
related (Stenstam, 1946; W illiams et al., 1983). Galactose ca taract is the easiest of 
the experimental sugar cataracts to produce in rats and in v itro  data obtained using
lens culture techniques have shown that, in the lens, galactose is metabolised by 
aldose reductase in preference to glucose (Kinoshita et a l., 1963). The ga lactito l 
produced is not fu rther metabolised in the lens; this is unlike sorbitol which is 
produced from glucose in the lens by aldose reductase and then metabolised to 
fructose by polyol dehydrogenase (Kinoshita et al., 1963). The cataractogenic 
properties o f galactose m ight, therefore, be considered to be o f greatest potentia l 
danger in normal man.
Galactose induced cataract is readily produced in rats and has been described 
in animals fed a d ie t containing as l i t t le  as 15% of the to ta l energy intake as 
galactose (Keiding and Mellemgaard, 1972) or 30% lactose by weight (M itche ll and 
Dodge, 1935). Consumption o f a yoghurt based diet containing 22% of its  to ta l 
energy as galactose produced cataracts in rats which otherwise grew and 
reproduced normally (R ichter and Duke, 1970). However, i t  is impossible to 
extrapolate quantita tive studies in rats to man since rats have a much lower 
tolerance o f galactose and the factors a ffecting galactose metabolism d iffe r  (Cori 
and Cori, 1934; Harding et al., 1934; Newstead, 1979; W illiams and Owens, 1984). 
The rate o f galactose uptake by the ra t live r was estimated to be ha lf tha t of the 
human live r (Tygstrup, Schmidt and Thieden, 1971).
The pathogenesis o f galactose-induced cataract has been extensively 
researched in rats (Van Heyningen, 1971; Kinoshita, 1974) and a s im ilar mechanism 
is thought to operate in man. In chronic galactosaemia blood galactose enters the 
aqueous humour and then the lens of the eye by diffusion and is metabolised in the 
lens to ga lac tito l (Figure 3). Aldose reductase is the enzyme involved in this 
reaction and treatm ent w ith  sorbinil, an aldose reductase inh ib itor, has been found 
to prevent cataract development in rats fed a d ie t containing 50% galactose by 
weight (Datiles e t al., 1983; Unakar and Tsui, 1983). Studies have shown tha t 
ga lac tito l is not metabolised fu rthe r in vivo and does not readily diffuse through 
biological membranes but accumulates in the lens (Van Heyningen, 1959). High 
levels o f ga lac tito l w ith in  the lens fibres exert a strong osmotic e ffe c t and draw
water into the lens. I t  is this build up o f water which is thought to in itia te  cataract 
form ation since, i f  sustained, i t  results in a rupturing of the cells and an imbalance 
of electrolytes, amino acids, adenosine phosphates, giutathione and proteins w ith in 
the lens (Kinoshita et al., 1962; Kinoshita, 1965). This cataractogenic process in 
rats has been graded according to appearance of the lens (Sipple, 1966) and 
becomes irreversible several days before the formation o f a white opacity, i.e. 
a fte r 10-14 days on a 35% by weight galactose diet (Patterson and Patterson, 
1965). The production o f new lens fib re  has been demonstrated in rats w ith  fu lly  
developed mature cataracts subsequent to reintroduction of a chow diet; however, 
the dense nuclear opacity of the lens remained (Fournier and Patterson, 1970).
Age has been reported as being an im portant facto r in determining the 
susceptib ility to cataract form ation. Galactose cataracts are known to develop 
sooner and to mature faster in the young ra t than in the old animal (R ichter and 
Duke, 1970), possibly due to a reduction in the e lastic ity  and perm eability of the 
lens to water w ith  increasing age (P irie, 1967). Additionally, cataracts can be 
induced in ra t foetuses by feeding the pregnant animal a d ie t high in galactose, 
thus demonstrating a trans-placental transfer of galactose (Segal and Bernstein, 
1963).
1.13.2 Importance o f Galactose Induced Cataract in Man
Epidemiological investigations have shown cataract to be a major disabling 
disease in man w ith  an estimated five  to ten m illion  new cases occurring annually 
world wide (Sommer, 1977). D ietary galactose is not considered to be an im portant 
cause of cataract in man since the incidence of the major disorders o f galactose 
metabolism is low (see earlier).
I t  is of in terest tha t recently a broad corre lation has been postulated between 
the magnitude o f the im pairm ent o f galactose metabolism and the risk o f galactose 
ca taract (Winder e t al., 1982). Lesser, heterozygous deficiencies o f enzymes 
involved in the Le lo ir Pathway o f galactose metabolism m ight, therefore, incur a
moderate risk o f galactose cataract. In accordance w ith this hypothesis a high 
prevalence o f galactosaemic heterozygosity, particu larly  for galactokinase, has 
been suggested in populations w ith  idiopathic cataracts (Skalka and Prchal, 1980) 
and deficiencies of erythrocyte galactokinase ac tiv ity  in the heterozygous range 
have been described in fam ilies w ith an incidence of cataract (Schoon, 1981; 
Winder et al., 1983). In these studies a ll patients investigated had developed pre- 
senile cataracts, that is before the age of 50. No significant reduction in 
erythrocyte galactokinase a c tiv ity  was seen in patients whose cataracts developed 
la te r in life  (Beutler et al., 1973). I t  is of in terest to note that no such association 
between partia l enzyme deficiencies and risk of pre-senile cataracts was found by 
other workers (Harley et al., 1974; Maraini, Leardi and Nuzzi, 1982; Magnani e t al.,
1983). This apparent discrepancy in results may have arisen through a fa ilu re  o f red 
cell enzyme activ ities  to accurately re fle c t the capacity fo r in vivo hepatic 
galactose metabolism; only data collected from  erythrocytes is reported in the
lite ra tu re  due to the inaccessibility o f the live r fo r analysis. A lte rna tive ly , i t  may
*
be due to the presence o f d iffe ren t forms of galactokinase in the newborn and in 
the adult (Mathai and Beutler, 1967; Srivastava et al., 1972) making i t  possible fo r 
persons w ith  severe reductions in enzyme a c tiv ity  during infancy, i.e. when 
galactose consumption is greatest, to show only minor losses la te r in l i fe  (Beutler 
e t al., 1973). No clear relationship has been demonstrated between the extent o f 
im pairment o f galactose metabolism in patients w ith  partia l galactokinase 
deficiencies and the risk o f pre-senile-cataract (Winder et al., 1983). Therefore, i t  
appears tha t the association between early onset of cataracts in man and m inor, 
incomplete enzymatic disorders o f galactose metabolism is variable and may, at 
least in part, be incidental. M inor deficiencies of enzymes involved in galactose 
metabolism, again particu la rly  o f galactokinase, have also been found in mothers o f 
enzym atica lly normal children w ith  congenital cataracts, thus suggesting an jn  
utero e ffe c t (Harley et al., 1974).
Other factors predisposing to cataract have been reviewed by Simoons (1982). 
He postulated a geographic link between m ilk consumption and senile cataract and 
described a high incidence of senile cataract in some populations who consumed 
large quantities of m ilk and lactose-rich foods and who had a high frequency of 
persistent lactase a c tiv ity  in adult life . Conversely, a low incidence of senile 
cataract was reported in populations who consumed a lactose-low or lactose-free 
diet a fte r weaning and who were fu rther protected from  galactose absorption by a 
low adult intestinal lactase a c tiv ity  (Simoons, 1982). Such an association between 
lactose absorption and cataract is fu rther suggested by the recent study of Rinaldi 
et al. (1984) in which 49-55% of adult Neopolitans w ith  idiopathic senile or pre- 
senile cataract were identified as lactose absorbers whereas only 16% of cataract 
free adults in the same area were found to absorb lactose.
An interrelationship between riboflav in  deficiency and galactose cataract has 
been postulated. In India, where cataract is a major epidemiological problem, 
abnormally elevated serum galactose concentrations have been described in 7 out 
o f 15 cataract patients 90 and 120 minutes a fte r ingestion of a 40g galactose load 
(Bhat and Gopalan, 1974). R iboflavin status was found to be poor in these patients 
as indicated by a s ign ificantly reduced erythrocyte glutathione reductase (EGR) 
a c tiv ity . However, although daily supplementation w ith  10 mg o f ribo flav in  
increased the EGR levels in riboflav in  defic ien t subjects no change was seen in 
the ir tolerance of peroral galactose (Bhat, 1974). Galactose-induced ca taract has 
been shown to develop faster in ribo flav in -de fic ien t rats (Srivistava and Beutler, 
1970). Since the reduced form  o f nicotinamide adenine dinucleotide phosphate 
(NADPH) is a cofactor fo r both glutathione reductase and aldose reductase i t  is 
believed that a deficiency o f ribo flav in  may increase the susceptib ility to  galactose 
cataract by fa c ilita tin g  the form ation o f ga lac tito l via a greater ava ila b ility  o f 
NADPH fo r the aldose reductase reaction (Srivastava and Beutler, 1972).
I t, therefore, seems possible tha t galactose-induced ca taract may be more 
prevalent in man than is suggested by the incidence of the c lin ica lly  recognised
forms of galactosaemia and that the involvement of dietary galactose in the 
development of idiopathic pre-senile and/or senile cataract may be under 
estimated. A heterozygous deficiency of galactokinase, i f  incurring a greater risk 
of galactose cataract form ation in an individual, would be of greater c lin ica l 
importance than the homozygous deficiency due to its higher incidence. Estimates 
have suggested the incidence o f heterozygous galactokinase deficiency to be in the 
order of 1 in 310 births (Tedesco et al., 1975; Magnani et al., 1982).
1.13.3 Other Aspects of Galactose Toxic ity
In addition to cataract development foetuses of rats fed a d iet containing 
40% galactose by weight during pregnancy showed pathological lesions of the live r 
and kidney (Spatz and Segal, 1965), growth retardation, a reduction in the number 
o f brain cells and accumulation of ga l-l-P  in brain tissue (Haworth, Ford and 
Younoszai, 1969); thus suggesting a transplacental galactose to x ic ity . The growth 
retardation was reversible and both body weight and brain cell number returned to 
normal fo llow ing in troduction o f a galactose free diet (Haworth et al., 1969). A 
high m orta lity  rate has frequently been reported when weanling rats are fed a d ie t 
containing 40% or more galactose by weight (Handler, 1947; Kuroda, 1971).
Consumption o f a high galactose d ie t by chicks resulted in a severe 
neuro toxic ity syndrome which was characterized by the onset of convulsions w ith in
2-3 days (Kozak, 1971; Knull and Wells, 1973) and which may be an exaggeration o f 
the mental re tardation seen in untreated human c lin ica lly  galactosaemic patients 
(Wells and Segal, 1969). However, the chick must be considered a poor animal 
model fo r demonstrating galactose to x ic ity  because, as a non-mammal, i t  would 
not naturally encounter galactose. The neurotoxic e ffe c t o f d ie tary galactose in 
chicks has been shown to be rapidly a lleviated by glucose adm in istration and an 
inh ib ition o f glucose transport across the blood-brain barrier is thought to be 
involved in the to x ic ity  (Knull and Wells, 1973). Recently a com petition between 
galactose and glucose fo r in flux into the brain via a shared transport ca rrie r has 
been established in the ra t; such an exclusion o f glucose from  the brain by
galactose may be an aetio logical facto r in the mental retardation o f classical 
galactosaemia (Daniel, Love and P ra tt, 1980). G alactito l accumulation in the brain 
may also be involved (Wells and Wells, 1967; Wells and Segal, 1969).
Hypergonadotrophic hypogonadism is another manifestation o f galactose 
to x ic ity  recently observed in c lin ica lly  galactosaemic women (Kaufman et al., 
1979; Kaufman et al., 1981). Although successful pregnancies have been reported 
(Roe et al., 1971; Tedesco, Morrow and Mellman, 1972), Kaufman et al. (1981) 
described ovarian fa ilure due to acquired ovarian atrophy in 12 out of 18 female 
patients presenting w ith  ga l-l-P  uridyltransferase deficiency galactosaemia. 
Prenatal exposure to galactose via the placenta and the endogenous production of 
ga l-l-P  during foeta l development and early childhood are thought to produce this 
e ffe c t (Chen et al., 1981). In contrast testicu lar insufficiency is rare ly seen in 
human c lin ica l galactosaemia and male progeny o f rats fed a 50% galactose d ie t by 
weight during pregnancy and lactation showed no testicu lar abnormality (Chen et 
al., 1984).
1.14 Conclusions
As the use o f lactose hydrolysate syrup in food manufacture becomes more 
widespread an increase in the per capita galactose consumption seems like ly . The 
metabolic e ffects apparent w ith in  hours a fte r the ingestion of a single galactose 
test meal are reported in the lite ra tu re . However, there have been few studies 
undertaken to investigate the chronic metabolic e ffects o f an increased 
consumption o f d ietary galactose in normal man. Elevated fasting serum 
trig lyceride  levels can be correlated w ith  the incidence of atherosclerotic coronary 
heart disease (Crowley, 1971; Carlson and Bottiger, 1972) and are seen in man 
fo llow ing an increased consumption o f d ietary carbohydrate (Antonis and Bersohn, 
1961). The possibility that an increased intake o f galactose as lactose hydrolysate 
syrup influences fasting serum trig lycerides must be investigated.
In addition, the study of galactose cataract and disorders o f galactose 
metabolism illus tra te  the potentia lly toxic effects of excess galactose to man. A 
greater knowledge of the chronic metabolic effects produced in man by an 
increased ingestion o f galactose as lactose hydrolysate syrup and of factors 
influencing the acute and chronic metabolic response to galactose in an individual, 
therefore, seems pertinent.
Since galactose is present in human m ilk i t  is essentially a monosaccharide of 
greater physiological significance in the female and an e ffe c t of female sex 
hormones on galactose tolerance is possible. Previous studies, although "crude", 
suggest that there is a sex difference in the tolerance o f peroral galactose (Rowe, 
1924; Stenstam, 1946) and that peroral galactose tolerance varies over the 
menstrual cycle (Rowe, 1935). An investigation of the influence of the sex of the 
consumer and the menstrual cycle on the acute metabolic response to a peroral 
galactose load would be o f in terest.
Using a suitable animal model i t  would be possible to investigate in greater 
deta il the chronic metabolic and tox ic e ffects  o f galactose that occur in man. 
Factors influencing the acute metabolic response to peroral galactose could also be 
investigated fu rther. Although the ra t has been a widely used animal in which to 
study galactose to x ic ity  i t  must be considered a poor model fo r extrapolation to 
man. I t  seems like ly  that the guinea-pig would be a be tte r animal model, however, 
increased data on the rate of hepatic galactose uptake and metabolism and on the 
susceptib ility to galactose induced cataract are needed in this species.
15 Aims of Studies
The aims of this work were, therefore, as follows:
To investigate some of the chronic metabolic effects produced in man by an 
increased consumption of galactose as lactose hydrolysate syrup.
To investigate the influence of the sex of the consumer and the menstrual 
cycle on the acute metabolic response to a peroral galactose load.
To investigate some of the chronic metabolic e ffects of d ietary galactose 
seen in rats and guinea-pigs.
CHAPTER 2 
METHODS AND PROCEDURES
2.1 Sample Collection
2.1.1 Serum
Blood samples of 8-10 ml were taken by venepuncture from  the antecubital 
vein. Samples were collected into unheparinized, sterile  blood tubes and allowed to 
stand fo r 15 minutes un til a firm  c lo t had formed. The clo t was then loosened and 
the sample spun fo r 15 minutes at 3000 rpm. The serum was removed and prepared 
for analysis as specified in the method. Prepared samples were stored in 
autoanalyser cups at -20°C.
2.1.2 Plasma
Blood samples were taken by cardiac puncture of the anaethetised animal. 
D iethyle ther (May and Baker cat. no. L-729) was used as the anaesthetic. Samples 
were collected into heparinized, sterile  blood tubes and gently mixed on a ro ta ry  
m ixer to prevent c lo tting . Samples were then spun fo r 15 minutes at 3000 rpm. The 
plasma was removed and prepared fo r analysis as specified in the method. Prepared 
samples were stored in autoanalyser cups at -20°C.
2.1.3 Red Blood Cells (RBC)
Blood samples were taken and spun as fo r plasma collection. The RBC 
remaining a fte r removal of the plasma were washed tw ice w ith an equal volume of 
ice cold, physiological saline solution (0.9% w/v). In between washings RBC and 
saline were mixed by inverting the tube. The sample was then spun fo r 15 minutes 
at 3000 rpm and the washings discarded. The washed RBC were removed and 
stored in autoanalyser cups at -80°C. RBC were haemolysed by thawing on the day 
o f assay.
2.1.4 Urine
Urine samples from  both human and animal studies were collected in to  s te rile  
containers. The volume was measured and aliquots stored in autoanalyser cups a t -
20°C. For 24 hour urine collections animals were housed individually in metabolic 
cages; access to food was prevented although water was provided ad lib itum .
2.1.5 Faeces
Complete 24 hour faecal samples were collected from  animals housed 
individually in metabolic cages as fo r 24 hour urine collections. Samples were 
stored in sealed 8-vials at -20°C.
2.1.6 L iver
Animals were k illed by cervical fracture. Livers were rapidly removed and 
samples prepared for analysis as specified in the method. Prepared samples were 
stored in 8-vials at -80°C.
2.2 Galactose Assay
2.2.1 Serum and Plasma Galactose
Galactose was assyed using a Cobas Bio Centrifugal Autoanaylser (Roche 
Diagnostica).
The assay method used was that of Wallenfels and Kurz (1961) as m odified by 
Rommel et al. (1968). Galactose dehydrogenase catalyses the oxidation o f 
galactose by NAD+ to galactonolactone.
D-galactose + NAD+ ------------------------------>  galactonolactone + NADH + H+
Galactose
dehydrogenase
The amount o f NADH so formed is sto ic iom etric  w ith  the amount o f galactose 
present and is measured spectrophotom etrically at 340 nm.
Sample Preparation:
An 0.2 ml aliquot of serum or plasma was deproteinized by addition o f 1.0 ml 
o f perchloric acid (0.33M). The sample was vortex mixed and centrifuged fo r 5 
minutes at 4000 rpm. The supernatant was removed and stored at -20°C fo r up to 8 
weeks before analysis. Prelim inary investigations showed that there was no loss o f 
galactose concentration in prepared serum samples stored at -20°C fo r up to 8 
weeks.
Standard Preparation:
A stock solution of lg /lOO m l o f d istilled  water was prepared. The galactose 
used was anhydrous D-galactose (Sigma cat. no. G-0750). A liquots were diluted 
w ith  distiled water to give standards of 0.15, 2.50 and 5.00 m m ol/L. In accordance 
w ith  the sample d ilution during preparation a d ilution facto r o f 6 was included in 
the preparation o f the standards. Standards were stored at 4°C fo r up to 5 days.
Reagent Preparation:
1. NAD+ solution: A 13mmol/L NAD+ solution was prepared by dissolving
1.38mg of NAD+ (Boehringer Mannheim cat. no. 127329) in 0.16ml of 
red istilled  water. The solution was stored at 4°C fo r up to 4 weeks.
2. Galactose dehydrogenase solution: Galactose dehydrogenase (^  20 u /m l) was 
obtained from  Boehringer Mannheim (cat. no. 104981).
Procedure:
An 0.16ml volume o f NAD+ solution was diluted w ith  4.80ml o f phosphate 
bu ffe r (0.2mol/L, pH = 7.5) and used as the main reagent on the Cobas Bio system. 
An 0.10ml volume of galactose dehydrogenase solution was diluted w ith  0.90ml o f 
phosphate bu ffe r (0.2mol/L, pH = 7.5) and used as the s ta rt reagent.
The Cobas Bio centrifugal autoanalyser was programmed fo r galactose 
analysis as follows:
1. Units
2. Calculation facto r
3. Standard 1 cone
4. Standard 2 cone
5. Standard 3 cone
6. L im it
7. Temperature (deg.C)
8. Type of analysis
9. Wavelength (nm)
10. Sample volume (y l)
11. D iluent volume (y l)
12. Reagent volume (y l)
13. Incubation time (sec)
14. S tart reagent volume (y l)
15. Time of f irs t reading (sec)
16. Time in terva l (sec)
17. Number of readings
18. Blanking mode
19. P rin tou t mode
mmol/L
0
0.15
2.5
5.0 
10
25.0 
6
340
10
20
155
10
10
1.0 
60 
10 
1 
1
A ll samples were assayed in duplicate.
The reproducib ility  o f the method was assessed by calculating the in te r and 
in tra  assay coe ffic ien t o f variation (CV):
in te r assay CV = 4.24% (n = 6) 
in tra  assay CV = 2.63% (n = 12)
2.2.2 Urine Galactose
The assay method used was as fo r serum and plasma galactose w ith  the 
fo llow ing m odifications. Urine samples were diluted 1:10 w ith  red is tilled  w ater on 
the day o f assay. Standards were prepared to include a d ilu tion fa c to r o f 10. A ll 
samples were assayed in duplicate.
The reproducib ility  o f the method was assessed by calculating the in te r and 
in tra  assay coe ffic ien t o f varia tion (CV):
in te r assay CV = 1.18% (n = 6) 
in tra  assay CV = 0.76% (n = 12)
2.2.3 Faecal Galactose
Faecal samples were prepared fo r analysis on the day of assay according to 
the method of K ra ffczyk, Helger and Bremmer (1972). The supernatant was assayed 
fo r galactose using the method described fo r serum and plasma analysis. No 
d ilution facto r was included during preparation of the standards. A ll samples were 
assayed in duplicate.
2.3 Glucose Assay
Serum or plasma glucose was assayed using a Cobas Bio C entrifuga l 
Autoanalyser (Roche Diagnostica).
The assay method used was tha t o f Werner, Rey and Wielinger (1970). 
Glucose oxidase catalyses the oxidation o f glucose to gluconate and hydrogen 
peroxide. In the presence o f peroxidase the hydrogen peroxide reacts w ith  the 
chromogen ammonium 2,2'-azino-bis-13 ethylbenzothiazoline-6-sulphate to  produce 
a green colour complex. The in tensity o f colour is proportional to the glucose 
concentration and is measured spectrophotom etrically at 610 nm.
Sample Preparation;
An 0.5ml aliquot of serum or plasma was deproteinized by addition o f 0.5ml 
o f perchloric acid (1.0M). The sample was vortex mixed and centrifuged fo r 5 
minutes at 4000 rpm. An 0.5ml aliquot of the supernatant was then neutralized by 
addition o f 0.1ml o f potassium carbonate solution (1.25M). The sample was again 
vortex mixed and centrifuged fo r 5 minutes a t 4000 rpm. The supernatant was 
removed and stored at -20°C fo r up to 8 weeks.
Standard Preparation:
A stock solution o f lg /lO O m l of d is tilled  water was prepared and stored a t 
4°C fo r 24 hours p rio r to use. The glucose used was anhydrous D-glucose (BDH cat.
no. 10117). A liquots were diluted w ith  d istilled water to give standards of 3, 6 and 
9mmol/L. In accordance w ith the sample d ilution during preparation a d ilution 
fac to r of 2.4 was included in the preparation of standards. Standards were stored at 
4°C for up to 5 days.
Reagent Preparation:
The GOD/PERID reagent was made up using the solution of a Boehringer 
Mannheim Glucose test k it  (cat. no. 124028) according to k it instructions.
Procedure:
The assay was carried out according to k it  instructions as modified fo r the 
Cobas Bio system. The GOD/PERID reagent was used as the main reagent. The 
Cobas Bio C entrifugal Autoanalyser was programmed fo r glucose analysis as 
follows:
1. Units m mol/L
2. Calculation facto r 0
3. Standard 1 cone 3.0
4. Standard 2 cone 6.0
5. Standard 3 cone 9.0
6. L im it 10
7. Temperature (deg.C) 37.0
8. Type of analysis 1
9. Wavelength (nm) 610
10. Sample volume (y l) 20
11. D iluent volume (y l) 10
12. Reagent volume (y l) 120
13. Incubation tim e (sec) 0
14. S tart reagent volume (y l) 0
15. Time of f irs t  reading (sec) 900
16. Time in terva l (sec) 10
17. Number o f readings 10
18. Blanking mode 1
19. P rin tou t mode 1
A ll samples were assayed in duplicate.
The reproducib ility of the method was assessed by calculating the in ter and 
in tra  assay coe ffic ien t o f variation (CV):
in ter assay CV = 0.89% (n = 6) 
in tra assay CV = 1.11% (n = 12)
Precinorm U quality control sera (Boehringer Mannheim cat. no. 171735) was 
assayed w ith  each run and was always w ith in the expected range.
2.4 Insulin Assay
Serum insulin was assayed using a radioimmunoassay technique involving a 
double antibody system.
The assay method used was that of Morgan and Lazarow (1963) as adapted by
the University o f Surrey C lin ica l Biochemistry Department (personal
communication). The method involves the com petitive binding o f serum insulin and 
125I-insulin to specific binding sites on the antibodies o f a guinea-pig anti-insulin
antiserum. Bound insulin is precip itated by the use of a second antisera containing
125antibodies to guinea-pig globulins. Bound I-insulin is inversely proportional to 
the serum insulin concentration and is measured by counting in a gamma counter 
(Multigamma 11. LKB).
Standard Preparation:
Standards o f 0-200mu/L were prepared from  a stock solution o f 200mu/L 
(National Institu te  o f B iological Standards and Controls, MRC Standard cat. no. 
66/304). Standards were diluted w ith  charcoal stripped sera on the day o f assay. 
Charcoal stripped sera was used as the zero standard.
Reagent Preparation:
1. Phosphate buffer diluent: 0.5g of Bovine Serum Albumin (Sigma cat. no. A - 
7888) was dissolved in 100ml o f phosphate buffer (0.04M, pH 7.4) and stored 
at 4°C fo r up to 2 weeks.
2. A n ti-insu lin  antiserum (Guildhay Antisera cat. no. MF/GP/9-V11A): 
Antiserum was diluted 1:100 w ith phosphate buffer (0.04M, pH 7.4) and a 
fu rther 1:200 w ith  prediluted normal guinea-pig serum. Normal guinea-pig 
serum was diluted 1:800 w ith phosphate buffer diluent prior to use. A n ti­
insulin antiserum was prepared on the day of assay.
125 1253. I-insulin (Radiochemical Centre, Amersham, cat. no. IM38): I-insulin
was diluted 1:80 w ith  phosphate buffer diluent on the day o f assay.
4. Anti-guinea-pig antiserum (Guildhay Antisera cat. no. HP/D/4/PE): 
Antiserum was diluted 1:16 w ith  buffer diluent on the day o f assay.
5. Polyethylene glycol 6000 (BDH cat no. 29577): A 4% w /v solution was 
prepared using phosphate buffer (0.04M, pH 7.4) and stored at 4°C fo r up to 1 
month.
6. Charcoal stripped serum: 20g o f no rit A charcoal was added to a 100ml serum 
pool and stirred fo r 24 hours. The m ixture was then centrifuged fo r 15 
minutes at 4000 rpm. The supernatant was filte red  through a seitz f i l te r  and 
aliquots stored in sealed, s terile  serum pots at -20°C. Each batch was 
checked before use to show i t  was insulin free.
Procedure:
The assay was carried out as follows:
Tube Buffer A n ti­ Sample 125i . Poly­ A n ti-
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A ll samples were assayed in duplicate.
The reproducib ility  o f the method was assessed by calculating the in te r and 
in tra  assay coe ffic ien t of variation (CV):
in te r assay CV = 4.70% (n = 6)
in tra  assay CV = 6.35% (n = 12)
Three serum samples of low, medium and high insulin concentration were 
used as quality controls. Serum at each concentration range was stored at -20°C in 
500 y l aliquots and analysed w ith each sample run. A t each concentration range 
values were always w ith in  + 2 standard deviations of the previously determined 
values.
2.5 Triglyceride Assay
Serum trig lycerides were assayed using a Cobas Bio C entrifugal Autoanalyser 
(Roche Diagnostica). The assay method used was that of Eggstein and Kreutz (1966) 
as modified by Bucolo and David (1973). Triglycerides are enzym ically hydrolyzed 
to glycerol and fa tty  acids w ith  a m ixture o f lipase and ci-chymotrypsin. The 
resulting free glycerol is then determined enzym ically by the fo llow ing series of 
reactions:
G lycerol + ATP --------------------------->  G lycerol-l-Phosphate + ADP
glycerol kinase
ADP + Phosphoenolpyruvate ----------------------------->  ATP + Pyruvate
pyruvate kinase
Pyruvate + NADH + H+ — —------- ~ -■ - •— — -->  Lactate + NAD+
lactate dehydrogenase
The decrease in NADH is proportional to the concentration o f trig lyce ride  and is 
measured spectrophotom etrically as a decrease in absorbance at 340 nm.
Reagent Preparation:
The reagents were made up using the solutions o f a Roche Diagnostica 
trig lyceride  rapid test k it  (cat. no. 0710865) according to  k it  instructions.
Procedure:
The assay was carried out according to k it instructions fo r the Cobas Bio 
system. A ll samples were assayed in duplicate.
The reproducib ility  of the method was assessed by calculating the in te r and 
in tra assay coe ffic ien t o f variation (CV):
in ter assay CV = 2.13% (n = 8)
in tra assay CV = 2.25% (n = 12)
P recilip  quality control sera (Boehringer Mannheim cat. no. 125059) was 
assayed w ith  each run and was always w ith in the expected range.
2.6 Cholesterol Assay
Serum cholesterol was assayed using a Cobas Bio C entrifugal Autoanalyser 
(Roche Diagnostica). The assay method used was tha t o f Richmond (1973) as 
modified by Harders and Helger (1977). Free cholesterol and cholesterol liberated
4
from its  esters by enzymic hydrolysis is oxidised to A -cholesten-3-on and hydrogen 
peroxide. Cholesterol oxidase catalyses the reaction. The hydrogen peroxide then 
transforms iodide to iodine in the presence o f molybdate. The amount o f iodine 
formed is proportional to the to ta l cholesterol concentration and is measured 
spectrophotom etrically a t 365nm.
Standard Preparation:
P recilip  quality contro l sera (Boehringer Mannheim cat. no. 125059) was used 
as the standards.
Reagent Preparation:
The reagents were as supplied in a Roche Diagnostica cholesterol test k it  
(cat. no. 0710687) and were ready fo r use.
Procedure:
The assay was carried out according to k it  instructions fo r the Cobas Bio 
system. A ll samples were assayed in duplicate.
The reproducib ility  o f the method was assessed by calculating the in ter and 
in tra  assay coe ffic ien t o f variation (CV):
in te r assay CV = 1.03% (n = 12)
in tra  assay CV = 1.88% (n = 15)
P recilip  quality control sera (Boehringer Mannheim cat. no. 125059) was 
assayed w ith  each run and was always w ith in  the expected range.
2.7 Albumin Assay
Serum and plasma albumin was assayed using a Cobas Bio C entrifugal 
Autoanalyser (Roche Diagnostica). The assay method used was tha t o f Dow and 
Pinto (1969) as modified* by Schirardin and Ney (1972). In aqueous solution w ith  
bromocresol green albumin produces a colour change which is measured 
spectrophotom etrically at 620nm.
Standard Preparation:
Precinorm U quality control sera (Boehringer Mannheim cat. no. 171735) was 
used for the standards.
Reagent Preparation:
The reagent was as supplied in a Roche Diagnostica albumin test k it  (cat. no. 
0714119) and was ready fo r use.
Procedure:
The assay was carried out according to k it  instructions fo r the Cobas Bio 
system. A ll samples were assayed in duplicate.
The reproducib ility  of the method was assessed by calculating the in te r and 
in tra assay coe ffic ien t o f variation (CV):
inter assay CV = 1.29% (n = 12)
in tra assay CV = 1.67% (n = 12)
Precinorm U quality control sera (Boehringer Mannheim cat. no. 171735) was 
assayed w ith each run and was always w ith in the expected range.
2.8 Alkaline Phosphatase Assay
Serum alkaline phosphatase was assayed using a Cobas Bio C entrifugal 
Autoanalyser (Roche Diagnostica). The assay method used was tha t recommended 
by the German Society fo r C lin ica l Chemistry (1972). A lkaline phosphatase 
catalyses the hydrolysis o f p-nitrophenylphosphate to p-nitrophenol and phosphoric 
acid. The amount o f p-nitrophenol formed is proportional to the phosphatase 
a c tiv ity  and is measured spectrophotom etrically at 405 nm.
Reagent Preparation:
The reagents were made up using the solutions of a Roche Diagnostica 
alkaline phosphatase test k it  (cat no. 0713171) according to k it instructions.
Procedure:
The assay was carried out according to k it  instructions fo r the Cobas Bio 
system. A ll samples were assayed in duplicate.
The reproducib ility  o f the method was assessed by calculating the in te r and 
in tra assay coe ffic ien t o f varia tion (CV):
in te r assay CV = 3.92% (n = 8)
in tra  assay CV = 3.37% (n = 12)
Precinorm U quality control sera (Boehringer Mannheim cat. no. 171735) was 
assayed w ith  each run and was always w ith in the expected range.
2.9 Aspartate Amino Transferase (GOT) Assay
Serum GOT was assayed using a Cobas Bio Centrifugal Autoanalyser (Roche 
Diagnostica). The assay method used was that recommended by the German 
Society o f C lin ica l Chemistry (1972). GOT catalyses the reaction o f L-aspartate 
w ith  2-oxoglutarate to form  oxaloacetate plus L-glutam ate. The oxaloacetate so 
formed is then reduced by NADH to form  L-m alate and NAD+. Malate 
dehydrogenase is used as a catalyst. The decrease in NADH is proportional to the
concentration of GOT and is measured by recording spectrophotom etrically the
decrease in absorbance at 340nm.
Reagent Preparation:
The reagents were made up using the solutions of a Roche Diagnostica GOT 
test k it  (cat. no. 0714410) according to k it  instructions.
Procedure:
The assay was carried out according to k it  instructions fo r the Cobas Bio 
system. A ll samples were assayed in duplicate.
The reproducib ility  o f the method was assayed by calculating the in te r and 
in tra  assay coe ffic ien t o f varia tion (CV):
in te r assay CV = 3.62% (n = 6)
in tra  assay CV = 0.59% (n = 12)
Precinorm  U quality contro l sera (Boehringer Mannheim cat. no. 171735) was 
assayed w ith  each run and was always w ith in  the expected range.
2.10 Bilirubin Assay
Serum b ilirub in was assayed using a Cobas Bio Centrifugal Autoanalyser 
(Roche Diagnostica).
The assay method used was that of Jendrassik and Grof (1938). B ilirub in  
reacts w ith  4-sulphobenzenediazonium chloride to form  the red azo-dye, 
azobilirubin, which is measured spectrophotom etrically at 546nm.
Reagent Preparation:
The reagents were made up using the solutions of a Roche Diagnostica 
b ilirub in test k it  (cat. no. 0710032) according to k it instructions.
Procedure:
The assay was carried out according to k it  instructions fo r to ta l b ilirub in  
determ ination on the Cobas Bio system. A ll samples were assayed in duplicate.
The reproducib ility  o f the method was assessed by calculating the in te r and 
in tra  assay coe ffic ien t of varia tion (CV):
in te r assay CV = 2.43% (n = 12)
in tra  assay CV = 2.70% (n = 12)
P recilip  qua lity contro l sera (Boehringer Mannheim cat. no. 125059) was 
assayed w ith  each run and was always w ith in  the expected range.
2.11 y-Glutamyl Transferase (y-GT) Assay
Serum y-G T was assayed using a Cobas Bio C entrifuga l Autoanalyser (Roche 
Diagnostica). The assay method used was tha t o f Szasz (1969). Y-GT catalyses the 
transfer o f the glutam yl group o f y -g lu tam y l-p -n itran ilide  to g lycylg lycine. The p- 
n itran ilide  so produced is proportional to the transferase a c tiv ity  and is measured
spectrophotom etrically at 405nm.
Reagent Preparation:
The reagents were made up using the solutions of a Roche Diagnostica y-GT 
test k it  (cat. no. 0713147) according to k it instructions.
Procedure:
The assay was carried out according to k it  instructions fo r the Cobas Bio 
system. A ll samples were assayed in duplicate.
The reproducib ility  of the method was assessed by calculating the in te r and 
in tra  assay coe ffic ien t o f variation (CV):
in te r assay CV = 1.74% (n = 8)
in tra  assay CV = 1.29% (n = 12)
Precinorm U quality control sera (Boehringer Mannheim cat. no. 171735) was 
assayed w ith  each run and was always w ith in  the expected range.
2.12 Creatinine Assay
Urine creatinine was assayed using a Cobas Bio C entrifuga l Autoanalyser 
(Roche Diagnostica). The assay method used was tha t o f Bartels and Bohmer (1971) 
and u tilizes the Ja ffe  reaction. In an alkaline medium creatin ine form s a yellow - 
red colour complex w ith  p icric  acid and is measured spectrophotom etrically at 
500nm.
Reagent Preparation:
The reagents were made up using the solutions o f Boehringer Mannheim 
creatin ine test k it  (cat. no. 124192) according to k it  instructions.
Procedure:
The assay was carried out according to k it  instructions fo r the Cobas Bio 
system. A ll samples were assayed in duplicate.
The reproducib ility  of the method was assessed by calculating the in te r and 
in tra  assay coe ffic ien t o f variation (CV):
in te r assay CV = 2.87% (n = 8)
in tra  assay CV = 2.82% (n = 12)
Precinorm U quality control sera (Boehringer Mannheim cat. no. 171735) was 
assayed w ith  each run and was always w ith in the expected range.
2.13 Paracetamol Assay
Serum paracetamol was assayed using a Cobas Bio Centrifugal Autoanalyser 
(Roche Diagnostica). The assay method used was tha t o f Price, Hammond and 
Scawen (1983). Paracetamol (acetaminophen) is hydrolysed to acetate and p- 
aminophenol by aryl-acyi-am ide aminohydrolase. The p-aminophenol is then 
coupled w ith  0-cresol in the presence of ammonia and copper ions to form  a blue 
indophenol dye which is measured spectrophotom etrically at 615nm,
Reagent Preparation:
The reagents were made up using the solutions of a Cambridge L ife  Sciences 
paracetamol test k it  (cat. no. 10020C) according to k it  instructions.
Procedure:
The assay was adapted fo r use on the Cobas Bio system as described by 
H a llw orth (1983) w ith  the fo llow ing m odifications. Standards o f 12.5, 25 and 250 
lim o l/L  were prepared from  the stock paracetamol solution of 2m m ol/L and the 
assay lim it  was set at 1000ijm ol/L. A 12yl aliquot o f serum or standard was 
diluted w ith  lO y l o f d is tilled  water diluent during the analysis. A ll samples were 
assayed in duplicate.
The reproducib ility  o f the method was assessed by calculating the in te r and 
in tra  assay coe ffic ien t o f varia tion (CV):
in te r assay CV = 2.61% (n = 23)
in tra  assay CV = 0.57% (n = 10)
Three serum samples of low, medium and high paracetamol concentration 
were stored in 200 y l aliquots at -20°C and used as quality controls. An aliquot of 
each serum concentration was assayed w ith each sample run; values were always 
w ith in  + 2 standard deviations o f the previously determined value.
2.14 17 6-oestradiol Assay
Serum 178-oestradiol was assayed using a radioimmunoassay technique 
involving a double antibody system.
The assay method used involves the com petitive binding o f serum oestradiol 
125and I-oestradiol to specific binding sites on the antibodies o f an anti-oestradio l
antiserum. Bound oestradiol is then precip itated by use of a solid-phase second 
125antibody. Bound I-oestradiol is inversely proportional to the serum oestradiol 
concentration and is counted in a gamma counter (Multigamma ll.L K B ) .
Reagent Preparation:
125The reagents were made up using the solutions of a Steranti Research I- 
oestradiol d irec t test k it  (cat. no. ER-155) according to k it  instructions.
Procedure:
The assay was carried out according to k it  instructions. A ll samples were 
assayed in duplicate.
The reproducib ility  o f the method was assessed by calculating the in tra  assay 
coe ffic ien t o f varia tion (CV):
in tra  assay CV = 4.8% (n = 20)
A ll samples were assayed on the same day. Calculation o f the in te r assay CV 
was, therefore, not performed.
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2.15 Progesterone Assay
Serum progesterone was assayed using an enzyme-linked immunosorbent 
assay (ELISA) technique. The assay method used was developed by the University of 
Surrey C lin ica l Biochemistry Department (personal communication) and involves 
the adsorption o f antibodies o f an anti-progesterone antiserum onto a solid phase. 
Unlabelled serum progesterone and enzyme labelled progesterone compete fo r 
binding to the antibodies. The serum progesterone concentration is then determined 
by the addition of a chromogenic substrate fo r the enzyme. The colour form ation is 
inversely proportional to the serum progesterone concentration and is measured 
spectrophotom etrically at 405nm using a Dynatech MR580 microelisa auto reader 
(Dynatech Ltd).
Standard Preparation
Standards of 0-50 ng/m l were prepared from  a stock solution o f lg  o f 
progesterone (Sigma cat. no. P-0130) in 1ml o f absolute ethanol. Standards were 
diluted w ith  charcoal stripped sera on the day o f assay. Charcoal stripped sera was 
used as the zero standard.
Reagent Preparation:
A ll reagents were prepared on the day of assay.
1. Anti-progesterone antiserum (Guildhay Antisera cat. no. HP/S/645 IVD):
Freeze-dried antiserum was stored at room temperature un til used and was 
reconstituted to a fina l d ilu tion o f 1 in 20,000 w ith  sodium acetate (0.15mM, 
pH 9.0) as required.
2. PAS-gel bu ffe r (0.1M): l.Og of gelatin (BDH cat. no. 44045) was dissolved in
900ml o f red istilled  water, cooled and added to  100ml o f phosphate bu ffe r
(1.0M, pH 7.0).
3. Conjugate: A lkaline phosphatase-labelled progesterone was used as the 
conjugate and was obtained as a g if t  from  M.J. Sauer and J.A. Foulkes 
(M inistry of Agricu lture, Fisheries and Food, Reading).
I t  was prepared according to the method of Sauer et al. (1986) and stored at a 
d ilu tion of 28.5yg/200yl of PAS-gel bu ffe r (0.1M) at 4°C for up to 1 month. It  
was fu rther diluted 1 in 4,000 w ith  PAS-gel buffer (0.1M) for use.
4. Substrate buffer (1M, pH 9.8): lOOg of diethanolamine (Sigma cat. no. D-8885) 
was dissolved in 1 litre  o f red istilled water and the pH adjusted. Magnesium 
chloride was then added to a concentration of 0.1016g/L (0.5mM).
5. Substrate solution: p-nitrophenyl phosphate (Sigma cat. no. 104-0) was used as 
the enzyme substrate and was dissolved in substrate buffer at 140mg/25ml.
6. Charcoal stripped sera: this was prepared as fo r the insulin assay (chapter 2, 
section 3).
Procedure:
P rio r to the assay polyvinyl m ic ro titre  plates (Dynatech Laboratories cat. no. 
M29) were washed w ith  2.3% v/v Decon 90, 1% v/v HC1, three changes o f tap w ater 
and three changes of red istilled  water respectively. A fte r  drying 200 y l o f d iluted 
antiserum was added to each well and the plates le f t  fo r 8 hours a t room 
temperature. The plates were then emptied and the wells filled  w ith  200yl o f PAS- 
gel bu ffe r before storing at 4°C  overnight.
The assay was carried out as follows:
Well
Sample PAS-gel Conjugate 
y l buffer y l
y l
Substrate
solution
yl
Standard
*NSB
10 200 
(zero 
stand)
200
Vu
ro
0.39-50
standards
Test
Zero
standard
10
10
10
*NSB= non specific binding
A ll samples were assayed in duplicate
The reproducib ility  o f the method was assessed by calculating in te r and in tra  
assay coe ffic ien t o f variation (CV):
in te r assay (between plate) CV = 10.38% (n = 4)
in tra  assay (w ith in  plate) CV = 6.54% (n = 6)
Three serum samples of low, medium and high progesterone concentration 
were used as qua lity controls. Serum at each concentration range was stored a t - 
20°C in 200 y l aliquots and an aliquot o f each was analysed w ith  each sample run. 
A t each concentration range values were always w ith in  + 2 standard deviations of 
the previously determined value.
2.16 Sodium and Potassium Assay
Plasma and urine were assayed fo r sodium and potassium using a Nova 1. 
Na/K  analyser (Nova Biomedicals). The assay method used involves the 
development o f a voltage across a sodium or potassium electrode in response to
changes in sodium or potassium concentrations in plasma and urine. A chloride 
electrode is included in the system as a reference electrode to complete the 
e lectrica l c ircu it. The voltage produced is logarithm ically proportional to the 
sample e lectro ly te  concentration and is measured, am plified, d ig ita lized and 
presented to a m icrocomputer fo r translation into sodium and potassium 
concentration.
Procedure:
The assay was carried out according to instructions fo r the Nova 1. Na/K 
analyser system. A ll samples were assayed in duplicate.
The reproducib ility  o f the method was assessed by calculating the in te r and 
in tra  assay coe ffic ien t o f varia tion (CV):
Sodium in te r assay CV = 0.83% (n = 6) Potassium in te r assay CV = 0.85% (n = 6) 
Sodium in tra  assay CV = 1.31% (n = 6) Potassium in tra  assay CV = 1.67% (n = 6)
2.17 Galactokinase Assay
2.17.1 L ive r Galactokinase
Galactokinase was measured using the methods o f Cuatrecasas and Segal 
(1965) and Roberts and Morse (1978) as modified by Brady (personal 
communication). In the presence o f ATP galactokinase catalyses the conversion of 
D-galactose to D -g a l- l-P . Inclusion o f "^C-galactose in the reaction system allows 
the reaction to be quantified. Galactose and ga l-l-P  are separated by ion exchange 
paper chromatography. ^ C -g a l- l-P  is then counted using a Rackbeta liquid 
sc in tilla tion  counter (LKB).
Sample Preparation:
L ive r tissue was prepared fo r analysis according to  method o f Cuatrecasas 
and Segal (1965) w ith  the fo llow ing m odifica tion. A 2g portion of liv e r tissue was
homogenized at 0°C w ith  4 volumes of 0.01M phosphate buffer, pH 6.7, containing 
0.01M N-acetylcystein (Sigma cat. no. A-7250) and 5mM EDTA (BDH cat. no. 
10093). Preparations were stored at -80°C fo r up to 2 months.
Reagent Preparation:
The assay reagent was prepared on the day of assay according to the method 
of Cuatrecasas and Segal (1965). Mercaptoethanol was replaced w ith  2 mmoles o f 
d ith io th re ito l (Sigma cat. no. D-0632). The ^C -ga lac tose  used was supplied by the 
Radiochemical Centre, Amersham cat. no. CFA.435). To start the reaction a lO y l 
aliquot o f live r preparation was added to 90yl o f the assay reagent. The assay was 
then carried out according to the method o f Roberts and Morse (1978). A ll samples
were assayed in duplicate. Enzyme units are expressed as nmoles of g a l-l-P  formed
per minute per mg of tissue protein at 37°C.
The reproducib ility  of the method was assessed by calculating the in te r and 
in tra  assay coe ffic ien t o f varia tion (CV):
in te r assay CV = 13.80% (n = 6)
in tra  assay CV = 6.93% (n = 18)
2.17.2 Red Blood C ell Galactokinase
The assay method used was a m odifica tion of that used fo r live r analysis. No 
sample preparation was required. Samples were analysed w ith in  3 months o f 
collection.
Reagent Preparation:
The assay reagent was prepared on the day of assay as adapted fo r  RBC 
analysis by Beutler, Paniker and Trinidad (1971). "^C-galactose was supplied by the 
Radiochemical Centre, Amersham (cat. no. CFA.435) and did not require 
pu rifica tion  p rio r to use.
Procedure:
To s ta rt the reaction a lOOyl aliquot of haemolysate was added to lOOyl of 
assay reagent. The assay was then carried out as for live r preparations. 50yl 
aliquots of reaction m ixture were used fo r counting. A ll samples were assayed in 
duplicate. Enzyme units are expressed as nmoles of ga l-l-P  formed per minute per 
mg of haemoglobin at 37°C.
The reproducib ility  o f the method was assessed by calculating the in te r and 
in tra  assay coe ffic ien t o f variation (CV):
in ter assay CV = 10.56% (n = 6)
in tra  assay CV = 10.57% (n = 6)
2.18 UDP-Galactose-4-Epimerase Assay
2.18.1 L iver UDP-Gal-4-Epimerase
UDP-gal-4-epimerase was measured using the two step radiodilu tion method
of Shin et al. (1982). UDP-gal-4-epimerase catalyses the reversible in te r-
+
conversion o f UDP-gal and UDP-gluc. The presence o f UDP-gal and NAD in the 
f irs t step reaction m ixture ensures that the reaction goes in the d irection of UDP- 
gal to UDP-gluc. The UDP-gluc is then phosphorylated to g luc-l-P  by the enzyme 
pyrophosphorylase. Inclusion o f ^C -U D P -g lu c  in the reaction system allows the 
reaction to be quantified. UDP-gluc and g luc-l-P  are separated by ion exchange 
column chromatography.
14The amount of C-UDP-gluc le f t  in the system is proportional to the amount 
o f unlabelled UDP-gluc produced in step 1 and is counted using a Rackbeta L iquid 
S c in tilla tion  Counter (LKB).
Sample Preparation:
A lg  portion o f live r tissue was homogenized at 0°C w ith  4 volumes of ice 
cold 0.1M potassium chloride. The homogenate was then diluted 1:6 w ith  d is tilled
water and centrifuged at 30,000g fo r 30 minutes at 4°C. The supernatant was 
stored at -80°C for up to 9 months.
Standard Preparation:
Standards of 0-150ymol of UDP-gluc/L of giyglycine buffer (166 m m ol/L, pH 
9.0) were prepared on the day of assay. The UDP-gluc used was obtained from 
Sigma (cat. no. U-4625).
Reagent Preparation:
The assay reagents were prepared on the day of assay according to the 
method o f Shin et al. (1982) as recommended fo r live r preparations. The ^ C -U D P - 
gluc used was obtained from  the Radiochemical Centre, Amersham (cat no. 
CFB.102).
DEAE Cellulose Column Preparation:
The DEAE cellulose used was Whatman DE-23 (cat. no. 4053-010) and was 
prepared according to the recommendations fo r product usage. Prepared DEAE 
cellulose was stored at 4°C fo r up to 1 week. On the day of assay disposable plastic 
syringes (2ml) were plugged w ith  glass wool and filled  w ith  prepared DEAE 
cellulose up to the 2ml mark. A ll columns were equilibrated w ith  30ml o f 30mM 
HC1 imm ediately prior to use.
Procedure:
The assay was carried out according to the method of Shin et al. (1982). 
UDP-gluc and g luc -l-P  were separated by addition o f a 50yl aliquot o f the end 
reaction m ixture onto an unused DEAE cellulose column. Columns were then 
developed using 10ml o f 30mM HC1 followed by 10ml o f 20mM HC1. The separation 
o f each sample was checked by collection o f 2ml fractions which were ind iv idually
counted fo r rad ioactiv ity . Counts recovered in the 200mM HC1 fractions were due 
to elution o f "^C-UDP-gluc and were summed when calculating the amount of 
unlabelled UDP-gluc present. A ll samples were assayed in duplicate. Enzyme units 
are expressed as nmoles o f UDP-gluc formed per minute per mg of tissue protein at 
37°C.
The reproducib ility  of the method was assessd by calculating the in te r and 
in tra assay coe ffic ien t o f variation (CV):
in ter assay CV = 10.43% (n = 6)
in tra  assay CV = 13.69% (n = 6)
2.18.2 Red Blood Cell UDP-Gal-4-Epimerase
The assay method used was a m odification o f tha t used fo r live r analysis. No 
sample preparation was required. Samples were analysed w ith in  10 months o f 
collection.
Preparation o f standards and DEAE cellulose columns was as fo r live r tissue.
Reagent Preparation:
The assay reagents were prepared on the day o f assay according to the 
method of Shin et al. (1982) as recommended fo r RBC. The "^C -U D P-gluc used was 
obtained from  the Radiochemical Centre, Amersham (cat. no. CFB.102).
Procedure:
The assay was carried out as fo r live r tissue. A ll samples were assayed in
duplicate. Enzyme units are expressed as nmoles o f UDP-gluc formed per m inute
per mg o f haemoglobin at 37°C.
The reproducib ility  o f the method was assessed by calculating the in te r and 
in tra  assay coe ffic ie n t o f variation (CV):
in te r assay CV = 6.63% (n = 4) 
in tra  assay CV = 7.45% (n = 7)
2.19 Haemoglobin Assay
Preparations of RBC were assayed fo r haemoglobin using the method of Van 
Kampen and Z ijls tra  (1961). Haemoglobin reacts w ith  cyanide and ferricyanide to 
form  cyanomethaemoglobin which is then measured spectrophotom etrically at 
546nm using a Cecil CE 272 spectrophotometer (Cecil Instruments).
Reagent Preparation:
The reagent was made up using the solutions o f a Boehringer Mannheim 
haemoglobin test k it  (cat. no. 124729) according to k it  instructions.
Procedure:
The assay was carried out according to test k it  instructions. A ll samples were 
assayed in duplicate.
The reproducib ility  of the method was assessed by calculating the in tra  assay 
coe ffic ien t o f variation (CV):
in tra  assay CV = 6.57% (n = 6)
A ll samples were assayed on the same day. Calculation o f the in te r assay CV 
was, therefore, not performed.
2.20 Protein Assay
L ive r preparations were assayed fo r to ta l protein using the protein-dye 
binding method o f Bradford (1976). When the dye Coomassie B r illia n t Blue G-250 
binds to protein its  absorption maximum shifts from  465 to 595nm. This increase in 
absorption at 595nm is proportional to the amount o f protein present and is 
measured spectrophotom etrically using a C ecil CE 272 spectrophotom eter (Cecil 
Instruments).
Sample Preparation:
Protein determ ination was carried out in the live r tissue prepared fo r 
galactokinase and UDP-gal-4-epimerase analysis.
Standard Preparation:
Standards of 10-10Qyg protein/lOOyl of phosphate buffer were prepared on 
the day o f assay. The phosphate buffer used was that used in the sample 
preparation. Bovine serum albumin (Sigma cat. no. A-7888) was used as the protein 
standard.
Reagent Preparation:
The Coomassie B rillia n t Blue G-250 used was obtained from  Sigma (cat. no. 
B-1131) and was prepared according to the method of Bradford (1976).
Procedure:
The assay was carried out according to the method of Bradford (1976). A ll 
samples were assayed in duplicate.
The reproducib ility  o f the method was assessed by calculating the in tra  assay 
coe ffic ien t o f varia tion (CV):
in tra  assay CV = 2.50% (n = 10)
A ll samples were assayed on the same day. Calculation o f the in te r assay CV 
was, therefore, not performed.
2.21 Peroral Galactose Tolerance Tests
A ll tests were carried out before 10.00 am. P rio r to each test volunteers 
were asked to fast from  m idnight of the day preceding the test. On the morning o f 
the test each volunteer consumed a test meal o f 0.5g o f galactose/kg body weight
(B.W.) dissolved in 4ml o f d is tilled  water/kg B.W. Test meals were made up the 
evening before and stored at 4°C. The galactose used was anhydrous D-galactose 
(BDH cat. no. 38026). Body weights were recorded at the tim e of the f irs t 
tolerance test and were assumed to remain constant for subsequent tests.
Blood samples were taken (2.1.1) prior to consumption of the test meal (t = 0) 
and at 13,30,60 and 90 minutes a fte r. Serum was assayed for galactose (2.2.1). The 
area under the serum galactose response curve was calculated (2.22) and used as an 
index o f peroral galactose tolerance.
2.22 Statistical Methods
The mean (x) and standard error of the mean (SE) were calculated fo r a ll 
groups o f data. Data was fu rther analysed as described in each study. Only 
significances of P<0.02 are reported.
Areas under serum response curves were calculated using the trapezoid 
method (Yeh and Kwan, 1978). The area under the curve is given by the form ula:
(b+a)(t1- t Q)+(c+b)(t2- t 1)+(d+c)(t^-t2)+(e+d)(t4-t^ )
2 2 2 2
where a,b,c,d and e are concentrations in subsequent serum samples and t Q, t^ , t 2, 
t-j and t^  are the corresponding tim e values.
CHAPTER 3
SOME OF THE CHRONIC METABOLIC EFFECTS PRODUCED 
IN  MAN BY AN INCREASED CONSUMPTION OF GALACTOSE 
AS LACTOSE HYDROLYSATE SYRUP
3.1 Introduction
Lactose hydrolysate syrups (LHS) are produced commercially by acidic or 
enzymic hydrolysis of whey, a by-product o f cheese manufacture. During this 
process approximately 80% of the lactose present in whey is hydrolysed to glucose 
and galactose, resulting in a syrup which is more soluble and sweeter than lactose 
per se. The manufacture, properties and applications o f LHS have been recently 
reviewed (Harju and Kreula, 1980; Eustace, 1982; Moxon, 1986). Possible uses 
include the partia l replacement of sucrose in dairy products such as ice cream and 
yoghurt, and in bakery products, confectionery, wine and beer. I t  can also 
successfully replace invert sugar in canned f ru it  and be used as a partia l replacer 
o f egg in cake manufacture. I t  is like ly  that the use o f LHS in the food industry w ill 
increase fu rthe r as the hydro lytic techniques improve and applications in food 
manufacture increase. A rise in the £er capita galactose consumption w ith in  the 
United Kingdom is, therefore, possible.
Although the acute metabolic e ffects  of d ietary galactose in man have been 
reported, l i t t le  work has been published on the chronic m etabolic e ffects . 
Furthermore, there has been no specific study of the chronic m etabolic e ffec ts  
produced in man by an increased intake o f d ietary galactose when consumed 
together w ith  glucose as in LHS. Simultaneous glucose ingestion is known to 
influence the acute metabolic reponse to peroral galactose (Stenstam, 1946; 
W illiams et al., 1983) and i t  is possible that i t  may s im ila rly  influence the chronic 
metabolic response to d ietary galactose.
A sign ificant increase in fasting serum galactose levels has been reported in 
baboons fed a d iet containing 80% carbohydrate by weight as supplied by LHS fo r a 
ten week period. The same d ie t produced a s ign ificant increase in the mean 
fasting serum trig lyceride  level in female baboons but not in males (W illiam s and 
Macdonald, 1982b). A d iet containing 40% lactose by weight was found to increase 
fasting serum trig lyceride  levels in 2 out o f 3 female and 1 out o f 3 male baboons 
(Kritchevsky et al., 1980). The e ffe c t o f d ie tary LHS or lactose on fasting serum
trig lycerides in the female baboon is of in terest since the baboon is considered to 
be a good model of lip id  metabolism for extrapolation to man (Kritchevsky et al., 
1962; Gresham and Howard, 1969).
An increased intake of carbohydrate has been shown to produce a transient 
increase in fasting serum trig lyceride  levels in normolipaemic man (Antonis and 
Bersohn, 1961; Lees and Fredrickson, 1965). However, in man the 
hypertrig lyceridaem ic response to d ietary carbohydrate predominates in the male 
(Beveridge et al., 1964) and dietary sucrose has been found to exert a greater 
e ffe c t on fasting serum trig lyceride  levels in males and post-menopausal women 
than in pre-menopausal women (Macdonald, 1965b; Macdonald, 1966a). In men but 
not in young women fasting serum trig lyceride  levels have been shown to be 
d irec tly  correlated w ith the increase in serum fructose concentrations produced 
subsequent to ingestion of a sucrose test meal (Crossley, 1967) and i t  has been 
suggested tha t a sex difference in fructose metabolism may be involved 
(Macdonald, 1970). A faster rate o f trig lyceride  clearance from the serum o f pre­
menopausal women has also been postulated (Sheorain, M attock and Subrahmann- 
Yam, 1979).
The type of carbohydrate consumed is believed to a ffe c t fasting serum 
trig lyceride  levels in man and sucrose has been found to produce a greater 
hypertrig lyceridaem ic e ffe c t than glucose, starch (Macdonald and B ra ithw a ite , 
1964; Hodges and Krehl, 1965; Macdonald, 1965a) or lactose (Anderson e t al., 1963). 
I t  has been suggested that fructose is the monosaccharide component of sucrose 
involved (Macdonald, 1966b). When consumed as dried whey at the level o f 80g/day 
lactose was found not to s ign ifican tly  increase fasting serum trig lycerides in 
normolipaemic man over a three week period (Stahelin and R itze l, 1979). In 
contrast, an increase in fasting serum trig lyceride  levels was reported fo llow ing 
addition o f lg  o f lactose/kg B.W. to the usual d ie t o f normolipaemic volunteers fo r 
a two week period (Phillips, Macdonald and Keyser, 1978).
The influence o f d ietary carbohydrate on fasting to ta l serum cholesterol 
levels is believed to be small when compared to that of dietary fa t (Anderson et 
al., 1973). Several studies have described a hypocholesteraemic e ffe c t of whole or 
skimmed m ilk  in the diet o f rats (Manilow and McLaughlin, 1975; Nair and Mann, 
1977; Kritchevsky et al., 1979). However, these findings were not substantiated in 
the recent study of Massey and Davidson (1983). A hypocholesteraemic e ffe c t of 
whole or skimmed m ilk (Howard and Marks, 1977) and yoghurt (Mann, 1977) has 
been described in man and it  has been suggested that lactose is the facto r in m ilk 
involved in this response (Helms, 1977). Consumption of lOOg of lactose/day fo r a 
period o f three weeks was found to reduce fasting to ta l serum cholesterol 
concentrations in patients w ith  coronary arte ry disease (Agarwal e t al., 1980). 
However, the patients were c lin ica lly  hypercholesteraemic and no details of the 
d ietary fa t intake over the study period were provided. A dm in istra tion o f a 
synthetic d ie t containing 50% of the energy intake as lactose, 20% as protein and 
30% as fa t and providing lg  o f cholesterol per day fa iled to a lte r fasting to ta l 
serum cholesterol levels in healthy volunteers over a three week period (Shamma'a 
and A l-K ha lid i, 1963). No change was seen in the fasting to ta l serum cholesterol 
concentrations in normolipaemic volunteers fed 80g o f lactose per day as dried 
whey (Stahelin and R itze l, 1979); details o f the daily fa t consumption o f these 
volunteers were not documented. In contrast, Wells and Anderson (1962) reported a 
rise in fasting to ta l serum cholesterol levels in healthy male volunteers fed a d ie t 
containing 160g of lactose and lg  o f cholesterol per day and providing 28% of the 
to ta l energy as fa t. Therefore, in healthy man, d ietary lactose is generally thought 
to have l i t t le  e ffe c t on fasting to ta l serum cholesterol levels and does not appear 
to be the hypocholesteraemic fac to r in m ilk.
As discussed (1.12), chronically elevated blood galactose levels and 
accumulation o f g a l- l-P  in body tissues are tox ic to man. The m etabolic e ffec ts  
associated w ith  a chronically increased intake of galactose as LHS in man are,
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therefore, o f additional in terest. French legislation prevents the 
commercialisation o f lactose-hydrolysed m ilk because of the possible long term  
effects of galactosaemic peaks on the human lens. This legislation was based on 
experimental data obtained in rats which showed a greater galactosaemia and jn  
vivo ga lactito l accumulation in animals fed hydrolysed lactose when compared w ith  
those fed lactose per se (Adrian, P o iffa it and David, 1981). In the above study 
hydrolysed lactose was fed at 40% of the energy intake; non-physiologic doses of 
galactose were, therefore, administered. Furthermore, rats are known to have a 
lower tolerance of galactose than man (Tygstrup et al., 1971) and, unlike in man, 
simultaneous glucose adm inistration fa ils to reduce the serum galactose response 
to an acute peroral galactose load (Newstead, 1979; W illiams and Owens, 1984). As 
yet no study has been undertaken to investigate the e ffe c t o f a chronically 
increased consumption o f d ietary galactose as LHS on blood galactose levels in 
man.
The aim o f this study was to investigate some of the chronic m etabolic 
e ffects  produced in man by an increased consumption o f galactose as LHS.
Before onset of the study permission fo r experimentation was granted by the 
University o f Surrey E th ica l Com m ittee. P rio r to investigation the w ritten , 
informed consent was obtained from  a ll volunteers in accordance w ith  guidelines 
outlined in the University o f Surrey eth ica l guidelines for research and teaching.
3.2 Subjects, Materials and Methods
Seven female and five  male volunteers were assigned to the test group; five  
female and seven male volunteers were assigned to the contro l group. A ll were 
aged between 20 and 28 years and were considered to be in good health, non-obese, 
non-diabetic and w ith  no history of lactose intolerance.
P rio r to and on completion o f the study, details were recorded o f the height, 
weight, smoking habits, habitual usage o f any medications or hormone preparations
and the recreational sporting ac tiv ities  of each volunteer. Sporting ac tiv ities  were 
graded into ligh t, moderate or heavy exercise using the categories described by 
Durnin and Passmore (1967). Before the study the diet of each volunteer was 
assessed using a 7 day recall technique; diet was also assessed tw ice during the 
study using a 24 hour recall method. Daily intakes of energy, carbohydrate, protein, 
fa t and alcohol were calculated using food tables (Paul and Southgate, 1978). Daily 
intakes of galactose from  liquid m ilk were also calculated fo r each test volunteer.
For a 10 week period each test volunteer was required to eat 7% o f the ir 
to ta l energy intake as carbohydrate provided by LHS; each control volunteer was 
required to eat 7% of the ir to ta l energy intake as carbohydrate provided by a 
glucose/m altodextrin m ixture. The daily quantity o f LHS or glucose/m altodextrin 
m ixture to be consumed was calculated from  the pre-study dietary analysis. 
According to preference the test or control carbohydrate source was eaten in 
specially prepared flapjacks, biscuits and cakes or used d irec tly  as a sweetner. 
Details o f the confectionery produce used are provided in the Appendices (pages 
211-214). Each week the volunteers were given seven daily portions o f LHS or 
glucose/m altodextrin m ixture and asked to use them to replace s im ila r d ietary 
items and not to use them to supplement the ir d iet. The LHS used in this study was 
Sweet Dairy Concentrate SDS-04 as supplied by Specialist Dairy Ingredients. The 
glucose/m altodextrin m ixture used was Dextrose Monohydrate C90/Spray Dried 
Glucose Syrup 47DE as supplied by Beecham Products. Ana ly tica l details are given 
in the Appendices (page 210).
On two occasions prior to the study and at weekly intervals during the study 
fasting serum samples were assayed fo r galactose, glucose, insulin, trig lycerides 
and to ta l cholesterol (2.2 - 2.6). P rio r to the study, in weeks 1-4 inclusive and in 
week 8 serum was additionally assayed fo r alkaline phosphatase, aspartate amino 
transferase (GOT), y -g lu tam y l transferase (y-GT), b ilirub in  and albumin (2.7 -2.11). 
Serum alkaline phosphatase, GOT, y-GT, bilirub in  and albumin values were used as
a test of live r function and live r cell damage. On two occasions prior to the study, 
in weeks 1-4 inclusive and in week 8 volunteers collected an early morning urine 
specimen a fte r an overnight fast. Urine was assayed fo r galactose and creatinine 
(2.2 and 2.12) and tested for the presence of b ilirub in, urobilinogen (Bilugen Test 
Strips, Boehringer Mannheim cat. no. 126063) and glucose (C lin is tix  Test Strips, 
Ames cat. no. 2844).
Six test females and three test males completed a peroral galactose 
tolerance test before and a fte r the study period (2.2). For the female volunteers 
the day of the menstrual cycle on which galactose tolerance was assessed was 
noted.
The mean (x) and standard error of the mean (SE) were calculated fo r a ll data 
which was grouped according to week o f study and sex. I f  no sex d ifference was 
apparent data fo r males and females were combined. Mean values obtained during 
the study were compared w ith  pre-study values using a Student's t- te s t fo r paired 
data. Mean values recorded in the test group o f volunteers were compared w ith  
those recorded in the contro l group using a Student's t-te s t fo r unpaired data.
3.3 Results
L it t le  change occurred in the recreational sporting ac tiv itie s  or in the 
smoking habits o f the volunteers studied. Use o f medications or hormone 
preparations by each volunteer remained unchanged throughout the study period.
3.3.1 D ietary Analyses
Details o f the mean dietary analyses are given in Table 1. The mean 
percentages o f the to ta l energy consumption provided as d ie ta ry protein 
carbohydrate and fa t are illus tra ted  in Figure 4.
A ll groups o f volunteers showed variations in the mean daily energy, fa t and 
protein intakes, the mean intakes increased more in the females than the males.
TABLE 1.1
D ietary Analyses As Recorded Pre-Study, Mid-Study and End-Study 
fo r Test Volunteers Fed LHS
Females (n = 7) Males (n = 5)
Pre- Mid- 
Study Study
End-
Study
Pre- Mid- End- 
Study Study Study
Energy X 1870 2307 2116 2856 3152 2818
(E) SE+ 80 177 128 294 347 249
Kcal/day
Protein X 67 81 83 109 98 90
g/day SE+ 5 5 7 22 10 10
%E X 14 13 16 15 12 13
CHO X 229 288 237 307 367 315
g/day SE+ 9 25 22 35 49 49
%E X 49 50 45 43 46 44
Fat X 76 93 93 120 135 122
g/day SE+ 6 9 7 12 16 10
%E X 37 37 40 37 39 39
Alcohol X 7 6 7 25 20 23
g/day SE+ 3 4 4 3 2 3
Galactose X 6 5 6 5 7 7
from
Liquid SE+ 1 1 1 1 2 2
M ilk g/day
Recommended Intakes/Day:
Females, 18-54 years, most occupations: Energy = 2150 kcal
P rotein = 54g
Males, 18-34 years, moderately active: Energy = 2900 kcal
Protein = 72g
(Department o f Health and Social Security, Report on Health and Social 
Subjects, 1981)
TABLE 1.2
D ietary Analyses as Record Pre-study, Mid-study and End-study 
for Control Volunteers Fed a G lucose/Maltodextrin M ixture
Females (n = 5) Males (n = 7)
Pre- M id- End- Pre- M id- End-
study study study study study study
Energy x 1815 2073 2107 2465 2751 2668
(E) SE+ 74 125 91 142 236 210
Kcal/day
Protein X 58 73 60 73 84 73
g/day SE+ 3 4 6 4 10 4
%E X 13 14 11 12 12 11
CHO X 205 225 255 318 344 341
g/day SE+ 11 19 16 29 22 40
%E X 45 43 48 52 50 51
Fat X 79 91 90 93 109 104
g/day SE+ 5 8 5 9 15 9
%E X 39 40 38 34 36 35
Alcohol X 14 14 12 17 17 17
g/day SE+ 5 5 4 6 6 8
Recommended Intakes/Day:
Females, 18-54 years, most occupations: Energy = 2150 kcal
Protein = 54g
Males, 18-34 years, moderately active: Energy = 2900 kcal
Protein = 72g
(Department o f Health and Social Security, Report on Health and Social 
Subjects, 1981)
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Figure 4 The Mean Percentages o f D ie ta ry  Energy Obtained from  P ro te in  (P), 
Carbohydrate (C) and Fa t (F) by Test Volunteers Fed LHS and by 
C ontro l Volunteers Fed a G lucose/M altodextrin M ix ture
The mean daily carbohydrate intake increased in each volunteer group. However, 
the mean consumption o f galactose from liquid m ilk changed l i t t le  in the test 
volunteers. The mean daily alcohol consumption decreased in the test males mid­
study, but changed li t t le  during the study period in the other volunteer groups. 
None of these dietary changes were significant and there was no sign ificant 
difference in the mean daily intake of to ta l energy, carbohydrate, protein, fa t or 
alcohol between the test and control group o f volunteers. In all volunteer groups 
the mean percentage of the to ta l energy consumption provided as carbohydrate, fa t 
and protein showed l i t t le  change over the study period.
In the test group of volunteers the mean daily intake of carbohydrate from  
LHS was 34 + 2g by the females and 32 + 5g by the males. This quantity 
represented 6% o f the to ta l energy intake o f the females and 7% o f the to ta l 
energy intake of the males. LHS provided the test females w ith  a mean galactose 
intake o f 14 + lg /day and the test males w ith  a mean galactose intake o f 22 + 
2g/day. In the control group o f volunteers the mean intake o f carbohydrate from  
the glucose/m altodextrin m ixture was 32 + lg  by the females and 43 + 3g by the 
males. This quantity represented 6% of the to ta l energy intake o f males and 
females. The mean daily to ta l galactose intake was s ign ificantly  greater in the test 
females and test males at both the mid-study and end of study dietary assessments 
than in the contro l females (P<0.001) and contro l males (P<0.001).
3.3.2 Body Weight
The mean body weights are recorded in Table 2 and illus tra ted  in Figure 3.
Although individual fluctuations in body weight occurred during the study 
there was no s ign ificant change from  the pre-study mean weight in any volunteer 
group. No test volunteer showed a body weight change of more than 3.8 kg. In the 
contro l group the maximum body weight change was 2.6 kg. There were no 
sign ificant differences in the mean body weights between the test and contro l 
volunteers.
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3.3.3 Fasting Serum Galactose
Mean fasting serum galactose concentrations were below 0.01 m m ol/L fo r 
test and control volunteers. No sign ificant change was seen in the mean fasting 
serum galactose levels recorded in the test volunteers during the study. There was 
no sign ificant difference in the mean fasting serum galactose levels between the 
test and control volunteers.
3.3.4 Fasting Serum Glucose
Mean fasting serum glucose concentrations are recorded in Table 3 and 
illustra ted in Figure 6.
There was no significant change in the mean fasting serum glucose level of 
the test volunteers during the dietary period. In the control volunteers the mean 
fasting serum glucose concentration recorded during week 9 was sign ifican tly  
greater than the mean pre-study level (P<0.01) and was s ign ifican tly  higher than 
the mean value recorded a fte r 9 weeks in the test group (P<0.01). No other 
s ign ificant differences in mean fasting serum glucose levels were observed between 
the test and control volunteers.
3.3.5 Fasting Serum Insulin
Mean fasting serum insulin concentrations are recorded in Table 3 and 
illustra ted  in Figure 7.
Mean fasting serum insulin concentrations did not a lte r s ign ifican tly  during 
the study period w ith in  e ither the test or contro l group o f volunteers. Although the 
mean fasting serum insulin concentrations recorded in the contro l group o f 
volunteers pre-study and throughout the study period were higher than those 
recorded in the test group these differences were not sign ificant.
3.3.6 Fasting Serum Cholesterol
Mean fasting serum cholesterol concentrations are recorded in Table 3 and 
illus tra ted  in Figure 8.
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The mean fasting serum cholesterol level did not change sign ificantly from  
the pre-study value in the test or control group o f volunteers. No significant 
difference was found in the mean fasting serum cholesterol values between the test 
and control volunteers.
3.3.7 Fasting Serum Triglycerides
Mean fasting serum trig lyceride  concentrations are recorded in Table 4 and 
illustrated in Figure 9.
The fasting serum trig lyceride  response to LHS in the test volunteers and to 
the glucose/m altodextrin m ixture in the control volunteers showed a sex 
difference.
The mean fasting serum trig lyceride  level o f the test females was 
s ign ificantly  raised above the mean pre-study value at the end o f weeks 1 (P<0.02) 
and 2 (P<0.01). For the remainder of the study the mean levels returned to near 
pre-study values. In the test males mean fasting serum trig lyceride  concentrations 
rose during the f irs t  five  weeks of the study w ith  values recorded during weeks 2 
and 3 being s ign ifican tly  elevated (P<0.01). Mean fasting serum trig lyceride  values 
then fe ll to near pre-study levels during weeks 6 and 7 but were again s ign ifican tly  
elevated during week 10 (P<0.02).
A fte r  9 weeks the mean fasting serum trig lyceride  level o f the contro l 
females was sign ifican tly  greater than the mean pre-study level (P<0.01). A lthough 
the mean fasting concentrations recorded during weeks 1, 7 and 10 were also higher 
than the mean pre-study value these differences were not s ign ifican t due to the 
larger standard errors recorded at these times. The mean fasting serum 
trig lyceride  level o f the contro l males rose during weeks 2 and 3-10 inclusive. 
However, mean fasting serum trig lyceride  values were s ign ifican tly  elevated during 
weeks 2 (P<0.02) and 10 (P<0.01) only.
No s ign ificant d ifference was found in mean fasting serum trig lyce ride  
concentrations between the test and contro l volunteers.
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3.3.8 U rinary Galactose: Creatinine Ratio
The mean urinary galactose: creatinine ratios of the early morning urine 
specimens are recorded in Table 3 and illustrated in Figure 10.
In the test group of volunteers the mean urinary galactose: creatinine ratios 
recorded in weeks 1-4 inclusive and in week 8 were all sign ificantly greater than 
the pre-study mean ra tio ; the P values being P<0.02 fo r week 1, P<0.01 fo r weeks 
2, 3 and 4 and P<0.001 for week 8. No significant change from the pre-study mean 
ra tio  was seen in the control volunteers. There was no significant d ifference in the 
mean urinary galactose: creatinine ratios between the test and contro l volunteers.
3.3.9 Peroral Galactose Tolerance
The mean serum galactose response to a peroral galactose test meal 
administered pre and post-study is recorded in Table 6 and illustrated in Figure 11.
Inclusion o f LHS in the diet did not s ign ifican tly  a lte r the mean serum 
galactose response to an acute peroral galactose load in the test volunteers.
3.3.10 Tests o f L iver Function and L ive r Cell Damage
Mean fasting serum albumin, b ilirub in, alkaline phosphatase, yGT and GOT 
concentrations are recorded in Table 7.
The fasting serum alkaline phosphatase, yGT and GOT levels o f the test and 
contro l volunteers showed a sex difference.
The mean fasting serum albumin concentration did not change s ign ifican tly  
during the study w ith in  either the test or contro l group o f volunteers. Mean serum 
b ilirub in  concentrations showed sign ificant changes in the test volunteers only; the 
mean serum concentrations recorded during weeks 2 and 3 were s ign ifican tly  lower 
than the pre-study mean value (P<0.001, P,<0.01 respectively). Although 
fluctuations were seen in the mean serum alkaline phosphatase and GOT levels o f 
a ll volunteer groups sign ificant changes were only observed in the males. Mean
a y
TABLE 5
Mean Galactose: Creatinine Ratios in the Early Morning Urine 
Specimens o f Test Volunteers Fed LH5 and Control Volunteers Fed a 
G lucose/Maltodextrin M ixture w ith  Standard Errors (SE) 
and P Values fo r Comparison w ith  Pre-Study Ratios when P<0.02
Study Week
Pre-study 1 2 3 4 8
Test x 0.01 0.02 0.02 0.02 0.03 0.02
Volunteers
(n = 12) SE+ 0.00 0.01 0.01 0.01 0.01 0.00
PC0.02 P<0.01 P<0.01 P<0.01 P<0.001
Contro l x 0.01 0.01 0.01 0.01 0.01 0.01
Volunteers
(n = 12) SE+ 0.00 0.00 0.00 0.00 0.00 0.00
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TABLE 6
Mean Serum Galactose Levels w ith Standard Errors (SE) Recorded Before 
and at Timed Intervals A fte r a Galactose Test Meal in Test Volunteers 
Before and A fte r the LHS D ie t (n = 9)
Time (mins)
Area
0 15 30 60 90 Under
Curve 
(Arb. units)
Serum galactose (mm ol/L)
Pre-study x 0.00 0.37 1.24 1.25 0.19 74.2
SE+ 0.00 0.15 0.38 0.43 0.07 22.1
Post-study x 0.00 0.54 1.48 1.46 0.18 81.6
SE + 0.00 0.10 0.23 0.25 0.05 44.9
A Before LHS (n=9)
1.6
A After LHS (n=9)
1.4
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Figure 11 The Mean Serum Galactose Response to Peroral Galactose in Test 
Volunteers Before and A fte r  10 Weeks o f LHS Feeding; T = Mean + 
SE. 1
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TABLE 7.1
Mean Serum Albumin, B ilirub in, A lkaline Phosphatase, yGT and GOT 
Levels in Test Volunteers Fed LHS (n = 12) w ith Standard Errors (SE) 
and P Values fo r Comparison w ith  Pre-Study Values when P<0.02
Study Week
Pre-study 1 2 3 4 8
Serum Albumin (G/L)
X 47.52 49.74 50.72 50.83 48.69 49.47
SE + 0.57 1.01 0.84 1.18 0.77 0.54
Serum B ilirub in  (ym ol/L )
X 9.16 7.57 7.04 6.84 7.32 8.36
SE + 0.70 1.01 0.74 0.76 0.88 1.02
P<0.001 P<0.01
Serum Alkaline Phosphatase (U /L)
Females X 93.35 98.82 104.68 106.13 106.56 101.58
(n = 7) SE + 6.44 7.51 7.85 8.80 6.61 7.75
Males X 91.79 98.13 102.50 106.21 97.74 105.70
(n = 5) SE + 9.17 8.26 8.14 7.70 10.34 13.17
P<0.01
Serum yGT (U/L)
Females X 6.09 5.61 6.97 7.84 7.34 7.37
(n = 7) SE + 0.73 0.57 0.67 0.82 0.60 0.64
P<0.01
Males X 10.79 10.64 12.48 12.23 11.71 12.78
(n = 5) SE + 2.72 2.40 3.07 2.82 1.65 2.26
Serum GOT (U/L)
Females X 8.06 8.32 9.16 9.47 9.93 10.72
(n = 7) SE + 0.25 0.48 0.75 0.69 0.65 1.21
Males X 9.30 10.94 10.42 10.35 10.25 12.08
(n = 5) SE + 0.32 0.80 1.10 0.45 0.99 0.87
PC0.02
NORMAL SERUM VALUES:
Albumin
B ilirub in
A lka line Phosphatase
YGT
GOT
38 - 30 g /L  (Henry, 1984)
3.4 - 17.1 ym ol/L  (P re llw itz , 1976)
F e t a l L V T o V  (Bchlebusch et a l.; 1974)
Males 6 - 2 8  U /L  (Szasz, 1969)
Females 4 - 1 8  U /L
Males 5 - 1 7  U /L  (Schlebusch et al., 1974) 
Females 5 - 1 5  U/ L
TABLE 7.2
Mean Serum Albumin, B ilirub in, A lkaline Phosphatase,
YGT and GOT Levels in Control Volunteers Fed a G lucose/Maltodextrin 
M ixture (n -  12) w ith  Standard Errors (SE) and P Values for 
Comparison w ith  Pre-Study Values when P<Q.Q2
Study Week
Pre-study 1 2 3 4
Serum Albumin (G/L)
X 46.46 48.90 48.85 48.16 46.92
SE + 0.69 1.73 1.10 0.98 0.84
Serum B ilirub in  (ym ol/L )
X 9.77 10.16 12.09 8.99 10.07
SE + 1.02 1.80 2.34 1.27 1.48
Serum A lka line Phosphatase (U /L)
Females X 71.30 72.96 72.96 70.73 62.13
(n = 5) SE + 5.81 9.97 7.63 7.91 4.31
Males X 88.67 93.63 101.81 89.20 93.04
(n = 7) SE + 6.40 7.27 9.04 5.75 5.97
P<0.02 PC0.02
Serum yGT (U/L)
Females X 5.40 7.64 8.19 6.12 6.03
(n = 5) SE + 0.66 0.76 1.08 0.95 0.77
P<0.01 P<0.01
Males X 8.24 9.37 10.34 8.04 8.57
(n = 7) SE + 1.20 0.74 1.05 0.93 0.99
P<0.001
Serum GOT (U /L)
Females X 6.96 5.88 6.82 6.69 5.93
(n = 5) SE + 1.03 0.30 1.04 0.30 0.49
Males X 9.04 9.70 7.57 9.33 8.07
(n = 7) SE + 0.49 1.37 0.47 0.71 0.79
P<0.01
NORMAL SERUM VALUES:
Album in
B ilirub in
A lka line Phosphatase
yGT
GOT
38 - 50 g /L (Henry, 1984)
3.4 - 17.1 ym o l/L  (P re llw itz , 1976)
Males 50 - 190 U /L  
Females 40 - 190 U /L (Schlebusch et al.,
Males 6 - 2 8  U /L  (Szasz, 1969)
Females 4 - 1 8  U /L
Males 5 - 1 7  U /L  (Schlebusch et al., 1974) 
Females 5 - 1 5  U/ L
8
44.33
0.87
10.32
1.97
69.31
6.66
95.10
7.65
5.80
0.81
8.77
1.49
8.01
0.42
10.05
0.99
1974)
serum alkaline phosphatase concentrations were s ignificantly greater than the 
mean pre-study level during week 2 for the test males (P<0.01) and during weeks 1 
and 2 (P<0.02 at each tim e) fo r the control males. Significant changes from  the 
pre-study mean serum GOT levels were recorded during week 8 (P<0.02) fo r the 
test males and during week 2 (P<0.01) fo r the control males. The pre-study mean 
serum yGT concentration of the test females was sign ificantly increased during 
week 3 (P<0.01); no significant changes were seen in the test males. In the control 
group o f volunteers the pre-study mean serum yGT was sign ifican tly  increased 
during weeks 1 and 2 fo r the females (P<0.01 at both times) and during week 2 fo r 
the males (P<0.001).
No sign ificant differences were seen in the mean serum concentrations o f 
b ilirub in, alkaline phosphatase, albumin, GOT or yGT between the test and contro l 
volunteers at any tim e during the study.
B ilirub in  and urobilinogen were not detected in the urine o f any volunteer 
during the study.
Glucose was not detected in the urine of any volunteer.
3.4 Discussion
Fasting serum lipids in man are known to be influenced by such non-dietary 
factors as age (Carlson, 1960; Svanborg and Svennerhoim, 1961; Feldman, Benkel 
and Nayak, 1963; Hallberg et al., 1966), sex (Lewis et al., 1974) c igare tte  smoking 
(Hjermann et al., 1981), physical exercise (Hickey et al., 1975; Cooper e t al., 1976; 
Cooper et al., 1977) and use o f drugs such as oral contraceptive agents (Wynn, Doar 
and M ills, 1966; Wynn et al., 1969). However, since l i t t le  change was seen in these 
factors the ir influence on fasting serum lip id  levels is assumed to be m inim al. 
Although body weight changes have been associated w ith  a lterations in fasting 
serum lipids in man (Anderson, Law ler and Keys, 1957) subsequent studies have 
shown tha t carbohydrate induced lipaemia can occur independently o f energy
balance (Lees and Fredrickson, 1965). The small fluctuations in body weight 
reported during this study are, therefore, not thought to have influenced fasting 
serum lip id concentrations.
Variations were seen in the daily intake of protein, fa t, to ta l carbohydrate, 
alcohol, and energy o f a ll volunteers during the study. I t  is like ly  tha t these 
variations were due, at least in part, to sources of error inherent in the d ietary 
recall methods used to estimate nutrien t intake. D ietary recall techniques re ly 
heavily on memory and errors can arise from  an over or under estim ation of portion 
sizes or from a fa ilure of the subject to recall a ll food items consumed. Their 
va lid ity  and reproducib ility  has been discussed by M arr (1971). A lcohol consumption 
has been found to influence fasting serum lipids (S irto ri et al., 1972; Caste lli, 1977) 
and fo r this reason i t  was specifica lly recorded. Since none of the d ietary changes 
were found to be sign ificant and the percentage o f energy provided as d ietary 
protein, carbohydrate and fa t changed l i t t le  i t  seems reasonable to assume tha t any 
metabolic changes seen during the study are the result o f changes in the type of 
carbohydrate consumed.
LHS contains both galactose and glucose, therefore, i t  is not possible to 
a ttribu te  the metabolic e ffects described in the test volunteers to an increased 
consumption of galactose per se. However, the comparison of data recorded in the 
test volunteers w ith  those seen in the age-matched contro l group fed a 
glucose/m altodextrin carbohydrate m ixture in place o f LHS allows the chronic 
metabolic e ffects associated w ith  an increased intake o f galactose as LHS to be 
discussed. Consumption o f the LHS increased the galactose intake o f the test 
volunteers to levels s ign ifican tly  greater than those o f the controls.
Inclusion of LHS in the diet of the test volunteers so tha t approxim ately 7% 
of the ir to ta l energy intake was supplied by carbohydrate in the syrup did not 
influence fasting serum galactose levels over a ten week period. In a ll test 
volunteers the fasting serum galactose concentration remained below the maximum 
normal fasting value o f 0.24 m m ol/L (Rommel e t al., 1968) and did not d iffe r  from
the fasting values recorded fo r the control group of volunteers. These findings are 
in contast w ith  those reported in baboons fed LHS at a much higher level and in 
which a significant increase in fasting serum galactose levels was seen (Williams 
and Macdonald, 1982b). W illiams and Macdonald (1982b) suggested that this rise in 
fasting blood galactose concentrations was due to an inhib ition of galactokinase 
a c tiv ity  in the live r by the greater post-prandial galactose concentration in the 
porta l-vein o f baboons fed galactose as LHS. I t  may be that s ign ifican tly  elevated 
fasting serum galactose concentrations would have been s im ilarly  produced in 
human volunteers follow ing inclusion of LHS in the diet at a much higher level than 
was used here. However, any fu rthe r increase in the quantity of LHS to be 
consumed would be d iff ic u lt  w ithout incurring greater changes in the fa t, protein, 
carbohydrate and energy intakes of the volunteers and would be in excess of the 
like ly  consumption o f LHS w ith in  the population. Furtherm ore, d irec t 
extrapolation of the metabolic e ffects o f LHS seen in baboons to man is impossible 
since adult baboons are lactose in to lerant and galactose is not norm ally available 
fo r catabolism in the adult animal.
Acute studies in man have shown blood galactose levels to retu rn to near 
fasting concentrations w ith in  120 minutes a fte r adm inistration o f peroral galactose 
loads of up to 50g (Stenstam, 1946). In this study the mean daily galactose intake as 
LHS was lower than 50g w ith  no test volunteer receiving more than 27g of 
galactose/day as LHS. A dditiona lly , the LHS was consumed throughout the day and 
volunteers fasted overnight p rio r to co llection o f blood fo r galactose 
determ ination. I t  is, therefore, not unreasonable that l i t t le  change was seen in the 
fasting serum galactose levels o f the volunteers during the study.
The LHS used contained galactose and glucose in equal quantities. Acute 
studies in man have shown a hypogalactosaemic e ffe c t o f glucose when given 
perorally (Harding and Grant, 1933; Carpenter 1937; Stenstam 1946; W illiam s et 
al., 1983) or intravenously (Stenstam, 1946; Morgan et al., 1979; W illiam s et al.,
1983) together w ith  peroral galactose. A reduced galactosaemia has also been seen
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in normal volunteers given glucose and galactose in the form  o f lactose (W illiams 
et al., 1983). The mechanism by which glucose is thought to reduce the blood 
galactose response to an acute peroral galactose load has been discussed earlier 
(1.10). I t  is possible that a simultaneous glucose ingestion might s im ila rly  influence 
the fasting serum galactose concentrations produced in man by a chronically 
increased consumption o f dietary galactose. The low fasting serum galactose levels 
seen here subsequent to inclusion of LHS in the diet m ight, therefore, be due to the 
presence o f both glucose and galactose in the syrup. I t  is o f in terest tha t a 
hypogalactosaemic e ffe c t of glucose, when given together w ith  galactose as an 
acute peroral load, has also been shown in lactose in to lerant volunteers (W illiams 
and Macdonald, 1982a). This suggests that the fasting serum galactose response of 
lactose in to lerant man to LHS-containing foods would be the same as tha t seen in 
lactose to leran t subjects.
A lte rna tive ly , i t  maybe tha t the maintenance of normal fasting serum 
galactose levels reported in the volunteers fed LHS is the result o f an increased 
urinary galactose excretion. Inclusion of LHS in the diet of the test volunteers 
produced a sign ificant increase in the galactosercreatinine ra tio  o f the early 
morning urine specimen, suggesting a rise in the urinary galactose excretion. In a 
given individual the 24 hour urinary creatinine excretion is believed to be re la tive ly  
constant (Folin, 1903) although daily fluctuations in excretion have been reported 
(Bingham and Cummings, 1983; Webster and Garrow, 1985; W aterlow, 1986). 
Expression of urinary galactose levels against the concentration o f creatin ine in 
the urine sample allows the use o f a single urine sample instead o f a 24 hour 
co llection (Daly, 1978). However, lack o f data on the to ta l 24 hour urinary 
galactose excretion o f the test volunteers means tha t i t  is impossible to compute 
the percentage o f d ie tary galactose excreted in the ir urine. Such data would have 
been of in terest since i t  is unlikely tha t consumption o f galactose as LHS at the 
level used would exceed the maximum capacity fo r hepatic galactose uptake and 
metabolism in normal, healthy volunteers and cause an increase in the amount o f
galactose excreted in the urine. Furthermore, addition of glucose to an acute 
peroral galactose load has been shown to reduce the loss of galactose in the urine 
(Harding and Grant, 1933; Carpenter, 1937) and might sim ilarly reduce the urinary 
excretion of galactose when consumed as LHS. There was no significant difference 
between the galactosercreatinine ratios of the early morning urine specimens of 
the test and control volunteers. It, therefore, seems unlikely that the maintenance 
of pre-study fasting serum galactose concentrations seen in volunteers fed LHS is 
the result o f an increased urinary galactose excretion.
Peroral galactose tolerance was not influenced by the inclusion of LHS in the 
diet at the level used. Any influence of the menstrual cycle on peroral galactose 
tolerance in the test females was reduced since females were investigated pre- 
study and at the end of the study during the same phase of the ir cycle. Alcohol 
ingestion has been shown to reduce the tolerance of an acute peroral galactose load 
(Stenstam, 1946), however, although the test males had a s ign ifican tly  greater 
mean alcohol intake than the test females this was not re flected in fasting serum 
galactose levels or peroral galactose tolerance.
Ingestion of LHS in the quantities used did not a lte r fasting serum glucose or 
insulin concentrations over a ten week period. In test and control volunteers fasting 
serum glucose and insulin levels were consistently w ith in  the normal fasting serum 
range of 3.9-3.6 m m ol/L fo r glucose and 6-26 mu/L fo r insulin (Z ilva and Pannall, 
1982). In contrast, baboons fed a d ie t containing 80% carbohydrate by weight as 
supplied by LHS fo r a ten week period showed a fa ll in fasting serum glucose 
concentrations which was thought to be due to an influence of the high galactose 
diet on hepatic glucose metabolism (Williams and Macdonald, 1982b). G itzelm an 
and Hansen (1980) have shown tha t accumulation o f ga l-l-P  in the liv e r impairs 
glucose metabolism in patients w ith  c lin ica l galactosaemia and i t  is possible tha t i t  
s im ila rly  impaired glucose metabolism in the live r of baboons fed LHS. The absence 
o f any hypoglycaemic e ffe c t o f LHS in the diet of the test volunteers suggests th a t 
in healthy man consumption o f LHS at the level used here does not result in
accumulation o f ga l-l-P  in body tissues.
Inclusion o f LHS in the diet at the level used in this study did not a lte r 
fasting serum to ta l cholesterol levels over a ten week period. In man fasting serum 
to ta l cholesterol values are normally w ith in  the range 3.9 - 6.5 m m ol/L (Henry,
1984). Fasting serum to ta l cholesterol concentrations of test and contro l 
volunteers remained w ith in  this range throughout the study period. These findings 
are in agreement w ith  previous work which showed no change in the fasting serum 
to ta l cholesterol concentrations o f normolipaemic volunteers fed high lactose diets 
(Shamma'a and A l-K ha lid i, 1963; Stahelen and R itze l, 1979) and suggest tha t 
lactose is not the hypocholesteraemic fac to r in m ilk. In this study the to ta l fa t 
intake showed litt le d  change over the ten week period. The fa ilu re  o f an increased 
intake of d ietary galactose as LHS to a lte r fasting serum to ta l cholesterol levels is 
understandable because the influence o f d ietary carbohydrate on the to ta l fasting 
serum cholesterol level is believed to be small when compared to tha t o f d ie tary 
fa ts (Anderson et al., 1973).
During weeks 1 and 2 the mean fasting serum trig lyceride  concentration was 
sign ifican tly  greater than the pre-study value in the female volunteers fed LHS. 
This suggests tha t the hypertrig lyceridaem ic e ffe c t of LHS seen in female baboons 
does not occur in female Homo sapiens at considerably lower levels o f ingestion. In 
this study consumption of LHS caused the greatest hypertrig lyceridaem ic e ffe c t in 
males and the mean fasting serum trig lyceride  level was s ign ifican tly  greater than 
the pre-study value in the test males during weeks 2, 3 and 10. These findings are 
in accordance w ith  the previously documented greater hypertrig lyceridaem ic 
e ffe c t of d ie tary carbohydrate in males (Beveridge et al., 1964; Macdonald, 1965b; 
Macdonald, 1966a). However, i t  is of in terest tha t s ign ificant increases in fasting 
serum trig lyceride  concentrations were also observed in the male and fem ale 
contro l volunteers fed a glucose/m altodextrin m ixture . Furtherm ore, when mean 
fasting serum trig lyce ride  levels recorded in the male and female test volunteers 
were compared w ith  those recorded in the male and female contro l volunteers
respectively no significant difference was found. I t  is possible, therefore, that the 
increase in fasting serum trig lyceride  concentrations seen in the test group o f 
volunteers is not a specific e ffe c t of an increased consumption of galactose as 
LHS.
In man fasting serum trig lyceride levels are normally between 0.11 -
2.09 m m ol/L (Henry, 1984). Mean fasting serum trig lyceride concentrations were 
w ith in  this range in all volunteer groups throughout the study period. This suggests 
that the changes seen are of l i t t le  c lin ica l importance. In addition, the influence o f 
d ietary carbohydrate on the fasting serum trig lyceride levels in normolipaemic man 
has been shown to be transient (Antonis and Bersohn, 1961; Lees and Fredrickson,
1965). Chronically elevated fasting serum trig lyceride concentrations in response 
to changes in dietary carbohydrates are, therefore, unlikely in healthy subjects.
The influence of d ietary carbohydrate on fasting serum trig lyceride  levels has 
been shown to be greater in c lin ica lly  hypertrig lyceridaem ic man than in 
individuals w ith normal fasting blood trig lyceride levels (Anderson, 1967). In the 
present investigation the maximum individual fasting serum trig lyceride  response 
to d ietary LHS was seen in a male volunteer who, on one occasion prior to onset of 
the study, had a fasting serum trig lyceride  concentration which was s ligh tly  above 
the maximum normal value of 2.09 m m ol/L. Fasting serum trig lyceride  levels in 
this volunteer were consistently elevated.
Since dietary galactose is p rim arily  metabolised in the live r tests o f live r 
function and hepatocellular damage were an im portant part of this investigation. 
The tests used included measurement o f serum albumin, b ilirub in , alkaline 
phosphatase, YGT and GOT levels and investigation o f urine samples fo r the 
presence of b ilirub in and urobilinogen. Abnormal levels o f one or more these are 
seen in patients w ith  live r disease and the ir use in the diagnosis and assessment of 
hepatic disorders has been reviewed in c lin ica l biochem istry texts (Z ilva and 
Pannail, 1982). Albumin is synthesised in hepatic cells, a chronic extensive 
im pairm ent of hepatocellular function is re flected in a reduction in its  synthesis
and a fa ll in serum concentrations. Hepatocellular damage can be demonstrated by 
elevated serum GOT levels whereas involvement of the b iliary tra c t in the disease 
process is characterised by raised blood concentrations of hepatobiliary enzymes 
such as alkaline phosphatase and yGT. Raised blood concentrations of both 
conjugated and unconjugated bilirub in can result from hepatocellular damage or 
from in tra  or extra hepatic cholestasis; such patients often excrete b ilirub in  and 
urobilinogen in the urine.
Although fluctuations in serum albumin, b ilirub in, alkaline phosphatase, yGT 
and GOT were seen in volunteers given LHS or the glucose/m altodextrin m ixture 
all values were in the normal c lin ica l range. There were no sign ificant differences 
in the mean concentrations of the test and contro l volunteers. This suggests that, 
at the level o f intake used, a chronically increased galactose consumption as LHS is 
unlikely to im pair live r function in healthy subjects.
3.5 Conclusions ajid Future Work
This study describes some of the chronic metabolic e ffects  produced in
normal, healthy young adults by a d ie t containing a moderate quantity o f LHS over
a ten week period. The quantity o f LHS used produced an increased intake of
d ietary galactose which is like ly  to exceed that resulting from  increased use of
LHS in food manufacture. Inclusion of LHS in the diet of volunteers over a ten
week period did not increase fasting serum galactose levels and did not a lte r the
tolerance of an acute peroral galactose load. I t  io^-t-hopef-ofey-un liko ly  tho t o
chronically increastrd-eonoumpt ion-of ■galactoso-ao LH S-AArefcri^-p&sult-in-symptomo of-
galactose to x ic ity  in normal mar*. Consumption of LHS-containing foods a t the
level used here did not appear to influence fasting serum glucose or insulin
concentrations and did not a lte r fasting serum to ta l cholesterol levels in
normolipaemic subjects. Although an increase in fasting serum trig lycerides was
at the time
seen fo llow ing inclusion o f LHS in the diet this was not of c lin ica l importancej^and 
could not be a ttribu ted  to an increased consumption o f d ie tary galactose per se.
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When consumed as LHS an increased intake o f dietary galactose is unlikely to 
a ffe c t normal live r function.
A ll vounteers investigated here were healthy and were w ith in  a narrow age 
range. It is not known if  s im ilar metabolic effects would have been seen in 
volunteers of d iffe ren t ages since it  has been suggested that the rate of galactose 
clearance from the blood varies w ith  age (Relander, 1968). Various endocrine 
disorders have been shown to influence the acute peroral galactose tolerance (1.10) 
and any chronic metabolic e ffects associated w ith  an increased consumption of 
d ietary galactose as LHS requires specific investigation in these patients. Peroral 
and intravenous tolerance of an acute galactose load have been shown to be 
impaired in patients w ith  live r disease (Stenstam, 1946) and an investigation o f the 
chronic metabolic e ffects  produced by inclusion o f LHS in the d ie t of these 
individuals is necessary. In addition, a fu rthe r investigation of the influence o f a 
chronically increased consumption o f galactose as LHS on fasting serum 
trig lyceride  levels in c lin ica lly  hypertrig lyceridaem ic subjects would be o f in terest.
Simultaneous ingestion o f alcohol reduces the tolerance o f an acute peroral 
or intravenous galactose load (1.10). The possible use of LHS in the manufacture o f 
alcoholic drinks remains o f in terest and a study of the acute and chronic metabolic 
e ffects  associated w ith  the consumption o f LHS together w ith  alcohol would be of 
use.
CHAPTER 4
THE INFLUENCE OF THE SEX OF THE CONSUMER 
AND THE MENSTRUAL CYCLE ON THE ACUTE 
METABOLIC RESPONSE TO PERORAL GALACTOSE
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4.1 Introduction
The serum galactose response to peroral galactose, given either as a standard 
galactose meal or as a body weight related load, varies considerably between 
individuals (Roe and Schwartzman, 1932; Stenstam, 1946; W illiams et al., 1983). 
However, l i t t le  data is available on the reproducib ility  of a galactose tolerance 
test in the same individual.
Several studies have reported a variation in the serum glucose response to 
peroral glucose in females during d iffe ren t weeks of the menstrual cycle (Okey and 
Robb, 1925; Ja rre tt and Graver, 1968; Macdonald and Crossley, 1970). In v itro  
studies demonstrated that the maximum rate o f glycolysis occurs just before 
ovulation and that blood levels of la c tic  and pyruvic acid peak at this tim e (Duboff 
c t al., 1961). An improvement in glucose tolerance m ight, therefore, be expected 
m id-cycle. However, in vivo studies have not supported this; the blood glucose 
response to peroral glucose being lowest during the phase o f menstrual flow  (Okey 
and Robb, 1925; Ja rre tt and Graver, 1968) and greatest during days 13-18 o f a 29 
day cycle (Macdonald and Crossley, 1970). This suggests tha t in women of 
reproductive age the maximum tolerance o f peroral glucose occurs during 
menstruation. In contrast, a deterioration in diabetic control has been described in 
female patients at or about the tim e of menstruation (Cramer, 1942; Hubble, 1954; 
Green, 1958) and it  is possible that ovarian hormones have an opposite e ffe c t when 
carbohydrate tolerance is already impaired (Gershberg, Javier and Hulse, 1967).
An a ltera tion in the metabolic response to d ietary carbohydrate has been 
reported in women using oral contraceptive agents although the results appear 
confusing; the effects seen depend upon the type and dose o f preparation used. 
Although raised fasting blood glucose levels have been reported in women taking 
oral contraceptives (Javier and Gershberg, 1964; Besch et al., 1965; Di-Paola et al., 
1968) this was not always confirm ed (Spellacy and Carlson, 1966; Wynn and Doar,
1966). Most authors, however, agree tha t trea tm ent w ith  a high dose, combined 
oestrogen-progestagen preparation impairs peroral glucose tolerance (Gershberg,
Javier and Hulse, 1964; Buchler and Warren, 1966; Wynn and Doar, 1966 and 1969; 
Di-Paola et al., 1968) and that it  is the oestrogen component which is involved in 
this e ffe c t (Javier and Gershberg, 1964; Wynn and Doar, 1969). Low dose 
preparations did not sign ificantly a lte r the metabolic response to peroral glucose 
(Spellacy, Buhi and Birk, 1980) and use o f very low dose oral contraceptives has 
been suggested to improve glucose tolerance (Clinch, Turnbull and Khosla, 1969). 
The known diabetogenic e ffec t of human pregnancy further suggests an influence 
o f ovarian steroids on glucose tolerance (Fisher, Sutherland and Brewsher, 1980).
Early work suggested that the tolerance of an acute peroral galactose load 
could be influenced by the sex o f the individual w ith females showing the greatest 
tolerance. Rowe (1924) reported that the mean peroral galactose load which 
produced galactosuria was 30g fo r males and 40g fo r females. The detection of 
galactosuria was based on the presence o f reducing bodies in the urine. Stenstam 
(1946) reported lower blood galactose levels in women than in men a fte r a 30, 40 or 
50g peroral galactose load, the differences were not significant. In both studies 
standard peroral galactose loads were administered and, i f  expressed per kg body 
weight, i t  is like ly  that the women received re la tive ly  more galactose than did the 
men.
A variation in peroral galactose tolerance in females over the menstrual 
cycle and an influence of pregnancy and lactation on peroral galactose tolerance 
has been reported. The urinary loss of lactose a fte r a peroral lactose load has been 
found to be less in females during pregnancy or menstruation than in males or in 
females during the in ter-m enstrual phase (Watkins, 1928). A progressive decrease 
in the urinary lactose excretion subsequent to peroral lactose has also been 
reported to occur as lacta tion advances (Watkins, 1928). Again the results were 
based on the excretion o f urinary reducing bodies, which were in terpre ted as 
indicating the presence o f lactose, although i t  is possible they may have re flected
the presence o f galactose in the urine. These results suggest an improvement in 
the tolerance of peroral lactose, and possibly galactose, in females during 
pregnancy and menstruation. They are in contrast to data reported by Rowe (1935) 
which showed that less peroral galactose was required to induce a galactosuria in 
pregnant or menstruating females, suggesting a reduction in peroral galactose 
tolerance at these times. Removal of the ovaries has also been found to lower 
peroral galactose tolerance in women of reproductive age (Rowe, 1935).
The present studies were undertaken to re-investigate the influence of the 
sex of the consumer and the menstrual cycle on the tolerance o f an acute, body 
weight related peroral galactose load.
Before onset of the study permission fo r experimentation was granted by the 
University o f Surrey E th ica l Com m ittee. P rio r to investigation the w ritten , 
informed consent was obtained from  a ll volunteers in accordance w ith  guidelines 
outlined in the University o f Surrey eth ica l guidelines fo r research and teaching.
4.2 A Preliminary Investigation
The acute metabolic response to peroral galactose was investigated in women 
at d iffe ren t times o f the menstrual cycle and in men on repeated testing. 
D ifferences in the response between men and women were studied. An abstract of 
this work has been published (Williams and Owens, 1985) and a copy is in the 
Appendices (page 216).
4.2.1 Subjects, M ateria ls and Methods
Seven female and six male volunteers, aged between 18 and 33 years, were 
studied. A ll were considered to be in good health, non-obese and w ith  no history of 
lactose intolerance or diabetes. A ll the female volunteers were nullipare and had 
histories o f regular 24-31 day menstrual cycles. None used any form  o f medication
or hormone preparation during the study period. Basal body temperature and onset 
o f menstruation were recorded by each female volunteer prior to and throughout 
the study period. An example of a basal body temperature chart recorded over a 28 
day ovulatory menstrual cycle is given in the Appendices (page 217).
Peroral galactose tolerance was measured in the female volunteers during 
each of the weeks 1, 2, 3 and 4 o f the ir menstrual cycle, starting at onset of 
menses and subsequently as best judged from  a previously recorded cycle. In the 
males tolerance was measured at weekly intervals over a four week period. 
Tolerance was assessed in each volunteer as described in 2.21. Serum was also 
assayed fo r glucose and insulin (2.3 and 2.4). Urine was collected fo r six hours from  
the tim e of ingestion of the test meal, the to ta l volume was recorded and an 
aliquot assayed fo r galactose (2.2).
For purposes o f comparison each female was assigned an a rb itra ry  28 day 
menstrual cycle. Each male was also assigned an arb itra ry  28 day cycle. Day 1 was 
taken as the f irs t  day o f menstruation in the females and the date o f the f irs t  
tolerance test in the males. Data was grouped according to sex and week 1 (day 27- 
3), 2 (day 6-12), 3 (day 13-19) or 4 (day 20-26) o f the 28 day cycle. The areas under 
the serum galactose, glucose and insulin response curves were calculated fo r each 
individual (2.22). Total urinary galactose excretion over the six hour co llection 
period was calculated and expressed as a percentage of the peroral load. The mean 
(x) and standard error of the mean (SE) were calculated fo r a ll groups of data and 
the means compared using a Student's t-te s t fo r paired data. Male and female data 
were compared using a Student's t-te s t fo r unpaired data.
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4.2.2 Results
4.2.2.1 The acute response to peroral galactose in female volunteers over 
the menstrual cycle
The mean serum galactose, glucose and insulin concentrations and the mean 
percentages of peroral galactose excreted in the urine are recorded in Table 8. 
Figure 12 shows the mean areas under the serum galactose response curves.
Peroral galactose produced an increase in the mean serum galactose 
concentration which rose to a maximum at e ither 30 or 60 minutes and had 
returned to near fasting values at 90 minutes. The mean serum galactose response 
to peroral galactose was found to be greatest during week 4 of the menstrual cycle 
but did not a lte r s ign ificantly  over the cycle.
When each female was considered individually the greatest serum galactose 
response was seen in a ll but one during either week 3 or 4 of the menstrual cycle. 
The one female who did not show this response did not show the rise in basal body 
temperature associated w ith  the occurrence o f ovulation and did not show any 
alteration in tolerance of peroral galactose over the menstrual cycle.
The mean serum glucose and insulin values were observed to increase s ligh tly  
in response to peroral galactose. However, there were no notable differences in the 
response over the menstrual cycle. Maximum mean serum glucose and insulin levels 
were consistently seen 13 minutes a fte r galactose ingestion. No s ign ifican t 
differences were found in the urinary excretion o f galactose over the menstrual 
cycle.
4.2.2.2 The acute response to peroral galactose in male volunteers during 
repeated galactose tolerance tests
The mean serum galactose, glucose and insulin concentrations and the mean 
percentages o f peroral galactose excreted in the urine are recorded in Table 9. 
Figure 12 shows the mean areas under the serum galactose response curves.
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Peroral galactose produced an increase in the mean serum galactose 
concentration which rose to a maximum at 30 minutes and had returned to near 
fasting values at 90 minutes. The differences recorded in the mean serum galactose 
response to peroral galactose on repeated testing in the males were much less 
marked than those found in the females during d iffe ren t weeks of the menstrual 
cycle. Unlike the females when the males were considered individually no pattern 
was observed in the serum galactose response to peroral galactose on repeated 
testing.
The mean serum glucose and insulin response to peroral galactose did not 
a lte r in repeated tests and there was no difference in the mean urinary galactose 
excretion.
4.2.2.3 Sex differences in the acute response to peroral galactose during
repeated galactose tolerance testing
The overall mean serum galactose, glucose and insulin response in the males 
is recorded in Table 10 and was compared w ith  the female response during each of 
the weeks 1, 2, 3 and 4 of the menstrual cycle.
No s ign ificant sex d ifference was seen in the mean area under the serum 
galactose response curve to peroral galactose. The overall mean area under the 
serum glucose response curve to peroral galactose in males was s ign ifican tly  
greater than in females during weeks 1, 2 (P<0.01) and 3 (P<0.001) of the menstrual 
cycle. Although the mean serum insulin levels o f male subjects a fte r galactose 
ingestion were higher than those recorded in the female group during any week o f 
the menstrual cycle no sign ificant sex difference was found in the mean areas 
under the response curves. There was no sex difference in the percentage o f 
ingested galactose excreted in the urine.
To estimate the varia tion in peroral galactose tolerance occurring at 
d iffe ren t times in the same subject the areas under the serum galactose response
TABLE 10
The Overall Mean Serum Galactose, Glucose and Insulin Response 
to Peroral Galactose in Males; w ith  Standard Errors (5E) 
and P values for comparison w ith the Female Reponse during 
Weeks 1, 2, 3 and 4 of the Menstrual Cycle when P<0.02
Minutes a fte r Galactose Ingestion Area 
under 
response 
curve- 
arb. units
0 13 30 60 90
Galactose X 0.03 0.66 D 1.78 1.45 0.32 98.85
(m m ol/L) SE +
0.02 0.08 0.17 0.28 0.13 10.68
• ■
Glucose X 4.83 # 5.37 •5.13 d 4.76 a 4.78 §448.40
(m m ol/L)
SE + 0.08 0.10 0.20 0.03 0.10 6.72
Insulin X 8.3 23.3 J20.8 10.6 8.6 1362.8
(mu/L)
SE + 0.6 2.3 2.6 0.6 0.7 109.4
D P<0.01 when compared to females during week 1. 
■ PC0.01 when compared to females during week 2. 
•  P<0.01 when compared to females during week 3. 
a  P<0.02 when compared to females during week 3. 
O P<0.001 when compared to females during week 3. 
A P<0.02 when compared to females during week 4.
curves on repeated testing in an individual were combined and the mean areas 
calculated. For each volunteer areas obtained during weeks 1, 2, 3 and 4 o f testing 
were expressed as a deviation from the ir mean area. The variance of these 
deviations was computed and was found to be sign ificantly greater fo r women than 
for men (P<0.025); the variance for women being 1255 and for men 514.
4.2.3 Discussion
The results show that there was no significant sex difference in the acute 
serum galactose response to a body weight related peroral galactose load. The 
serum glucose response to galactose was sign ificantly less in females during weeks 
1, 2 and 3 of the menstrual cycle than in males, but not during week 4 when peroral 
galactose tolerance in females was at its lowest. D ifferences in fasting serum 
glucose levels were not involved. The increase in blood glucose concentrations 
seen a fte r galactose ingestion is believed to be due to the hepatic conversion of 
galactose to glucose (Royle et al., 1978). I t  is possible, therefore, tha t a smaller 
glycaemic response to peroral galactose may re fle c t a lower galactose metabolism 
jn  vivo and hence a lower tolerance o f peroral galactose. However, the 
s ign ificantly  lower serum glucose response to peroral galactose seen in women 
during weeks 1, 2 and 3 of the menstrual cycle when compared to men was not 
associated w ith  a s ign ificantly  lower galactose tolerance. In accordance w ith  the 
greater serum glucose response to peroral galactose in the males, higher serum 
insulin concentrations occurred in men than in women subsequent to galactose 
ingestion although the difference was not significant.
An in ter-ind iv idua l variation in peroral galactose tolerance was seen w ith in  
both male and female groups o f volunteers and is in agreement w ith  earlie r work 
(Roe and Schwartzman, 1932; W illiams et al., 1983). Investigation o f the in tra - 
individual variation in peroral galactose tolerance showed a s ign ifican tly  greater 
variation in tolerance o f peroral galactose on repeated testing in young women
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Figure 13 Schematic Diagram of A Normal Ovulatory Menstrual Cycle
than in men and suggests an influence o f at least one additional variable on peroral 
galactose tolerance in the female.
The mean area under the serum galactose response curve to peroral galactose 
did not a lter s ign ifican tly  over the menstrual cycle although it  is of in terest that 
the maximum serum galactose response was consistently seen during week 3 or 4. 
D ifferences in renal galactose excretion were not involved. There was no pattern 
of variation in the serum galactose response to peroral galactose w ith in  individual 
men. An influence of the menstrual cycle on the tolerance of peroral galactose in 
females is possible.
A variation in serum oestrogen and progesterone levels occur during a 
normal, ovulatory menstrual cycle (Figure 13) and i t  is possible tha t cyc lic  
fluctuations in the serum level of these hormones influence peroral galactose 
tolerance in young women. Although basal body temperatures are able to confirm  
the occurrence of ovulation they cannot be re liab ly used to comment on hormone 
levels (Moghissi, Syner and Evans, 1972). Serum oestrogen and progesterone 
concentrations must be measured at the tim e of each tolerance test.
Ovulation has been found to be associated w ith  a sharp rise in the rate o f 
liquid gastric emptying which then declines steadily up to the ensuing ovulation 
(Macdonald, 1956). I t  has been suggested tha t this a ltera tion in gastric a c tiv ity  may 
account fo r the variation in tolerance o f peroral glucose observed in women during 
the menstrual cycle (Macdonald and Crossley, 1970) and i t  is possible tha t i t  may, 
at least in part, explain the variation in peroral galactose tolerance seen in the 
women investigated here.
4.3 The Influence of the Menstrual Cycle on the Acute Metabolic Response to
Peroral Galactose
4.3.1 Introduction
The prelim inary investigation suggested an influence of the menstrual cycle
on the tolerance o f peroral galactose in young women. I t  is possible that 
fluctuations in serum progesterone and/or oestrogen levels occurring during an 
ovulatory menstrual cycle a ffe c t peroral galactose tolerance and that variations in 
the rate o f liquid gastric emptying are involved. The aim of this study was to 
investigate the variation in peroral galactose tolerance in females during the 
menstrual cycle by studying women over several cycles and by measuring serum 
progesterone and oestrogen levels and the rate of liquid gastric emptying. I t  was 
decided to measure the tolerance of peroral galactose in women during the 
menstrual phase of the cycle when serum progesterone and oestrogen levels are 
low, at the pre-ovulatory oestrogen surge when serum oestrogen levels are high and 
progesterone levels are low and during the late secretory or early pre-menstrual 
phase when serum levels o f both hormones are high.
Rapid gastric emptying has previously been shown to be associated w ith  an 
early appearance of high peak plasma paracetamol levels in response to peroral 
paracetamol (Heading et al., 1971). These authors found a corre lation between 
serum paracetamol concentrations a fte r 30 or 60 minutes and the ha lf tim e of 
liquid gastric emptying. I t  was decided to assess the rate of liquid gastric emptying 
at the tim e of each tolerance test using this method.
4.3.2 Subjects, M ateria ls and Methods
Eight female volunteers, aged between 20 and 37 years, were studied. A ll 
were nullipare and had histories of regular 26-36 day menstrual cycles. Subject 
selection was as before. Basal body temperature and onset of menstruation were 
recorded by each volunteer fo r a minimum two cycles prior to onset o f the study 
and throughout the study period. Temperature records were used to select the date 
of the galactose tolerance test fo r each individual.
Peroral galactose tolerance was measured in females during the menstrual 
phase (test A), at the m id-cycle oestrogen surge (test B) and during the la te
secretory or early pre-menstrual phase (test C). Each volunteer was studied over 
two or three complete menstrual cycles. Tolerance was assessed as described in 
2.21. A t the tim e of each tolerance test 20mg of paracetamol (panadol soluble, 
Winthrop Pharmaceuticals)/kg. B.W. was dissolved in the galactose test meal and 
the resulting serum paracetamol concentration a fte r 60 minutes was used as an 
index o f liquid gastric emptying tim e. Serum was collected (2.1) and assayed fo r 
galactose, glucose, insulin and paracetamol (2.2, 2.3, 2.4 and 2.13). Fasting 
samples were also assayed fo r progesterone and 17-8-oestradiol (the active 
metabolite o f oestrogen) (2.14 and 2.15).
As before each female was assigned an arb itra ry  28 day menstrual cycle. 
Data was grouped according to test A (days 27-6), B (days 13-17) and C (days 18- 
26). The areas under the serum galactose, glucose and insulin response curves were 
calculated fo r each individual (2.22). The mean (x) and standard error o f the mean 
(SE) were calculated fo r a ll groups of data and the means compared using a 
Student's t-te s t fo r paired data. Product moment coe ffic ien t o f corre lation was 
applied in the corre lation studies. To m inim ize the in ter-ind iv idua l varia tion values 
recorded fo r an individual were combined and the means calculated. Data a t each 
testing tim e were expressed as a deviation from  this mean fo r use in corre la tion 
studies.
4.3.3 Results
4.3.3.1 The Acute Response to Peroral Galactose in Female Volunteers
over the menstrual Cycle
The mean serum galactose, glucose and insulin concentrations are recorded in 
Table 11 and illustra ted as the mean serum galactose, glucose and insulin response 
curves (Figures 14 and 15).
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Peroral galactose produced an increase in the mean serum galactose 
concentration; the tim e taken for the peak value to occur and the duration of the 
galactosaemia were as described in the females investigated earlier. The greatest 
mean serum galactose response to peroral galactose was seen during test C 
although there was no significant difference in the mean response over the 
menstrual cycle. When each menstrual cycle was considered individually the 
greatest serum galactose response was seen during test C in 13 out of the 19 cycles 
fo r which complete data was available. The maximum response was recorded during 
test A in only 1 cycle studied.
The mean serum glucose and insulin values were observed to increase s lightly 
in response to peroral galactose and maximum values were consistently seen a fte r 
15 minutes. There were no notable differences in the mean serum glucose or 
insulin response to peroral galactose over the menstrual cycle.
4.3.3.2 The Acute Serum Paracetamol Response to Peroral Paracetamol
in Female Volunteers over the Menstrual Cycle
The mean serum paracetamol concentrations are recorded in Table 12. The 
mean serum levels recorded at 60 minutes are shown in Figure 16.
There was no difference in the mean serum paracetamol response to peroral 
paracetamol over the menstrual cycle; maximum mean serum levels were recorded 
at 60 minutes during tests A, B and C. When each menstrual cycle was considered 
individually maximum serum paracetamol concentrations were consistently seen at 
60 minutes.
No corre lation was found between the 60 m inute serum paracetamol 
concentrations and the areas under the serum galactose response curves to peroral 
galactose.
TABLE 12
Mean Serum Paracetamol Response to Peroral Paracetamol in Female Volunteers
at Test Times A, B and C of the A rb itra ry  28 day Menstrual Cycle (n=8)*;
w ith  and Standard Errors (SE)
Serum Paracetamol 
Test um ol/L
0 15 30 60 90
A x 2.63 74.70 115.00 135.54 117.29
SE + 0.32 9.60 6.26 3.65 4.68
B x 2.43 83.67 118.39 131.54 111.25
SE + 0.25 9.97 5.11 1.98 1.07
C x 2.72 77.63 127.52 137.40 115.15
SE + 0.40 5.43 3.88 4.79 3.99
*  8 volunteers each studies over 2 or 3 complete cycles
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Figure 16 The Mean Serum Progesterone, 17 8-oestradio l and Peak Paracetam ol 
Concentrations and Mean Areas under the Serum Galactose Response 
Cuves to Peroral Galactose in Females during Test Times A , B and C 
o f a 28 Day Menstrual cycle (n = 8 )*; T = mean + SE.
*8  Volunteers each studied over 2 or 3 complete cycles
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Figure 17 The Relationship Between Serum Progesterone Concentrations and
Areas under The Serum Galactose Response Curves to Peroral
Galactose in Females over a 28 Day Menstrual Cycle (n = 8 )* . (r =
0.52, P<0.01)
*8  Volunteers each studied over 2 or 3 complete cycles
4.3.3.3 Serum Progesterone and 17-8 oestradiol concentrations in Female
Volunteers over the Menstrual Cycle
The mean serum concentrations of progesterone and 17-3 oestradiol at test 
times A, B and C are shown in Figure 16. The relationship between serum 
progesterone levels and the area under the serum galactose response curve to 
peroral galactose is shown in Figure 17.
The greatest mean serum progesterone concentration was seen at test tim e C 
and was sign ificantly greater than the mean serum levels recorded at test times A 
and B (P<0.001 at both times).
The mean serum concentration of 17-3-oestradiol at test tim e A was 
s ign ificantly  lower than at times B (P<0.001) or C (P<0.02).
A positive corre lation was observed between serum progesterone levels and 
the area under the serum galactose response curve (b = 2.24, P<0.01). No 
corre lation was found between serum oestradiol levels and the area under the 
serum galactose response curve.
4.3.4 Discussion
These results are in agreement w ith  those of the prelim inary study and 
appear to confirm  the variation in tolerance o f a body weight re lated peroral 
galactose load over the menstrual cycle. Although the mean serum galactose 
response to peroral galactose did not a lte r s ign ifican tly  in females over the 
menstrual cycle, individual data again showed that the maximum response was 
consistently seen during the secretory or pre-menstrual phase. Furtherm ore, i t  is 
possible to combine data on peroral galactose tolerance at test times A, B and C 
w ith  data collected in the prelim inary investigation during weeks 1, 2 and 3 
respectively. When this is done the mean serum galactose response during days 18- 
26 o f a 28 day menstrual cycle was s ign ifican tly  greater than during days 27-6 
(P<0.01, n = 14). Therefore, i t  would seem that the tolerance of peroral galactose
in young women is least during the secretory or pre-menstrual phase of the 
menstrual cycle.
A ll menstrual cycles studied were ovulatory, as confirmed by individual data 
on basal body temperature and by the rise in serum progesterone levels seen during 
the secretory/early pre-menstrual phase of each cycle.
A variation in peroral galactose tolerance has been described previously in 
females over the menstrual cycle, however, in contrast to the present 
investigation, a reduction in tolerance was suggested to occur during menstruation 
(Rowe, 1935). I t  is possible that this discrepancy is due to a d ifference in the 
experimental protocol used; in the earlier study a series o f galactose test meals of 
increasing concentrations were used to produce a transitionary galactosuria which 
was assumed to indicate an exceeded lim it  o f galactose u tiliza tio n  in vivo* 
Detection of galactose in the urine a fte r low peroral loads was used as an index o f 
a low tolerance. In addition specific, quantita tive enzymic assays fo r galactose 
were not available at the tim e of the earlie r work and no data was provided on the 
blood galactose concentrations subsequent to galactose ingestion. Watkins (1928) 
reported that the urinary loss of lactose a fte r adm inistration of a peroral lactose 
load was less in females during menstruation than during the in ter-m enstrual phase. 
Again, the results were based on the excretion of reducing bodies and may have 
re flected the presence o f galactose in the urine. I f  so the data suggest a greater 
tolerance of peroral galactose during menstruation and are in agreement w ith  those 
reported here.
An increase in blood glucose concentrations subsequent to galactose ingestion 
has been described before (Stenstam, 1946; Dormandy et al., 1959; Ganda et al., 
1979; W illiams et al., 1983) and is believed to be due to the hepatic conversion of 
galactose to glucose (Royle e t al., 1978). D ifferences in the rate o f galactose 
metabolism jn  vivo m ight, therefore, be expected to result in d iffe re n t serum 
glucose concentrations. Although slight changes were observed in the serum
glucose response to peroral galactose over the menstrual cycle none were 
s ta tis tica lly  significant and no pattern of variation was seen in individual women. 
This suggests that the variation in peroral galactose tolerance seen in females over 
the menstrual cycle was not due to differences in its hepatic metabolism to 
glucose. However, unlike serum galactose concentrations, serum glucose levels are 
sensitive to experimental manipulations and i t  is possible that fluctuations in serum 
levels due to such influences may have prevented any a lteration in the jn  vivo 
conversion of galactose to glucose from  being apparent.
A small rise in serum insulin levels a fte r galactose ingestion has also been 
reported previously (Shima at al., 1972; Ross and Dupre, 1978; Ganda et al., 1979; 
Morgan et al., 1979; W illiams et al., 1983). In accordance w ith the serum glucose 
results no significant change was seen in the serum insulin response to ingestion of 
a galactose test meal in females over the menstrual cycle.
Data presented here suggest that there is no variation in the rate o f liquid 
gastric emptying over the menstrual cycle and that there is no association between 
the rate o f liquid gastric emptying and serum concentrations of e ither progesterone 
or oestradiol. In contrast, Macdonald (1956) described a marked increase in the 
rate of liquid gastric emptying at ovulation followed by a gradual decrease up to 
the ensuing ovulation. Gastric emptying was measured by gastric in tubation 
whereas in this study the peak serum paracetamol concentration occurring 60 
minutes a fte r paracetamol ingestion was used as an index o f gastric a c tiv ity . 
D ire c t comparison o f results is thus impossible since data on paracetamol 
absorption re fle c t both the rate of liquid gastric emptying and the trans it tim e in 
the gut to the site o f absorption whereas gastric intubation is a measure o f gastric 
emptying only. A recent study, in which gastric emptying was determined d irec tly  
using a dual isotope scintigraphic technique, showed no e ffe c t o f the menstrual 
cycle on gastric a c tiv ity  and is, therefore, in agreement w ith  the present 
investigation (Horow tiz et al., 1985).
I t  would seem that alterations in gastric ac tiv ity  do not cause the difference 
in peroral galactose tolerance seen in females at d iffe ren t times of the menstrual 
cycle. S im ilarly, a combined e ffe c t of gastric and intestinal a c tiv ity  over the 
cycle is unlikely to be involved since a prolonged gastrointestinal transit tim e has 
been described during the secretory phase (Wald et al., 1981; Davies et a l., 1986), 
i.e. when the serum galactose response to peroral galactose is greatest.
The variation seen in serum progesterone and oestradiol concentrations over 
the menstrual cycle was as expected and showed that the maximum tolerance of 
peroral galactose occurs at a tim e when serum levels of both hormones are low. 
Conversely, simultaneously elevated hormone concentrations were associated w ith  
a reduced peroral tolerance, A slight positive corre lation was observed between 
serum progesterone levels and the area under the serum galactose response curve 
to peroral galactose whereas no such association occurred fo r serum oestradiol 
values. This suggests a possible influence of progesterone on the tolerance o f a 
peroral galactose load in the female. However, consideration of isolated hormonal 
e ffects is of lim ited  physiological importance since several factors are like ly  to be 
in operation jn  vivo and an in teraction between variables influencing peroral 
galactose tolerance is possible. To investigate the combined e ffe c t o f a lterations in 
serum progesterone and oestradiol levels over the menstrual cycle on peroral 
galactose tolerance the m ultip le corre lation coe ffic ien t was computed to be 0.52 
(P<0.05). Therefore, i t  would appear that fluctuations in serum progesterone and 
oestradiol concentrations occurring in females over the menstrual cycle may 
account fo r the variation seen in peroral galactose tolerance. Serum progesterone 
levels seem to be o f greater importance although a combined influence of 
progesterone and oestradiol is possible.
Elevated serum progesterone concentrations or simultaneously elevated 
serum progesterone plus oestradiol concentrations appear to reduce the tolerance 
o f a bodyweight related peroral galactose load. A lte rna tive ly , i t  may be tha t a
decrease in blood levels o f both these hormones, as is seen during menstruation, 
improves peroral galactose tolerance in females. Data from the prelim inary study 
show that the overall mean serum galactose response to peroral galactose in males 
was sim ilar to that observed in females during weeks 3 or 4 of the menstrual cycle 
but was greater than the female response seen during weeks 1 or 2. Although no 
significant differences were observed in the serum galactose response between men 
and women these results appear to suggest an improvement in peroral tolerance in 
females during the f irs t half of the cycle. However, when each female was 
considered individually the maximum response to peroral galactose was 
consistently seen during the second half of the cycle whereas occurrence of the 
minimum response during menstruation was less consistent; thus suggesting a 
possible reduction in peroral galactose tolerance at a tim e when serum 
progesterone and oestradiol levels are raised.
A greater knowledge of the peroral galactose tolerance in females during 
pregnancy and lacta tion and in post-menopausal women or in women using oral 
contraceptives would be of interest. However, i t  is unlikely tha t such studies would 
fu rthe r elucidate the mechanism involved. Peroral galactose tolerance has been 
found to be least in women taking a triphasic oral contraceptive agent (trino rd ia l) 
when the dose o f exogenous steroids was at its  maximum; the reduction in 
tolerance was not s ign ificant (Smith, personal communication). The mean serum 
galactose response to peroral galactose recorded in these women during d iffe re n t 
phases o f the 28 day "p ill cycle" is shown in the Appendices (page 218). 
U nfortunate ly serum progesterone and oestradiol concentrations were not 
measured at the tim e o f each tolerance test and fluctuations in the endogenous 
progesterone and oestradiol secretion are unknown.
4.4 Hypotheses and Future Work
The acute serum galactose response to a peroral galactose load can be 
influenced by changes in gastrointestinal transit tim e and hence in the rate of 
galactose absorption, by changes in galactose uptake and metabolism in the tissues 
and by alterations in its urinary excretion. A lterations in the amount o f galactose 
excreted in the urine, in the rate of liquid gastric emptying and in the in testinal 
transit time do not appear to account for the variation in tolerance of peroral 
galactose seen in females over the menstrual cycle. The mechanism involved in this 
variation is unknown although several hypotheses are available. Corre lation data 
suggest a possible influence of fluctuations in blood progesterone or progesterone 
plus oestradiol levels on peroral galactose tolerance in women. A specific influence 
of progesterone and oestradiol on galactose metabolism has been demonstrated in 
animals and the occurrence o f a sim ilar influence in women must be considered.
Earlier jn  v itro  work has shown progesterone to stim ulate the oxidation of 
g a la c to s e - l-^ C  to in rabbit live r slices (Pesch and Topper, 1958) and slices
of small intestine (Simon, Pesch and Topper, 1959). Progesterone adm inistration 
has also been found to s ign ifican tly  increase the ab ility  to oxidise galactose to CC^ 
in three pre-pubertal males w ith  congenital galactosaemia (Pesch, Segal and 
Topper, 1960). However, such an e ffe c t has not been reported in normal post- 
pubertal males (Segal and B la ir, 1961). The mechanism by which progesterone 
exerts a stim ulatory e ffe c t on galactose oxidation is thought to involve an increase 
in the UDP-gal-4-epimerase a c tiv ity  subsequent to a reduction in the level of 
NADH due to progesterone inhib ition o f NADH form ation (Simon e t al., 1959; 
Topper, Maxwell and Pesch, 1960). I f  such a mechanism is in operation over the 
normal female menstrual cycle an improved tolerance o f peroral galactose would 
be expected to coincide w ith  raised serum progesterone levels. This was not 
apparent, a reduced tolerance o f peroral galactose was associated w ith  elevated 
serum progesterone levels.
A lterations in the a c tiv ity  of ga l-l-P  uridyltransferase and UDP-gal 
pyrophophorylase have been demonstrated during the ra t oestrous cycle (Nelson et 
al., 1977). Oestradiol adm inistration has been found to increase the a c tiv ity  of gal- 
l-P  uridyltransferase (Nelson, Jato-Rodriguez and Mookerjea, 1975) and to 
decrease the a c tiv ity  of UDP-gal pyrophosphorylase (Jato-Rodriguez, Nelson and 
Mookerjea, 1976) in the endometrium of ovariectomized rats. Progesterone was 
reported to prevent this e ffe c t (Jato-Rodriguez et al., 1976). G a i-l-P  
uridyltransferase and UDP-gal pyrophosphorylase are both involved in the jn  vivo 
metabolism of galactose and alterations in the ir a c tiv ity  over the ra t oestrous 
cycle are thought to be conducive to an increased synthesis o f glycoproteins at 
ovulation.
In man mucous glycoproteins contain predominantly oligosaccharide groups 
attached to a polypeptide backbone either by L-serine-N-acetyl-D-galactosam ine 
or L-threonine-N-acetyl-D-galactosam ine linkages (Schachter, 1978). Although 
glucose is the major jn  vivo source o f the monosaccharide components of 
mammalian glycoproteins d ietary D-galactose can also enter the m etabolic 
scheme. Pre-ovulatory cervical mucous is known to be under oestrogenic contro l 
and from  menstruation to the tim e o f ovulation i t  progressively decreases in 
viscosity and increases in quantity and Spinnbarkeit (Doehr, 1977). Follow ing 
ovulation the secretory a c tiv ity  o f the epitheiia is inhibited by progesterone and 
cervical mucous is seen to increase in viscosity and to decrease in quantity and 
spinnbarkeit (Doehr, 1977). I t  is, therefore, possible tha t a lterations in serum 
oestradiol and progesterone levels over a normal menstrual cycle regulate the 
synthesis o f glycoproteins in the cervical mucous of female Homo sapiens. 
However, i t  is unlikely tha t this would result in a varia tion in the acute m etabolic 
reponse to peroral galactose. Furthermore, i f  such a mechanism is in operation 
over the female menstrual cycle and is re flected as a varia tion in tolerance o f an
acute peroral galactose load the greatest tolerance o f galactose m ight be expected 
to occur at around the tim e of ovulation when serum oestradiol concentrations are 
maximum and when serum progesterone concentrations are low. This was not seen 
here, the greatest tolerance of peroral galactose occurred during menstruation. 
Determ ination of galactose metabolising enzymes over the menstrual cycle in man 
would, however, be of interest. Since the human live r is inaccessible analysis of 
enzymic ac tiv ities  in red blood cells is envisaged. A lte rna tive ly , studies using a 
suitable animal model to investigate the influence of progesterone and oestradiol 
on the acute metabolic response to peroral galactose would be of in terest. The ra t 
is not a suitable animal model for galactose metabolism in man (Tygstrup e t al., 
1971; Newstead, 1979; W illiams and Owens, 1984).
I t  is possible that other cyclic female hormones may also a ffe c t galactose 
tolerance in vivo. Serum prolactin levels progressively increase during the 
p ro life ra tive  phase o f the menstrual cycle; maximum serum values are found at 
m id-cycle although concentrations recorded post-ovulation are greater than during 
menstruation (Vekemans et al., 1977). Such variations are of moderate amplitude 
when compared w ith  those fo r oestradiol and progesterone. In addition, changes in 
serum pro lactin  concentrations are d iff ic u lt  to detect in individual cycles since 
levels are influenced by circadian rhythms and episodic releases which may be o f 
greater e ffe c t than the menstrual cycle (Robyn e ta l. ,  1973). Serum pro lactin  levels 
were, therefore, not determined in this study. P rolactin has been suggested to 
influence peroral glucose tolerance in man (Horrobin, 1973) and has been shown to 
accelerate cataractogenesis in female rats fed 30% galactose by weight (Gona and 
Fu, 1982). However, this e ffe c t of pro lactin  on galactose cataract fo rm ation  has 
recently been shown to be mediated via an osmoregulatory action o f pro lactin  
(Gona and G orelli, 1985) and i t  is unlikely tha t serum pro lactin  concentrations 
would influence peroral galactose tolerance in females over the menstrual cycle.
A lte rna tive ly  i t  may be that the variation in peroral galactose tolerance seen 
over the menstrual cycle is a secondary e ffe c t of fluctuations in serum 
progesterone and oestradiol concentrations. Insulin binding to monocytes has been 
shown to be greater in females pre-ovulation than post-ovulation and appears to be 
inversely related to serum concentrations of 17-8 oestradiol, progesterone and 
17a-hydroxyprogesterone (Berto li et al., 1980). I t  is believed that this difference is 
prim arily  due to changes in receptor concentration rather than receptor a ff in ity  
(Berto li £ t al., 1980). Since monocyte receptors are believed to m irro r insulin 
receptors at target tissues (Gambhir, Archer and Bradley, 1978) a s im ilar variation 
in insulin binding at target tissues is assumed to occur over the menstrual cycle. A 
positive corre lation has been found between insulin binding and the rate of plasma 
glucose disappearance subsequent to an intravenous glucose load (Beck-Nielsen and 
Pedersen, 1978) and a decrease in insulin sensitiv ity caused by a reduction in the 
number of insulin receptors has been suggested to account for the deterioration of 
glucose tolerance in normal late pregnancy (Beck-Nielsen et al., 1979) and in the 
second ha lf of the menstrual cycle (Berto li et al., 1980).
The variation seen in tolerance of a body weight related peroral galactose 
load over the menstrual cycle mimics the variation reported to occur in peroral 
glucose tolerance (Okey and Robb, 1925; Ja rre tt and Graver, 1968; Macdonald and 
Crossley, 1970). I t, therefore, seems possible tha t alterations in serum 
progesterone and oestradiol concentrations influence tolerance of peroral galactose 
in females via an e ffe c t on insulin binding to receptor sites and hence on insulin 
sensitiv ity. Although galactose does not require insulin fo r its jn  vivo metabolism 
(Roe and Schwartzmann, 1932; Banjeree and Divakaran, 1957) several studies have 
shown tha t intravenous insulin adm in istration increases the volume of galactose 
d istribu tion in dogs, rabbits and rats (Levine et al., 1950; Goldstein e t al., 1953; 
Wick and Dury, 1953; Lotspeich and Wheeler, 1962; Kvam, 1964). Furtherm ore, i t  
has been demonstrated tha t insulin increases the uptake o f galactose by jn  v itro
muscle preparations (Kono and Colowick, 1961) and by epididymal fa t cells (Vega 
and Kono, 1978). A decrease in insulin sensitiv ity, occurring during the second half 
of the menstrual cycle when serum progesterone and oestradiol levels are raised, 
m ight thus reduce the tolerance of peroral galactose in females via a fa ll in tissue 
galactose uptake. Such a decrease in sensitiv ity to insulin would be expected to 
result in a rise in fasting serum glucose and insulin concentrations post ovulation. 
Although maximum fasting serum glucose values were seen during the 
secretory/early pre-menstrual phase of the menstrual cycle no sign ificant 
differences occurred and no sign ificant changes were observed in fasting serum 
insulin levels. However, as discussed earlier, serum glucose levels are d if f ic u lt  to 
in te rpre t and single fasting concentrations o f both glucose and insulin are of 
lim ited  value. O f possible greater use would be an investigation of the acute serum 
glucose and insulin response to an intra-venous glucose load in females during the 
phases o f the menstrual cycle in which peroral galactose tolerance has been 
assessed. Determ ination of insulin binding to monocytes at these times would also 
be of interest. In vivo studies on the influence of progesterone and/or 17-B- 
oestradiol on galactose uptake into body tissues are desirable and the use o f a 
suitable animal model is envisaged.
Cortiso l has been found to inh ib it galactose oxidation to CC^ in mice (Plager, 
Matsui and Ariyoshi, 1969) and to influence the tolerance of intravenous galactose 
in man (Hein-Sekula and Siedek, 1953). Progesterone binds to the corticostero id - 
binding globulin in the blood, thereby causing a displacement o f co rtiso l to the 
free, active frac tion  (Grodsky, 1980). I t, therefore, seems tha t a ltera tions in 
peroral galactose tolerance over the menstrual cycle due to an e ffe c t o f cortiso l 
cannot be discounted. An influence o f additional steroidal hormones such as 
androgens is also possible.
Since galactose is p rim arily  metabolsed in the live r an a lte ra tion  in general 
liv e r function over the female menstrual cycle could result in a varia tion in peroral
galactose tolerance. Anim al data has shown a sex difference in the metabolism of 
many drugs which is abolished fo llow ing hypophysectomy (Gustafsson and Stenberg, 
1976). A hormonal influence on live r function via an e ffec t on the p itu ita ry  gland 
has, therefore, been postulated (Gustafsson ejt al., 1980). I t  seems possible tha t a 
variation in hepatic a c tiv ity  m ight occur over the menstrual cycle due to an 
influence of the female steroids at the hypothalam o-pitu itary-liver axis and that 
this variation may cause an alteration in hepatic galactose metabolism and hence 
in peroral galactose tolerance.
However, in the physiological state i t  is like ly  that several in teracting 
variables influence the acute metabolic response to a peroral galactose load in man 
and i t  may well be that many factors influence peroral galactose tolerance in 
females over the menstrual cycle. Although of interest, the variation in tolerance 
o f peroral galactose occurring over an ovulatory menstrual cycle appears to be 
small and is unlikely to be o f any c lin ica l importance in normal, healthy women.
CHAPTER 5
AN INVESTIGATION OF SOME OF THE CHRONIC  
METABOLIC EFFECTS OF DIETARY GALACTOSE 
SEEN IN  RATS AND GUINEA-PIGS
5.1 Introduction
The pathogenesis of galactose-induced cataract has been described in rats fed 
high galactose diets (Korc, 1961; Patterson and Bunting, 1964; Patterson and 
Patterson, 1965) and a sim ilar mechanism is believed to operate in man. As 
discussed (1.13), chronically raised blood galactose levels in the ra t result in 
accumulation o f galactose in the lens of the eye. Cataract form ation is then 
thought to result from  the reduction o f galactose to ga lactito l which exerts an 
osmotic pressure and draws water into the lens. I f  sustained, this build up of water 
disrupts the crysta lline structure o f the lens and causes an imbalance o f 
electro lytes, amino acids, adenosine phosphates, glutathione and protein. G a lactito l 
accumulation has been demonstrated in the lens o f human patients w ith  c lin ica l 
galactosaemia and cataract (Quan-Ma et al., 1966).
Development o f cataract was f irs t reported in rats fed galactose as lactose in 
diets containing 70% or 50% w /w  lactose (M itche ll and Dodge, 1935). Studies have 
subsequently shown cataract development in rats fed diets containing 30-50% w /w  
galactose (Van Heyningen, 1959; Korc, 1961; Kinoshita et al., 1962; Patterson and 
Bunting 1964; Gona, 1984). Both the rate and severity o f galactose cataract 
form ation in the ra t have been shown to depend on age (R ichter and Duke, 1970) 
and on the quantity o f galactose consumed (Keiding and Mellemgaard, 1972). I t  has 
been suggested that cataractogenic changes occur in the lens when the galactose 
intake exceeds the capacity fo r galactose elim ination and tha t in young adult rats 
this level corresponds to as l i t t le  as 1% of the daily energy intake (Keiding and 
Mellemgaard, 1972). Galactose-induced cataract is, therefore, easy to  produce in 
young rats and fo r this reason they are a frequently used animal model in which to 
investigate galactose to x ic ity  (1.13). Other aspects of galactose to x ic ity  
demonstrated in rats include teratogenic e ffects  in the foetuses o f dams fed 40% 
o f the d ietary energy as galactose during pregnancy (Spatz and Segal, 1965; 
Haworth et al., 1969).
The ra t is not a good animal model o f galactose metabolism fo r man and i t  is 
impossible to extrapolate quantita tive studies in rats to man since rats have a 
much lower tolerance of galactose (Cori and Cori, 1934; Harding et al., 1934). The 
rate o f galactose uptake by the ra t liver was found to be about ha lf tha t o f the 
human live r (Tygstrup et al., 1971). In contrast, in v itro  studies on galactose 
metabolism in red blood cells have shown that the maximum galactose elim ination 
rate (Keiding, 1983) and the a c tiv ity  of galactokinase (Gupta, Irvine and Harley, 
1972) are greater in ra t than in human erythrocytes. This suggests tha t galactose 
metabolism in red blood cells may be of greater importance in the ra t than in man. 
However, i t  is unlikely tha t erythrocyte galactose metabolism would be o f major 
quantita tive importance when compared to the hepatic metabolism in e ither 
species. I t  has been suggested tha t d iffe ren t proteins may be responsible fo r 
galactose phosphorylation in the red blood cells of rats and man (Magnani e t al., 
1981). In addition, glucose does not reduce the serum galactose response to an 
acute peroral galactose load in the ra t as i t  does in man (Newstead, 1979; W illiam s 
and Owens, 1984). Since galactose is rare ly ingested as a monosaccharide but is 
usually consumed in the form  of lactose, the e ffe c t of glucose on peroral galactose 
tolerance must be considered when investigating its  metabolic e ffects  or potentia l 
to x ic ity  to man.
Using a suitable animal model i t  would be possible to investigate in greater 
deta il the chronic metabolic and tox ic  e ffects  o f galactose in man. Factors 
influencing the acute metabolic response to peroral galactose could also be 
investigated fu rther. Due to the inaccessibility o f the human live r, studies on 
galactose metabolism and to x ic ity  are frequently undertaken using an animal model 
or involve the determ ination o f galactose metabolising enzymes in human 
erythrocytes. However, the live r is the prim ary site o f galactose metabolism in 
vivo (1.7) and i t  is not known i f  changes in the ac tiv itie s  o f galactose m etabolising 
enzymes in the red blood cells re fle c t changes in the hepatic enzyme a c tiv itie s  and 
hence in hepatic galactose metabolism. Data on the relationship between galactose
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metabolising enzyme ac tiv ities  in the erythrocytes and in the live r o f a suitable 
animal model o f galactose metabolism would, therefore, be of value.
I t  has been suggested that the guinea-pig m ight be an appropriate animal
model in which to fu rther study galactose metabolism and tox ic ity  in man since i t
has been shown to respond in the same way to ingestion o f an acute peroral
galactose and glucose m ixture (W illiams and Owens, 1984). Like man, the guinea-
not
pig has a dietary requirement for ascorbic acid and was foundj^to develop cataract 
when galactose was administered together w ith  ascorbic acid in the drinking water 
(Kosegarten and Maher, 1978). Unfortunately, analytical details o f the d ie t used 
and the quantities o f galactose consumed were not provided. Increased data on the 
rate o f hepatic galactose uptake and metabolism and on the susceptib ility  to 
galactose-induced cataract are required in this species.
The mouse is not a suitable model o f galactose metabolism fo r man (W illiam s 
and Owens, 1984). Although the chick has been used to investigate galactose 
to x ic ity  (Wells and Segal, 1969; Mayes, M ille r and Myers, 1970) i t  must also be 
considered to be a poor model because it  is a non-mammal and would not natura lly  
encounter galactose in the diet.
I t  is o f in terest that an increased excretion o f urine has been frequently  
described in rats fed galactose (Craig and Maddock, 1953; Kuroda, 1971; C ryer and 
Bartley, 1973), lactose or hydrolysed lactose (David et al., 1980). An increased 
water consumption was also described in these animals although i t  was not 
quantified. Studies in obese, hypertensive and normal man have reported an 
increased urinary excretion o f sodium and potassium during fasting which was 
rapid ly abolished fo llow ing carbohydrate feeding (Veverbrants and A rky, 1969; 
North; Lascelles and Coates, 1974; K ra ik itpan itch , Chrysant and Lindeman, 1975). 
However, although glucose, fructose, sucrose and lactose a ll caused antinatriu resis 
and antikaliuresis, in fasting man galactose adm inistration produced antika liuresis 
only (Rebello, Hodges and Smith, 1983). These results are o f possible im portance in
the study o f hypertension and an investigation of the influence o f d ietary galactose 
on water and e lectro ly te  balance would be of interest.
The aim of this study was to investigate some of the chronic metabolic 
e ffects  of d ietary galactose seen in rats and guinea-pigs and to comment on the use 
of the guinea-pig as a model o f galactose metabolism for man. The influence of 
d ietary galactose on the water and e lectro ly te  balance in these animals was also 
investigated.
In this study the upper lim it  of galactose intake was set at 30% of the 
metabolisable energy to be supplied as galactose in order to correspond w ith  the
quantity o f galactose found to produce advanced nuclear cataract in rats (Keiding
and Mellemgaard, 1972). A lower level o f galactose intake was set at 20% of the
metabolisable energy to be supplied as galactose and was used to investigate the
relationship between dose and cataract development.
5.2 M ateria ls and Methods
Male weanling rats (Tuck Wistar) and quinea-pigs (Dunkin H artley) were 
randomly assigned to one of three groups and fed diets as described in Table 13. 
The percentage o f the metabolisable energy provided as carbohydrate, fa t and 
protein and the ra tio  o f polyunsaturated fa tty  acids: saturated fa tty  acids were as 
found in the usual chow diet of laboratory rats and guinea-pigs. The galactose used 
in the test diets was anhydrous D-galactose (BDH cat. no. 38026); the glucose used 
was D-glucose (BDH cat. no. 10117). A ll other d ietary ingredients were supplied by 
S c ien tific  D ie t Services (Essex, England). Further details of the diets are provided 
in the Appendices (page 219). The test animals were fed ad lib itum  fo r a ten week 
period. Each test animal was allocated a pair-fed contro l animal. Water was made 
free ly available to a ll animals.
Body weights were recorded before and at weekly in tervals during the study. 
The volume o f water consumed by each animal over a 24 hour period each week
143
TABLE 13
Composition of the Diets Fed to the Test (Groups A and B) 
and Control Animals; Showing the Percentage of Metabolisable 
Energy (E) Provided from Carbohydrate, Fat and Protein Sources
GROUP
A B Control
(% E) (% E) (% E)
Carbohydrate
Galactose 20 30 -
Glucose 56 46 76
*PU FA - Corn Oil 4.5 4.5 4.5
Fat
*SFA - Hydrogenated 3.5 3.5 3.5
Coconut O il
Protein Casein 16 16 16
*PU FA - Polyunsaturated fa tty  acids 
SFA - Saturated fa tty  acids
NB. A ll diets were fu lly  supplemented w ith  vitam ins and minerals 
according to species recommendations (Scientific  D ie t Services, 
maintenance diets) and contained a cellulose fib re  source
was measured. A 24 hour urine and faecal collection was made from  all rats a fte r 
1,3,5,7 and 9 weeks; urine and faeces were collected as described in 2.1. The to ta l 
volume o f urine collected was measured and aliquots assayed fo r galactose, sodium 
and potassium (2.2 and 2.16). The to ta l weight of faeces collected was recorded and 
samples assayed fo r galactose (2.2). The amount o f galactose excreted in the urine 
and faeces over 24 hours was expressed as a percentage of the amount ingested. 
The mean galactose intake of the two days preceding and the two days a fte r the 
urine co llection was used in the calculation. Metabolic studies were not possible 
for the guinea-pigs.
P rio r to and tw ice a week throughout the study the eyes o f a ll animals were 
examined ophthalmoscopically. Cataract development was graded as outlined by 
Keiding and Mellemgaard (1972). C ortica l ca taract was characterised by the 
appearance o f a sub-cortical opacity at the equator of the lens whereas nuclear 
cataract was recorded as a diffuse dense opacity over the to ta l lens which was 
visible to the naked eye.
A fte r  ten weeks animals were anaethetised w ith  d iethyl ether (BDH cat. no. 
10094) a fte r an overnight fast and a cardiac blood sample collected. The animals 
were then killed by cervical fracture  and the livers and lenses removed and 
weighed. Samples o f live r were assayed fo r galactokinase and UDP-gal-4-epimerase 
a c tiv ity  (2.17 and 2.18). Plasma was assayed fo r galactose, glucose, albumin, 
sodium and potassium (2.2, 2.3, 2.7 and 2.16). Red blood cells were assayed fo r 
galactokinase and UDP-gal-4-epimerase a c tiv ity  (2.17 and 2.18).
The mean (x) and standard error o f the mean (SE) were calculated fo r  a ll 
groups o f data. Mean values were compared using the appropriate Student's t- te s t. 
Product moment coe ffic ien t of corre lation was applied where appropriate.
5.2 Results
In the results the animal groups w ill be referred to as follows:
RATS GUINEA-PIGS
%E as Gal. 
in Test Diets
Test Pair-fed 
control
Test Pair-fed 
control
20 AR ARC AGP AGPC
30 BR BRC BGP BGPC
Only significance values fo r comparison o f the test animals to the ir pair-fed 
control group w ill be given in the tables and figures.
5 .3 .1  Body Weight
The mean body weights are recorded in Table 14 and illustra ted in Figures 18
Galactose fed rats showed an increase in body weight which did not d iffe r  
s ign ifican tly  from  that of the ir pair-fed contro l groups. The rate o f growth was 
s ign ificantly  less in the B group test rats than in the A group; the mean weight gain 
fo r group BR being s ign ifican tly  less during weeks 1, 3, 4, 8, 9 (P<0.01 a t each 
tim e) and 5 (P<0.001). L it t le  change was observed in the mean body weight o f a ll 
guinea-pig groups during the f irs t four weeks of the study. From week 4 onwards 
equal quantities o f hay were made available to a ll guinea-pigs and an increased 
growth rate was seen. There was no s ign ifican t d ifference between the mean 
changes in body weight per week o f the test A or B group guinea-pigs when 
compared to those o f the ir pair-fed contro l groups. There was no s ign ifican t 
d ifference in the mean growth rate between groups AGP and BGP. Two test and 
three contro l guinea-pigs died during the f irs t  four weeks o f the study.
and 19.
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TABLE 14
Mean Body Weights of Galactose fed Test and Glucose fed control 
Rats and Guinea-Pigs w ith  Standard Errors (SE)
STUDY WEEK
Anim al
Group Pre-study 1 2 3 4 3 6 7 8 9 10
Body Weight (g)
AR X 42 64 92 132 166 208 233 261 288 315 324
(n=6) SE + 2 2 2 3 3 5 4 4 4 6 6
ARC X 47 70 101 133 177 221 242 273 300 329 343
(n=6) SE + 3 1 2 2 2 4 4 4 4 5 6
BR X 80 96 122 150 176 205 233 261 276 288 299
(n=6) SE + 3 4 5 6 7 8 7 9 7 7 7
BRC X 76 89 112 141 167 190 214 245 271 292 302
(n=6) SE + 3 3 5 8 9 9 8 5 4 4 . 4
AGP x 174 178 187 209 212 223 265 289 302 340 373
(n=5) SE + 5 7 8 8 9 17 18 20 21 23 25
AGPC x 188 181 198 207 208 213 245 282 282 306 331
(n=4) SE + 2 1 3 9 12 14 19 16 10 11 9
BGP X 172 169 189 201 210 255 295 282 333 363 366
(n=5) SE + 4 4 3 5 9 10 10 14 18 16 12
BGPC X 186 192 200 200 209 245 262 252 292 329 341
(n=5) SE + 3 6 7 4 10 6 23 16 14 15 3
147
(9 )  1HDI3M AO 0 9
Fi
gu
re
 
18 
Th
e 
Me
an
 
Bo
dy
 
W
ei
gh
ts
 
of 
G
al
ac
to
se
 
Fe
d 
Te
st
 
an
d 
G
lu
co
se
 
Fe
d 
C
on
tro
l 
R
at
s;
 
i 
= 
Me
an
 
+ 
SE
148
tn
n
c
CL
O
CO
LD
II
C
U
CL
O
CO
□
□H
U J
H3
O)
co
U J
<0 w
to
>-
Q
D
J-
GO
CO
CM
uo
ii
c
C L
O
<
UJ
C L
C L
0>
00
(O  U J
U J
5
lO
>-
o
GO
CO
CM
J
oooin
*
O
o
*
oin
co
O
Oco
Oin
CM
O
O
CM
Oin
(D ) 1 H D I3 M  AQOQ
Fi
gu
re
 
19 
Th
e 
Me
an
 
Bo
dy
 
W
ei
gh
ts
 
of 
G
al
ac
to
se
 
Fe
d 
Te
st
 
an
d 
G
lu
co
se
 
Fe
d 
C
on
tro
l 
G
ui
ne
a-
Pi
gs
; 
{ 
= 
Me
an
 
+ 
SE
5 .3 .2  Urinary and Faecal Galactose Excretion
The mean amounts o f galactose excreted in the urine and faeces are recorded 
in Table 15 and illustrated in Figure 20.
The mean 24 hour urinary galactose excretion was greater in rats fed 
galactose than in the control rats. Group AR excreted a s ign ificantly  greater 
amount of galactose in the urine over 24 hours than did group ARC during weeks 3 
(P<0.02), 7 (P<0.01) and 9 (P<0.001). Group BR excreted sign ifican tly  greater 
amounts of galactose in the urine than did group BRC throughout the study period 
(P<0.01 during weeks 1, 3, 5 and 7; P<0.001 during week 9). Progressively greater 
quantities o f galactose were excreted in the urine o f test group A and B rats 
although the percentage of ingested galactose excreted did not increase. The mean 
24 hour urinary galactose excretion of A and B group test rats did not d iffe r  
s ign ifican tly  during the study except in week 9 when it  was s ign ifican tly  greater in 
group B (P<0.001). There was no sign ificant d ifference in the mean percentage o f 
ingested galactose excreted in the urine o f groups AR and BR. Both groups o f 
galactose fed rats excreted only a small proportion o f the galactose consumed in 
the urine, the maximum percentage of ingested galactose excreted in th is way 
being 2.3 + 0.6% fo r group AR and 2.4 + 0.2% fo r group BR.
The mean 24 hour faecal galactose excretion of the galactose fed rats was 
not s ign ifican tly  d iffe ren t from  that of the ir pair-fed control groups and there was 
no sign ificant difference in the mean excretion between groups AR and BR. Both A 
and B group test rats excreted very l i t t le  galactose in the faeces.
5.3.3 C ataract Development and Lens Weight
The mean lens weights are recorded in Table 16.
On in it ia l examination the ir is  of the rats appeared transparent whereas in 
the guinea-pigs i t  was opaque. A ll galactose fed rats developed b i- la te ra l c o rtica l 
ca taract w ith in  the ten week period. The mean length of tim e fo r the development
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TABLE 15
Mean Urinary and Faecal Galactose Excretion by Galactose Fed Test and 
Glucose-Fed Control Rats w ith  Standard Errors (SE) and P Values 
fo r Comparison to Pair-Fed Control Rats when P<0.02
Anim al
Group
STUDY WEEK 
7 9 1
24 hour Excretion of Galactose 
(mg)
Percentage of Ingested 
Galactose Excreted
■AR
(n=6)
X
SE +
48.9
15.3
63.9
12.2
42.9
16.7
69.7
16.9
94.5
9.4
2.3
0.6
1.9
0.4
0.9
0.3
0.6
0.4
2.1
0.2
ARC
(n=6)
X
SE + 
P
0.6
0.4
0.4
0.4
<0.02
0.6
0.4
0.0
0.0
<0.01
0.0
0.0
<0.001
BR
(n=6)
X
SE +
49.5
9.0
63.3
9.4
100.2
21.4
62.4
14.6
172.8
13.3
1.2
0.2
1.2
0.2
1.5
0.3
0.9
0.2
2.4
0.2
BRC
(n=6)
X
SE + 
P
0.0
0.0
<0.01
0.3
0.3
<0.01
0.9
0.6
<0.01
0.3
0.3
<0.01
0.6
0.6
<0.001
AR X 1.0 0.4 0.4 1.1 0.5 0.0 0.0 0.0 0.0 0.0
(n=6) SE + 0.2 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0
ARC X 0.4 0.5 0.4 0.4 0.3
(n=6) SE + 0.1 0.1 0.1 0.1 0.1
BR X 2.0 1.9 1.2 0.4 0.7 0.1 0.0 0.0 0.0 0.0
(n=6) SE + 0.5 1.1 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0
BRC X 0.5 0.2 0.3 0.3 0.3
(n=6) SE + 0.3 0.1 0.0 0.1 0.1
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TABLE 16
Mean Lens Weight (q) o f Galactose Fed Test and Glucose Fed Control 
Rats and Guinea-Pigs a fte r 10 weeks w ith  Standard Errors (SE) and 
P values fo r Comparison w ith  Pa ir-fed Control Animals when P<0.02
ANIM AL GROUP
AR ARC BR BRC AGP—-  AGPC BGP—-. BGPC
(n=6) (n=6) (n=6) (n=6) (n=5) (n=4) (n=5) (n=5)
X 0.02 0.04 0.02 0.04 0.06 0.06 0.06 0.06
SE + 0.003 0.003 0.003 0.000 0.002 0.003 0.003 0.006
P <0.02 <0.01
of co rtica l cataract was 7 days fo r both groups of rats fed galactose. Nuclear 
cataract was observed in only one B group test ra t (at day 34) and was not seen in 
any A group test ra t. There was no sign of cortica l or nuclear cataract 
development in any control ra t or in any test or control guinea-pig.
A t week 10 the mean lens weight was sign ificantly less in the galactose fed 
rats than in the ir pair-fed control groups (P<0.02 fo r group AR and P<0.01 fo r 
group BR). There was no significant difference between the mean lens weight 
recorded fo r group AR and BR. Galactose feeding did not a lte r the lens weight of 
the test guinea-pigs.
5.3.4 Plasma Galactose, Glucose and Albumin
The mean fasting plasma galactose, glucose and albumin concentrations are 
recorded in Table 17. Mean fasting plasma glucose and albumin concentrations are 
illustra ted in Figure 21.
Galactose feeding did not s ign ifican tly  a ffe c t the fasting plasma galactose 
levels of the test rats or quinea-pigs and there was no s ign ificant d ifference 
between the mean fasting plasma galactose concentration of the A and B group 
test animals.
A ll groups o f galactose-fed animals had higher mean fasting plasma glucose 
concentrations than did the ir pair-fed contro l group. However, the d iffe rence was 
only s ign ificant between ra t groups BR and BRC (P<0.02). No s ign ifican t 
difference was seen between the mean fasting plasma glucose concentrations of 
groups AR and BR or o f AGP and BGP.
The mean fasting plasma albumin concentration did not d iffe r  s ign ifican tly  
between any ra t or guinea-pig group investigated.
Table 17
Mean Fasting Plasma Galactose, Glucose and Albumin Concentrations of 
Galactose Fed Test and Glucose Fed Control Rats and Guinea-Pigs
SE +
x
SE + 
P
x
SE +
a fte r 10 weeks w ith  Standard Errors (SE) and P Values for 
Comparison w ith  Pair Fed Control Animals when P<0.02
ANIM AL GROUP
A R ____ ARC B R  BRC AGP----- AGPC BGP-
(n=6) (n=6) (n=6) (n=6) (n=5) (n=4) (n=5)
SERUM GALACTOSE (mm ol/L)
0.21 0.00 0.02 0.00 0.00 0.00 0.00
0.21 0.00 0.02 0.00 0.00 0.00 0.00
SERUM GLUCOSE (mm ol/L)
6.65 5.92 7.20 6.13 7.35 6.93 7.06
0.16 0.36 0.19 0.35 0.13 0.08 0.02
<0.02
SERUM ALBUMIN (g/L)
31.87 33.44 33.02 34.90 32.48 31.42 33.52
0.51 0.29 0.82 0.42 0.70 1.01 0.92
BGPC
(n=5)
0.00
0.00
6.54
0.46
29.72
0.80
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5.3.5 Enzyme A c tiv itie s  in the L iver and Red Blood Cells
There was no significant difference in the mean live r weight of the galactose 
fed rats or guinea-pigs when compared to the ir pair-fed control group i f  expressed 
as a percentage of the end of study body weight.
The mean galactokinase and UDP-gal-4 epimerase activ ities  in the live r and 
red blood cells are recorded in Table 18 and illustra ted in Figure 22.
A fte r  ten weeks there was no sign ificant d ifference in the mean 
galactokinase activ ities  in the live r or red blood cells o f any group of galactose fed 
animals compared to the ir pa ir-fed control group. The mean hepatic or e ryth rocyte  
galactokinase activ ities  recorded fo r the A and B group test rats were not 
s ign ifican tly  d iffe ren t. A s ign ifican tly  greater mean galactokinase a c tiv ity  was 
recorded in the live r o f test B group guinea-pigs compared to test A group (P<0.01). 
There was no sign ificant difference between the mean galactokinase a c tiv ity  
recorded in the red blood cells o f groups BGP and AGP.
The mean hepatic UDP-gal-4-epimerase a c tiv ity  fo r group A test rats was 
was s ign ifican tly  less than the mean a c tiv ity  recorded fo r the ir pa ir-fed contro l 
group (P<0.01). Test group B rats showed no sign ificant d ifference in the mean 
hepatic a c tiv ity  o f UDP-gal-4-epimerase compared to tha t of the ir pa ir-fed contro l 
group. There was no sign ificant difference in the mean UDP-gal-4-epimerase 
a c tiv ity  in the red blood cells between the test and pair-fed contro l ra t groups or in 
the mean hepatic or erythrocyte UDP-gal-4-epimerase a c tiv ity  between the test 
and pair-fed contro l guinea-pig groups. The mean ac tiv ities  o f UDP-gal-4- 
epimerase recorded in the live r or in the red blood cells of the A group test rats or 
guinea-pigs were not s ign ifican tly  d iffe ren t from  those of the B group test rats or 
guinea-pigs respectively.
There was no sign ificant corre lation between the a c tiv ity  o f galactokinase or 
UDP-gal-4-epimerase in the live r and red blood cells o f any animal group 
investigated.
L2!
TABLE 18
Mean Galactokinase and UDP-Galactose-4-Epimerase A c tiv itie s  
in the L iver and Red Blood Cells (RBC) of Galactose Fed 
Test and Glucose Fed Control Rats and Guinea-Pigs a fte r 
10 weeks w ith  Standard Errors (SE) and P Values for comparison 
w ith  Pair-Fed Control Animals when P<0.02
ANIM AL GROUP
A R ____ ARC B R   BRC AGP__ AGPC BGP—  BGPC
(n=6) (n-6) (n=6) (n=6) (n=5) (n=4) (n=5) (n=5)
LIVER GALACTOKINASE (nmol/m in/m g protein)
x 0.40 0.38 0.33 0.37 0.34 0.67 0.80 0.65
SE + 0.20 0.03 0.02 0.03 0.03 0.04 0.06 0.03
RBC GALACTOKINASE (nm ol/m in/m g haemoglobin x 10
x 7.06 5.09 4.73 4.03 8.19 11.21 8.41 7.79
SE + 2.03 0.83 0.90 0.42 1.01 1.68 1.24 0.98
LIVER UDP-GAL-4-EPIMERASE (nm ol/m in/m g protein)
x 4.10 17.30 10.60 12.10 8.20 7.20 18.30 12.50
SE + 0.88 1.79 2.84 1.22 3.94 1.79 2.41 2.79
P <0.01
RBC UDP-GAL-4-EPIMERASE (nm ol/m in/m g haemoglobin)
x 0.30 0.29 0.35 0.39 0.15 0.13 0.15 0.14
SE + 0.03 0.03 0.03 0.02 0.02 0.01 0.01 0.03
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5.3.6 Water and E lectro ly te  Balance
The mean 24 hour water consumption and urine production data are recorded 
in Table 19 and illustrated in Figures 23 and 24. The mean concentrations of sodium 
and potassium in the plasma and urine are recorded in Table 20 and mean urinary 
concentrations are illustrated in Figure 25.
Galactose-fed rats consistently drank more water than did the ir pair-fed 
contro l groups. The mean 24 hour water consumption of the A group test rats was 
sign ifican tly  greater than that of group ARC during weeks 2,3,4,8,9,10 (P<0.01), 5,6 
(PC0.001) and 7 (P<0.02); the mean consumption of the B group test rats was 
s ign ificantly  greater than that of group BRC during weeks 1,2,3,5,6,7 (P<0.001), 
4,8,9 and 10 (P<0.01). Test group B rats drank s ign ificantly  greater amounts of 
water than did test group A rats; mean 24 hour water intakes were s ign ifican tly  
greater fo r group BR during weeks 1,3,7 (P<0.001), 2,5,6,9,10 (P<0.01) and 4 
(P<0.02).
The mean volume of urine produced over 24 hours was also greater fo r the 
galactose-fed rats than fo r the ir pair fed contro l groups, however, the difference 
was only signifcant during weeks 7 (P<0.01) and 9 (P<0.02) fo r group AR and during 
week 9 (P<0.01) fo r group BR. There was no sign ificant difference between the 
mean 24 hour urine production of group AR and BR at any tim e during the study 
period.
Galactose feeding did not s ign ifican tly  increase the mean volume of water 
consumed over a 24 hour period by the test guinea-pigs.
The mean plasma potassium and sodium concentrations recorded fo r the test 
rats and guinea-pigs a fte r ten weeks were not s ign ifican tly  d iffe ren t from  those o f 
the ir pair-fed contro l animal group and there was no sign ificant d ifference between 
the mean plasma e lec tro ly te  concentrations o f the A and B group test animals.
Galactose-fed rats showed a greater mean 24 hour urinary excretion o f 
sodium and potassium than did the ir pa ir-fed contro l groups; s ign ifican tly  greater
1 6 U
TABLE 19
Mean 24 Hour Water Consumption and Urine Production of Galactose Fed Test 
and Glucose Fed Control Rats and Guinea-Pigs w ith  Standard Errors (SE) 
and P Values fo r Comparison w ith  Pair-Fed Control Animals when P<0.02
Animal
Group 0 1 2 3
WEEK OF STUDY 
4 5 6 7 8 9
WATER CONSUMPTION (ml)
AR
(n=6)
X
SE +
10.8
2.3
8.8
3.4
27.8
1.1
30.8
1.6
32.2
2.9
42.7
1.3
41.0
2.0
39.0
3.9
45.5
4.4
42.2
3.9
ARC
(n=6)
X
SE +
7.0
1.1
14.3
0.4
17.0
1.1
21.7
1.2
19.3
1.3
18.8
0.75
25.0
1.2
22.7
1.1
23.5
0.9
25.5
1.1
P< 0.01 0.01 0.01 0.001 0.001 0.02 0.01 0.01
BR x 
(n=6) SE +
16.7
2.2
40.7
3.0
38.3
2.2
49.3
2.6
50.0
4.9
60.0
4.8
59.8
4.3
58.8
1.6
58.5
4.7
62.4
5.1
BRC
(n=6)
X
SE +
7.2
2.1
9.7
1.0
13.5
1.3
20.2
2.2
15.7
1.4
20.2
2.6
20.2
3.3
25.8
2.9
23.8
1.4
26.2
2.4
P< 0.001 0.001 0.001 0.01 0.001 0.001 0.001 0.01 0.01
AGP
(n=5)
x "
SE +
11.7
6.1
52.7
12.8
90.0
18.7
111.3
21.9
76.7
10.5
106.3
11.0
71.8
12.3
130.2
14.0
164.0
25.5
124.0
18.3
AGPC x 
(n=4) SE +
46.7
13.3
166.6
18.5
117.5
22.7
83.0
29.9
106.3
21.1
108.8
24.6
116.5
26.0
127.8
24.0
185.3
27.3
127.0
22.6
P< 0.01
BGP
(n=5)
X
SE +
10.1
3.8
25.0
13.8
75.6
17.1
91.0
15.4
99.0
13.0
91.2
15.7
144.0
34.1
105.4
11.5
138.3
28.1
161.5
26.8
BGPC
(n=5)
X
SE + 
P<
8.7
2.1
61.6
5.4
119.8
14.3
92.0
17.2
89.8
9.5
103.0
13.4
109.8
20.2
111.3
21.1
105.5
25.6
170.0
45.8
URINE PRODUCTION (ml)
AR
(n=6)
X
SE +
9.3
1.4
11.4
2.1
12.5
2.5
21.8
3.3
13.3
1.1
ARC
(n=6)
X
SE + 
P<
9.7
0.5
9.3
1.4
6.8
1.4
7.1
0.9
0.01
9.0
1.7
0.02
BR
(n=6)
X
SE +
6.4
1.0
7.6
0.9
11.9
2.8
14.1
4.0
17.0
1.6
BRC
(n=6)
X
SE + 
P<
7.7
2.6
5.7
2.0
9.4
2.8
12.5
3.8
5.4
1.1
0.01
10
42.2
2.6
25.5
1.3
0.01
65.7 
4.8
34.5 
1.0
0.01
191.0
61.7
178.8
49.3
167.5
25.4
108.3
30.9
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mean 24 hour urinary sodium excretions were seen for test A group rats during 
weeks 7 and 9 (P<0.01 at both times) and fo r test B group rats during weeks 7 
(P<0.02) and 9 (P<0.001). There was no significant difference in the mean 24 hour 
urinary sodium excretion between test group A and B rats except during week 9. 
when it  was s ign ificantly greater in group BR (P<0.02).
The mean 24 hour urinary potassium excretion was sign ificantly greater in 
the A group test rats than in the ir pair-fed control group during weeks 7 (P<0.01) 
and 9 (P<0.02) and was sign ificantly  greater in the B group test rats than in the ir 
pair-fed control group during week 9 (P<0.001). No significant d ifference was seen 
in the mean 24 hour urinary potassium excretion between groups AR and BR.
5.4 Discussion
Consumption of diets containing 20 or 30% of the metabolisable energy as 
galactose fo r ten weeks did not s ign ificantly  a ffe c t the growth rate or mean serum 
albumin levels of young male rats or guinea-pigs when compared to those of contro l 
animals pair-fed a d iet containing glucose as the carbohydrate source. The rate of 
weight gain of rats fed galactose at the higher level o f intake was s ign ifican tly  less 
than that o f rats fed lesser amounts o f galactose. This m ight be explained by 
differences in the quantity of food ingested since, i f  expressed as weight o f food or 
amount o f energy consumed per gram of body weight, the mean daily intake was 
s ign ifican tly  less fo r test group B rats during weeks 1-4 inclusive than fo r test 
group A rats (Appendix 8).
The death of two test and three control guinea-pigs and the slow weight gain 
o f a ll remaining guinea-pigs during the f irs t four weeks of the study is believed to 
have been caused, at least in part, by an inadequate food intake by these animals. 
The mean food consumption, expressed per gram o f body weight, was s ign ifican tly  
less fo r groups A and B test guinea-pigs than fo r groups A and B test rats (Appendix 
8) and i t  is like ly  tha t the powdered textu re  o f the synthetic d ie t was less 
acceptable to the guinea-pigs than to the rats. In addition, u n til hay was made 
available, a ll guinea-pigs consumed the wood shavings bedding. I t  is thought tha t
this contributed towards the poor growth rate seen in itia lly  and that the subsequent 
ava ilab ility  of hay allowed an improved growth rate since it  was ingested in place 
of the wood shavings. The mean food consumption, expressed per gram of body 
weight, of the guinea-pig groups did not increase during the study and the 
mechanism of the marked increase in body weight seen during the second ha lf of 
the study is unclear. An improved absorption of nutrients from the gut, possibly as 
a result o f hay consumption, may be involved and faecal carbohydrate, fa t, protein 
and to ta l energy determinations would have been of interest. The poor growth rate 
seen in it ia lly  in the test guinea-pigs cannot be a ttributed to galactose ingestion 
since there was no significant difference in the mean weight gain o f animals fed 
the galactose-containing diets and those pair-fed the galactose-free contro l d iet.
Since the food intake per gram of body weight o f the test guinea-pigs was 
less than that o f the test rats differences in the ir re la tive  galactose consumption 
can be assumed. Although such differences are unlikely to have been great, d irec t 
comparison o f data collected fo r rats and guinea-pigs was not possible due to the 
poor weight gain of a ll guinea-pigs during the f irs t four weeks.
Previous studies have described poor growth and high m orta lity  rates in young 
rats fed diets containing 40% or more galactose by weight (Handler, 1947; Craig 
and Maddock, 1953; Cryer and Bartley, 1973). An impaired growth ra te  has also 
been demonstrated in young rats fed lactose in the diet at 40-50% w /w  (David e t 
al., 1980; De Angelis et al., 1983); ingestion o f pre-hydrolysed lactose improved the 
ra te  of weight gain in these animals and consumption of solely yoghurt in which 22- 
24% of the energy was galactose has been shown to sustain growth in rats (R ich ter 
and Duke, 1970). D irec t comparison o f the growth rates recorded in the present 
study w ith  those reported previously is, however, impossible since the ra tio  o f 
d ie tary carbohydrate: protein: fa t d iffe rs  and this m ight influence growth per se. 
I f  expressed by weight the galactose diets used provided 17% and 26% galactose 
but also included a cellulose fib re  source at 9% o f the weight. I t  is not known i f
the earlier studies included a source of fibre in the diet. I t  may be that a reduced 
rate o f growth would have been seen in animals fed galactose at much higher 
levels.
In both test diets galactose was provided together w ith glucose and i t  is 
possible that the ava ilab ility  of dietary glucose as an energy source fac ilita ted  
growth in the test animals. Acute studies have shown that simultaneous glucose 
ingestion reduces the serum galactose response to a peroral galactose load in 
guinea-pigs (W illiams and Owens, 1984) and man (Stenstam, 1946; W illiams et al., 
1983) but not in rats (Williams and Owens, 1984). An impaired galactose absorption 
from  the intestine or an increased urinary galactose excretion are not thought to 
be involved in man (Williams et al., 1983). I t  is, therefore, possible tha t 
consumption of glucose w ith  galactose improved the in vivo galactose u tiliza tio n  in 
the test guinea-pigs. This is unlikely to have occurred in the test rats and cannot 
explain the better growth rate of these animals compared to tha t reported 
previously in galactose-fed rats (Handler, 1947; Craig and Maddock, 1953; C ryer 
and Bartley, 1973).
The urinary galactose excretion data showed that, when ingested a t 20 or 
30% of the metabolisable dietary energy, less than 3% of the galactose consumed 
was excreted by rats in the urine. Earlie r studies have reported tha t in rats fed 
galactose at 70% of the d iet by weight approximately 20% of the galactose eaten 
was excreted in the urine (Cryer and Bartley, 1973) and i t  is like ly  tha t this greater 
loss of ingested galactose contributed towards the slower growth rate o f these 
animals. For technical reasons food was withheld in the present investigation 
during the period o f urine collection, the mean dietary galactose consumption o f 
the two days preceding and the two days a fte r the co llection was used to calculate 
the proportion o f ingested galactose excreted. It  is possible tha t greater quantities 
of galactose would have been excreted in the urine i f  food had been consumed 
throughout the collection period. Therefore, i t  would seem tha t the much lower 
percentage o f ingested galactose excreted by the rats in the urine compared to
previous reports is caused by a much lower galactose consumption and possibly by 
the d iffe ren t methods of urine collection used. Data on the urinary galactose 
excretion in the guinea-pigs would have been of interest but was not possible in this 
study.
A ll rats fed galactose developed cataracts which are assumed to be the result 
of galactose feeding since cataractogenic changes were not identified in the lens of 
any control ra t. In contrast to data presented in this thesis, Keiding and 
Mellemgaard (1972) described the development of nuclear cataract in young rats 
maintained on a diet containing 30% of the energy as galactose; this quantity of 
d ietary galactose produced nuclear cataract in only one ra t studied. The 
progression of early cortica l ca taract into mature nuclear cataract was not graded 
in the present study although the sign ificantly  lower mean lens weight recorded in 
the galactose-fed rats compared to the ir pair-fed control groups a fte r ten weeks 
suggest that cataract development had proceeded beyond the early stage o f sub- 
co rtica l opacity (cortica l cataract). The lenses of rats fed galactose have been 
shown to progressively increase in weight during the early stages o f ca taract 
development due to increased hydration; fu rthe r cataract development was 
associated w ith  a reduction in lens weight (Sipple, 1966).
I t  is of in terest that a deficiency of d ietary protein (Ratnakar, 1985) or 
ribo flav in  (Srivastava and Beutler, 1972) has been found to increase the 
susceptib ility of weanling rats to galactose-induced cataract. Folic acid was found 
to enhance galactose metabolism in the isolated perfused livers of suckling rats 
(Rogers and Segal, 1984) and i t  is possible tha t its deficiency in the diet m ight also 
predispose young rats towards galactose-induced cataract. This suggests tha t the 
difference in the severity o f cataract form ation seen in rats fed galactose w ith  
tha t previously described m ight be due to a d ifference in the nu trition a l 
composition o f the experimental diets used. I t  has been postulated tha t the 
adm in istration o f galactose as part o f a nu trition a lly  adequate d ie t delays or
prevents the form ation o f cataract (Heffley and Williams, 1974) and i t  is possible 
that advanced nuclear cataract development was delayed in the present study since 
a ll diets used were fu lly  supplemented w ith  vitam ins and minerals according to 
species recommendations and provided dietary fa t, protein and carbohydrate in the 
same proportion as is found in the usual laboratory diet. Furthermore, severe 
d ietary restrictions in young animals m ight influence the growth and development 
of the lens and thereby induce lens changes per se which would be d if f ic u lt  to 
d iffe ren tia te  from  those produced by galactose consumption.
The fa ilu re  o f galactose ingestion to produce cataract in guinea-pigs has been 
described before in animals given galactose as a 10% solution in the drinking water 
(Kosegarten and Maher, 1978). This suggests that the guinea-pig is less susceptible 
to galactose to x ic ity  than is the ra t and m ight be a better animal model fo r 
galactose metabolism in man. I t  is possible that the influence o f glucose ingestion 
on the serum galactose response to an acute peroral galactose load in the guinea- 
pig also occurs chronically when glucose and galactose are simultaneously 
consumed and that this reduces the to x ic ity  of d ietary galactose. The mechanism 
of galactose-induced cataract development has been described in 1.13 and is 
associated w ith  the accumulation of ga lac tito l, a metabolite of galactose, in the 
lens. The visual iden tifica tion  o f early cataractogenic changes in the lens of 
guinea-pigs is like ly  to be d iff ic u lt  since the guinea-pig iris, unlike tha t o f the 
albino ra t, appears opaque. Determ ination o f ga lac tito l concentrations in the lens 
m ight, therefore, be a better index o f early cataract development in th is species 
and its  determ ination would have been of in terest. However, there was no 
difference between the mean lens weights of the galactose-fed guinea-pig groups 
and those of the ir pair-fed contro l groups and this fu rther suggests tha t ca ta ract 
development did not occur in the guinea-pigs fed galactose. In the lens, aldose 
reductase reduces galactose to ga lac tito l and i t  has been suggested th a t species 
differences in the a c tiv ity  of this enzyme may cause differences in the ra te  o f 
development o f diabetic and galactose-induced ca taract (Parmar and Ghosh, 1981).
Determ ination of the a c tiv ity  o f aldose reductase in the lens o f rats and guinea- 
pigs would be of interest.
Cataract form ation was the only sign of galactose tox ic ity  observed in the 
rats fed galactose. Hepatomegaly and hepatic dysfunction are seen in patients w ith  
ga l-l-P -uridyltransferase deficiency galactosaemia (Woon et al., 1980; Kliegman 
and Sparks, 1985) and an increase in live r weight has been reported in rats fed 70% 
w/w galactose (Cryer and Bartley, 1973). Accumulation of ga l-l-P  in body tissues is 
believed to cause many of the symptoms of galactose to x ic ity  in the systemic and 
central nervous system (Schwarz, 1975; Rennert, 1977) and its determ ination in the 
live r, red blood cells and urine of all test and control animals would have been 
useful. I t  is of in terest that, at the levels of intake used, galactose feeding did not 
increase the re la tive  live r weight o f rats and guinea-pigs over a ten week period. 
This may suggest that any accumulation o f ga l-l-P  in the body tissues o f the 
galactose-fed animals was small and that the ga l-l-P -uridyltransferase present was 
able to metabolise in vivo any ga l-l-P  formed. Furthermore, ga l-l-P  is believed to 
inh ib it phosphoglucomutase, UDP-gluc pyrophosphorylase and gluc-6-P 
dehydrogenase (Schwarz, 1975; Rennert, 1977) and its  accumulation in the liv e r has 
been found to diminish hepatic glucose production in c lin ica l galactosaemia (Segal 
and B la ir, 1961; Gitzelman and Hansen, 1980). Baboons fed galactose as LHS so 
tha t 80% of the d iet by weight was carbohydrate provided by LHS showed a 
decrease in mean fasting serum glucose concentrations which was thought to have 
been due to an altered hepatic glucose metabolism (Williams and Macdonald, 
1982b). I t  seems reasonable to assume tha t accumulation of g a l-l-P  in the ra t or 
guinea-pig live r m ight s im ila rly  influence hepatic glucose metabolism and produce 
a decrease in fasting serum glucose concentrations. No such decrease in fasting 
blood glucose levels was seen in the rats or guinea-pigs fed galactose a t 20 or 30% 
of the metabolisable d ietary energy.
A decrease in fasting blood glucose levels has been described previously in 
rats fed dietary galactose a t 40% w /w  or more (Handler, 1947) but not in rats fed
galactose in the diet at 70% w /w (Cryer and Bartley, 1973). I t  has been postulated 
tha t a fa ll in in vivo blood and tissue glucose levels w ith chronic galactose feeding 
results in a depression o f glycolysis and an increase in gluconeogenesis (Cryer and 
Bartley, 1973). The reported decreased live r concentration of glycogen and 
g lyco ly tic  intermediates and the reduced amount of subcutaneous fa t in rats fed 
galactose (Handler, 1947; Craig and Maddock, 1933; Cryer and Bartley, 1973) 
appears to confirm  this and demonstrates the use o f fa t as an energy source in 
these animals. I t  would, therefore, seem that an influence of d ietary galactose on 
hepatic glucose metabolism is like ly in the rats and guinea-pigs studied in the 
present investigation and i t  is possible that the slightly greater fasting plasma 
glucose levels seen in the galactose fed animals when compared to the ir controls 
was due to a decrease in glycolysis and an increase in gluconeogenesis. 
A lte rna tive ly , i t  may be that the provision o f glucose in both galactose test diets 
was able to maintain fasting blood glucose levels; this would diminish or e lim inate 
the need of the test rats and guinea-pigs to use body protein and fa t as an energy 
source and thereby fa c ilita te  growth. Data on the hepatic concentration o f 
glycogen, g lyco ly tic  intermediates and g lyco ly tic  enzymes and on the amount of 
subcutaneous fa t in the galactose-fed and control animals would be of in terest and 
would allow a more detailed discussion o f the chronic metabolic e ffects  o f d ie tary 
galactose, when consumed together w ith  glucose, in rats and guinea-pigs.
Consumption o f galactose at 20 or 30% of the metabolisable d ie ta ry energy 
fa iled to s ign ifican tly  increase the a c tiv ity  of galactokinase or UDP-gal-4- 
epimerase in the live r or red blood cells o f young rats or guinea-pigs. This is in 
contrast to enzyme changes reported in the jejunum of rats fed galactose in the 
diet a t 68% w /w  (S tife l, Herman and Rosenweig, 1968). Rats fed galactose at 20% 
o f the metabolisable d ietary energy fo r ten weeks showed a s ign ifican tly  lower 
mean hepatic UDP-gal-4- epimerase a c tiv ity  than did the ir pa ir-fed contro l group. 
As discussed (1.7), UDP-gal-4-epimerase is the th ird  enzyme in the Le lo ir Pathway
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of galactose metabolism and converts UDP-galactose into UDP-glucose; a 
reduction in its  a c tiv ity  m ight, therefore, be expected to result in an accumulation 
of UDP-galactose in the live r and the determ ination of this metabolite in the livers 
of the test and control rats and guinea-pigs would have been of interest. In v itro  
live r perfusion studies have shown that UDP-galactose accumulates in suckling and 
adult galactose perfused ra t livers (Berman et al., 1978) and that the UDP-gal-4- 
epimerase specific a c tiv ity  decreases during perfusion o f suckling ra t livers w ith  
galactose fo r 60 minutes (Rogers and Segal, 1981). These studies are in agreement 
w ith  the chronic in vivo effects reported in this thesis in young rats fed a d ie t 
providing 20% of the metabolisable energy as galactose and suggest that UDP-gal- 
4-epimerase is the rate lim iting  enzyme in galactose disposition. Consumption of 
70% w /w galactose diets have been shown to increase cytoplasmic NADH levels in 
rats (Cryer and Bartley, 1973) and i t  is possible tha t such an increase m ight 
account fo r the reduced UDP-gal-4-epimerase a c tiv ity  in the live r of the A group 
test rats when compared to the ir controls since NADH is known to inh ib it UDP-gal- 
4-epimerase (Maxwell, 1937). However, consumption of the higher galactose d ie t by 
young rats did not s ign ifican tly  reduce the hepatic UDP-gal-4-epimerase a c tiv ity  
below that of the ir pair-fed control group or below that of the test A group rats. 
The reason fo r this is not known and data on the concentration o f NADH in the 
live r o f a ll test and control rats would be o f use. The fa ilu re  o f e ither galactose 
test diet to s ign ifican tly  change the specific a c tiv ity  o f UDP-gal-4-epimerase in 
the live r of guinea-pigs may re fle c t a species d ifference in galactose metabolism 
and suggests that, at the levels o f galactose intake used, UDP-galactose does not 
accumulate in the live r of these animals.
Consumption o f galactose at 20 or 30% o f the metabolisable d ie ta ry energy 
did not s ign ifican tly  change the hepatic or erythrocyte galactokinase a c tiv ity  in 
rats or guinea-pigs. This is in agreement w ith  previous studies in which a 40% w /w  
galactose d ie t was fed to adult rats (Cuatrecasas and Segal, 1963) or in which a 
70% w /w  galactose diet was fed to young rats of lOOg body weight (C ryer and
Bartley, 1973). I t  has been demonstrated that galactokinase a c tiv ity  is inhibited by 
ga l-l-P  (Cohn and Segal, 1973). The fa ilu re  of galactose consumption to a lte r the 
specific a c tiv ity  o f galactokinase in the red blood cells or the live r o f e ither test 
group of rats or guinea-pigs would seem to provide fu rther evidence against any 
substantial accumulation o f ga l-l-P  in these tissues.
The activ ities  of the galactose metabolising enzymes have been shown to be 
maximal during the suckling period of the ra t (Cuatrecasas and Segal, 1965; B e rto li 
and Segal, 1966; Cohn and Segal, 1969) and the guinea-pig (Kuroda, 1971). Changes 
in the live r galactokinase a c tiv ity  in response to dietary m odifications have been 
demonstrated in young rats (Cuatrecasas and Segal, 1965) and i t  is like ly  tha t 
suckling animals, fo r which galactose is an im portant dietary constituent are more 
receptive to alterations in the amount of galactose consumed than are older 
animals. In addition, i t  is possible that any influence o f dietary galactose on the 
ac tiv ities  o f the galactose metabolising enzymes m vivo is transient and 
measurement o f enzyme activ ites in the live r and red blood cells o f animals at 
in tervals during the study would have been interesting.
There was no significant corre lation between the a c tiv ity  o f galactokinase or 
UDP-gal-4-epimerase in the live r and the red blood cells of rats or guinea-pigs. 
This suggests that in these animals the metabolism of d ietary galactose in the 
eythrocytes does not re fle c t its  hepatic metabolism. I t  is possible tha t the 
galactose metabolising enzyme activ ities  in human red cells m ight s im ila rly  fa il to 
re fle c t ac tiv ities  in the live r.
An increase in water consumption and urine production has been described 
before in rats fed galactose at 70% of the d ie t by weight (Craig and Maddock, 
1953; Cryer and Bartley, 1973). However, the volumes of urine produced by the 
galactose fed rats in the earlie r studies were greater than those reported in the 
present investigation. The quantities of galactose in the test diets were also less in 
the present study and i t  may be tha t the volume o f urine produced increases w ith  
the amount o f galactose consumed. Although rats fed galactose at 20 or 30% o f the 
metabolisable d ietary energy produced greater urine volumes than did th e ir  pa ir-
fed control groups these differences were only significant during weeks 7 and 9 and 
there was no significant difference between the mean urine production of rats fed 
d iffe ren t amounts o f galactose. The galactose fed rats consistently drank 
s ign ificantly  greater amounts of water than did the ir pair-fed control animals and 
rats fed the higher galactose diet consumed sign ificantly greater amounts of water 
than did those fed lesser amounts of dietary galactose. Water consumption and the 
volume of urine produced over 24 hours were not measured simultaneously and i t  
was not possible to allow access to food during the period of urine collection. I f  
this had been done i t  may be that the d ifference in the volume of urine produced by 
the galactose-fed and control rats would have been greater and tha t an influence of 
the quantity o f galactose consumed on the volume of urine produced would have 
been seen. I t  is possible that galactose functions as a d iure tic in vivo. Unlike in the 
ra t, galactose feeding did not s ign ifican tly  increase water consumption in the 
guinea-pig; data on urine production was not available fo r the guinea-pigs.
S ignificantly greater mean 24 hour urinary sodium and potassium excretion 
values were recorded in rats fed galactose at 20 or 30% of the metabolisable 
d ietary energy fo r seven weeks when compared to pair-fed contro l animals. 
Plasma sodium and potassium concentrations were, however, unchanged in rats and 
guinea-pigs following galactose feeding.
5.5 Conclusions and Future Work
Consumption o f galactose at 20 or 30% of the dietary energy fo r ten weeks 
did not e ffe c t the growth rate o f young male rats or guinea-pigs when compared to 
tha t o f animals pair-fed the galactose-free control d ie t. However, rats fed the 
higher galactose d ie t showed a slower weight gain than did those fed lesser 
quantities o f galactose. A t  both levels o f intake d ietary galactose resulted in 
ca taract form ation in rats but not in guinea-pigs and i t  is suggested th a t the 
guinea-pig m ight be a be tte r animal model o f galactose metabolism fo r man.
Galactose fed rats excreted greater amounts o f galactose in the urine than did 
the ir pair-fed controls although, when expressed as a percentage of the amount 
ingested, the quantities excreted were small at both levels of intake. There was no 
difference in the fasting plasma albumin or galactose levels of galactose-fed 
animals when compared to the ir control animals. Fasting plasma glucose
concentrations were s ign ificantly  higher in rats fed galactose at 30% of the
metabolisable dietary energy when compared to the ir pair-fed controls and an
influence of galactose feeding on hepatic glucose metabolism is possible.
There was no difference in the hepatic or erythrocyte a c tiv ity  of
galactokinase between animals fed galactose at 20 or 30% of the metabolisable 
d ietary energy and those pair-fed w ith  a galactose free control d iet. Galactose- 
feeding reduced the hepatic a c tiv ity  o f UDP-gal-4-epimerase only when included in 
the diet o f rats at 20% of the metabolisable d ietary energy; no e ffe c t was seen in 
the hepatic UDP-gal-4-epimerase a c tiv ity  of guinea-pigs or in the erythrocyte 
UDP-gal-4-epimerase a c tiv ity  o f rats or guinea-pigs at e ither level o f galactose 
intake. In rats and guinea-pigs changes in the a c tiv ity  of galactose metabolising 
enzymes in red blood did not re fle c t changes in the ir a c tiv ity  in the live r.
Inclusion of galactose in the diets of rats increased the ir water consumption 
above tha t of the ir pair-fed control animals and this e ffe c t appeared to be dose 
related. The volume of urine produced and the urinary excretion of sodium and 
potassium were also greater in the galactose-fed rats than in the ir pa ir-fed 
controls a fte r seven weeks although plasma e lectro ly te  levels remained unchanged. 
The influence o f d ietary galactose on the urinary sodium and potassium excretion 
was not dependent on the amount of galactose consumed.
The results presented in this thesis are those seen in young, male rats and 
guinea-pigs fed moderate amounts of galactose in the d ie t together w ith  glucose. I t  
is not known i f  s im ilar results would have been seen in older animals or i f  galactose 
had been consumed in greater amounts. Data on the urinary and faecal galactose 
excretion o f guinea-pigs fed galactose at the levels used are necessary.
Increased data on the accumulation of ga l-l-P  and UDP-gal in the live r, red 
blood cells and kidneys o f rats and guinea-pigs fed diets containing 20 or 30% of 
the metabolisable energy as galactose would be of interest as would determ ination 
of the ir urinary excretion. Such data would allow a more detailed discussion of the 
chronic metabolic e ffects of moderate amounts of galactose when consumed by 
young rats and guinea-pigs as part of a nu tritiona lly  adequate diet. Previous studies 
have postulated an involvement of a d irect oxidative pathway fo r galactose in 
galactose fed rats (Rancour, Hawkins and Wells, 1979). This minor metabolic 
pathway fo r galactose has been described in 1.7 and the measurement o f galactonic 
acid, a m etabolite of galactose, in the urine and body tissues of rats and guinea- 
pigs fed galactose as in the present investigation is suggested. Estim ation of 
ga lac tito l and aldose reductase in the lens o f galactose-fed rats and guinea-pigs 
would be o f interest. Determ ination o f the concentrations of glycogen and 
g lyco ly tic  intermediates and of the ac tiv ities  o f g lyco ly tic  enzymes in the live r of 
rats and guinea-pigs fed galactose plus glucose chronically is recommended. I t  is 
suggested that in any subsequent chronic studies diets should be made in to  pellets 
fo r guinea-pig consumption in an attem pt to improve the ir acceptab ility .
CHAPTER 6 
GENERAL DISCUSSION
I t  is like ly that the per capita galactose consumption w ill increase in the 
United Kingdom as the use o f LHS in food manufacture becomes more widespread. 
Investigations o f patients w ith  inborn errors of galactose metabolism have 
illustrated the potentia lly  tox ic  e ffects of excess dietary galactose to man 
(Schwartz, 1975,* Rennert, 1977; Gitzelman and Hansen, 1980). Although the 
incidence of these major disorders is low (Beutler, 1973; Levy and Hammersen, 
1978) a broad corre lation between the magnitude of the impairment of galactose 
metabolism and risk o f cataract, a symptom of galactose to x ic ity , has been 
recently purported (Winder j j t  al., 1982). I f  such a corre lation exists, i t  seems 
possible tha t galactose m ight be a more im portant cause of cataract in man than is 
thought currently. A greater knowledge of the chronic metabolic e ffects  of 
d ietary galactose as LHS in healthy volunteers and of factors influencing galactose 
tolerance in man man is, therefore, desirable. The chronic e ffe c t of LHS in the diet 
is o f additional in terest because of the possible hypertrig lyceridaem ic effects. 
Chronically elevated fasting serum trig lyceride  concentrations have been 
associated w ith  an increased risk o f atherosclerotic coronary heart disease in man 
(Crowley, 1971; Carlson and Bottiger, 1972) and have been described in female 
baboons fed a d ie t containing 80% carbohydrate by weight as supplied by LHS fo r 
10 weeks (Williams and Macdonald, 1982b).
The acute serum galactose response to e ither a standard or body-weight 
related galactose load is known to vary considerably between individuals (Roe and 
Schwartzman, 1932; Stenstam, 1946; W illiams et al., 1983); l i t t le  in fo rm ation  is 
available on the variation w ith in  the same individual. Early work suggested tha t the 
tolerance of an acute peroral galactose load could be influenced by the sex o f the 
individual (Roe, 1924; Stenstam, 1946) and that in young women tolerance varied a t 
d iffe ren t times o f the menstrual cycle (Watkins, 1928; Rowe, 1935). However, the 
analytical methods used fo r the determ ination o f galactose in these early studies 
lacked spec ific ity  and accuracy. A re-investigation of the influence o f the sex o f 
the consumer and the menstrual cycle on peroral galactose tolerance is desirable.
The use of a suitable animal model of galactose metabolism fo r man would 
allow more detailed investigations of the chronic metabolic e ffects o f dietary 
galactose and o f factors influencing galactose tolerance. Rats are a frequently 
used animal model for investigating galactose tox ic ity . However, they have a lower 
tolerance o f galactose than man (Cori and Cori, 1934; Harding et al., 1934; 
Tygstrup et al., 1971) and do not show a modifying e ffec t of glucose on blood 
galactose levels (Newstead, 1979; W illiams and Owens, 1984). For these reasons 
they cannot be considered a good model of quantita tive galactose metabolism fo r 
man. I t  has been suggested that the guinea-pig m ight be an appropriate animal 
model (W illiams and Owens, 1984) although increased data on galactose metabolism 
is needed in this species.
The present studies were designed to investigate the chronic metabolic 
e ffects o f an increased consumption of galactose as LHS in man and the influence 
o f the sex o f the consumer and the menstrual cycle on the tolerance of a body- 
weight related peroral galactose load. Chronic metabolic e ffects  o f d ie tary 
galactose were also studied in rats and guinea-pigs.
Inclusion o f LHS in the diet o f healthy volunteers so tha t 6-7% of the ir to ta l 
energy intake was supplied by carbohydrate in the syrup fa iled to influence fasting 
serum galactose, glucose, insulin or to ta l cholesterol concentrations. A lthough an 
increase in fasting serum galactose levels m ight have been seen i f  LHS had been 
consumed at a much higher level such an increase would be d if f ic u lt  w ithou t 
incurring greater changes in the dietary fa t, protein, carbohydrate and energy 
intake and would be in excess o f any like ly  consumption w ith in  the population. 
Consumption of moderate amounts of LHS also fa iled to a ffe c t peroral galactose 
tolerance. The findings suggest tha t inclusion o f LHS-containing foods in the d ie t is 
unlikely to result in symptoms of galactose to x ic ity  in normal individuals. The LHS 
contained both galactose and glucose and acute studies in man have shown a 
hypogalactosaemic e ffe c t of glucose when given perorally together w ith  galactose 
(Harding and Grant, 1933; Carpenter, 1937; Stenstam, 1946; W illiams et al., 1983)
or as lactose (Williams et al., 1983). I t  is possible that the presence of glucose in 
the LHS prevented any increase in fasting serum galactose concentrations. These 
studies were undertaken using healthy volunteers o f a narrow age range and i t  is 
not known i f  sim ilar metabolic e ffects would have been seen in volunteers of 
d iffe ren t ages or in patients w ith a disorder of the p itu ita ry , thyroid, adrenal gland, 
ovary or live r since all have been shown to influence the tolerance of an acute 
peroral or intravenous galactose load (Rowe, 1935, Stenstam, 1946; Relander, 
1968). Simultaneous alcohol ingestion is known to reduce the tolerance of galactose 
in man (Stenstam, 1946; Salaspuro and Kesaniemi, 1973) and fu rthe r investigations 
of the chronic metabolic e ffects associated w ith  the use of LHS in the manufacture 
of alcoholic drinks are desirable.
Inclusion of LHS in the diet at the level used produced a transient increase in 
fasting serum trig lyceride  concentrations which was greater in males than females 
but was of l i t t le  c lin ica l importance in either sex and could not be a ttribu ted  to an 
increased consumption o f galactose as LHS per se. These results are in accordance 
w ith  the previously documented influence of dietary carbohydrates in 
normolipaemic man (Antonis and Bersohn, 1961; Beveridge e t al., 1964; Lees and 
Fredrickson, 1965) and suggest that there is no increased risk o f atherosclerotic 
coronary heart disease associated w ith the inclusion o f LHS-containing foods in the 
diet. An investigation of the influence of a chronically increased consumption of 
galactose as LHS on fasting serum trig lyceride  levels in c lin ica lly  
hypertrig lyceridaem ic patients would be of in terest since dietary carbohydrate has 
been shown to have a greater e ffe c t on fasting serum trig lyceride  concentrations in 
these individuals (Anderson, 1967).
The tolerance of a body-weight related peroral galactose test-m eal was not 
influenced by the sex of the consumer. However, the variation in peroral galactose 
tolerance on repeated testing was greater in young women than men, suggesting an 
influence o f at least one additional variable on tolerance in. the female. Healthy, 
ovulating females demonstrated a pattern of varia tion in the acute serum galactose
response to peroral galactose over the menstrual cycle which could not be 
explained by differences in renal galactose excretion or in the rate of liquid gastric 
emptying. Moreover, data on the increase in serum glucose concentrations 
subsequent to galactose ingestion suggested that i t  was not caused by differences 
in the m vivo metabolism of galactose to glucose. In young women the greatest 
mean serum galactose response to peroral galactose was consistently seen during 
the secretory or early pre-menstrual phase of an ovulatory menstrual cycle, i.e. at 
the tim e of raised serum progesterone and oestradiol levels. I t  is postulated that 
fluctuations in blood progesterone or progesterone plus oestradiol concentrations 
may influence the tolerance of peroral galactose in females, possibly via a 
secondary e ffe c t on insulin sensitiv ity. Insulin sensitiv ity appears to be inversely 
related to serum concentrations of oestradiol and progesterone and a decrease in 
sensitiv ity has been suggested to account fo r the deterioration o f glucose tolerance 
in the second half of the menstrual cycle (Berto li et al., 1980). I t  is possible that i t  
also reduces galactose tolerance at this tim e via a fa ll in tissue galactose uptake. 
Insulin adm inistration increased the volume of galactose d istribu tion in dogs, 
rabbits and rats (Levine et a l., 1950; Goldstein et al., 1953; Wick and Dury, 1953; 
Lotspeich and Wheeler, 1962; Kvam, 1964). In the physiological state i t  is like ly  
tha t several in teracting variables influence the acute metabolic response to a 
peroral galactose load in females over the menstrual cycle and fu rthe r 
investigations of the mechanism involved would be of in terest.
Galactose feeding did not a ffe c t growth, as measured by a gain in body 
weight, o f weanling rats and guinea-pigs when fed at 20 or 30% o f the 
metabolisable d ietary energy fo r 10 weeks. A slower weight gain was seen in rats 
fed galactose at the higher level o f intake compared to those fed the lower 
galactose diet and was a ttribu ted  to quantita tive  differences in the re la tive  
amount o f food consumed. When expressed per gram o f body weight, the food 
intake o f guinea-pigs was less than tha t o f rats. This was thought to be due to the
lower acceptab ility  of a "powdered" synthetic diet to guinea-pigs and i t  is 
suggested that the provision of a "pelleted" synthetic diet might improve the ir food 
intake. As expected, greater amounts of galactose were excreted in the urine of 
galactose fed rats than in the urine of rats fed a galactose-free control d iet. The 
quantity of galactose excreted in this way was, however, small when expressed as a 
percentage of the amount consumed. Faecal galactose excretion was small in rats 
fed galactose at both levels of intake.
The rapid onset of cataractogenic changes in the lenses of rats but not 
guinea-pigs fed galactose may indicate a lower tolerance of galactose in the ra t 
since cataract development is related to chronically elevated blood galactose 
levels. The guinea-pig m ight, therefore, be a better animal model than the ra t fo r 
extrapolation o f quantita tive studies o f galactose metabolism to man. The 
influence o f glucose on the tolerance o f an acute peroral galactose load in the 
guinea-pig has previously been shown to be the same as that in man, this was not 
seen in the ra t and fu rther suggests tha t the guinea-pig m ight be a more suitable 
model fo r the study o f human galactose metabolism (Williams and Owens, 1984). 
The galactose diets used in the present investigation contained glucose and i t  is 
postulated that the influence of glucose on the blood galactose levels produced in 
response to an acute peroral galactose load in the guinea-pig also occurs 
chronically and thereby reduces the to x ic ity  o f d ietary galactose in this species. 
Investigations of the mechanism by which simultaneous glucose adm in istration 
reduces the galactosaemia produced by galactose ingestion are recommended using 
a guinea-pig animal model.
Data presented in this thesis showed no change in the a c tiv ity  of 
galactokinase in the live r or red blood cells o f rats or guinea-pigs fed galactose at 
20 or 30% o f the metabolisable energy. The decrease in the hepatic a c tiv ity  o f 
UDP-gal-4-epimerase in rats fed the lower galactose diet, when compared to those 
pa ir-fed the galactose-free control d ie t, is in agreement w ith  results reported 
previously using in v itro  live r perfusion techniques and is thought to be due to an
accumulation of NADH. However, the lack of this e ffec t in rats fed galactose at 
the higher level of intake could not be explained. There was no corre lation 
between hepatic and erythrocyte ac tiv ities  of the galactose metabolising enzymes 
measured in e ither the rats or guinea-pigs. I t  is suggested that the galactose 
metabolising enzyme activ ities  in human red cells m ight s im ilarly fa il to re fle c t 
ac tiv ities  in the liver and care is recommended when in terpre ta ting data on 
erythrocyte galactose metabolism since the liver is the major site o f galactose 
metabolism m vivo. A possible influence of chronic galactose consumption on 
hepatic glucose metabolism is purported and fu rther studies are suggested.
The present investigations confirm  the previously reported increased water 
uptake and excretion o f urine by rats fed galactose when compared to those fed a 
galactose free control d iet; no increase in water uptake was seen in guinea-pigs fed 
galactose. The e ffec t o f galactose on water and e lectro lyte balance is o f possible 
importance in the study of hypertension and remains an interesting area fo r fu rthe r 
research.
In conclusion, although the development of LHS fo r use in food manufacutre 
is like ly  to increase the U.K. per capita galactose consumption these studies 
suggest that this w ill not result in symptoms of galactose to x ic ity  or increase the 
risk o f atherosclerotic coronary heart disease in healthy, young adults. An 
influence of variations in serum progesterone or progesterone plus oestradiol 
concentrations over an ovulatory menstrual cycle on acute peroral galactose 
tolerance in young women is possible but is unlikely to be of any c lin ica l 
importance or to a ffe c t chronic galactose to x ic ity . Studies o f acute and chronic 
galactose metabolism in human volunteers are usually lim ited  to analysis of blood, 
urine and faecal samples and when erythrocyte enzyme levels are measured care 
must be exercised in the ir in terpre ta tion. Use o f a suitable animal model o f 
galactose metabolism fo r man would allow more detailed investigations. The 
guinea-pig appears to be a more suitable animal model than the ra t and its  use in 
studies o f human galactose metabolism is supported.
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APPENDICES
APPENDIX 1
Composition of the Lactose Hydrolysate Syrup (Sweet Dairy
Concentrate - SDC-04), the Spray Dried Glucose Syrup (47 DE) 
and the Dextrose Monohydrate (C90)
Sweet Dairy Concentration (SC-04)
% By Weight
Hydrolysis 78 - 80%
Total solids 72%
Protein 8.0 - 9.5%
Fat 0.5 - 1.0%
Total Ash 3.0 - 4.5%
Sugars:
glucose 21.5 - 23.0%
galactose 21.5 - 23.0%
lactose 8.0 - 9.5%
pH 5.0 - 6.5
Spray Dried Glucose Syrup (47 DE)
% By Weight
Moisture content (102°C fo r 4 hr) 5% max
Ash 0.3% max
Protein (N x 6.25) 0.15% max
Dextrose equivalent 45 - 48%
Carbohydrate Composition (Approx):
Dextrose 5%
Maltose 50%
Polysaccharides 45%
Starch 0
pH of 50% w/w solution 4.8 - 5.2 
Dextrose Monohydrate (C90)
pH o f 20% w /w  solution at 20°C 5.5 min.
% By Weight
Moisture content 
Sulphated ash 
Dextrose equivalent
7.0 - 10.0% 
0.1% max 
99.5% min
Spray dried glucose syrup and dextrose monohydrate were mixed in the ra tio  o f 
17.4: 82.6 fo r use as contro l carbohydrate.
APPENDIX 2
Recipes Used Containing Lactose Hydrolysate Syrup or
the Control Carbohydrate Mix
Lactose Hydrolysate Syrup Recipes:
Biscuits:
170g Plain flour 
112g Soft brown sugar 
56g Margarine
84g Lactose hydrolysate syrup
3 level tsp. ground ginger/mixed spice/cocoa or substitute w ith  currants/chocolate 
chips/chopped nuts
Recipe yields 20 biscuits 
1 B iscuit = 4g lactose hydrolysate syrup
Orange Tea Bread
280g S.R. flour 
1/. tsp. salt 
5ug Margarine 
1 Egg
140 ml Orange ju ice/lem on juice 
Grated rind 2 oranges/lemons 
224g Lactose hydrolysate syrup
A lte rna tive  Recipe - substitute f ru it  ju ice w ith  m ilk, add mixed spice and mixed 
dried fru it
Recipe yields 10 portions 
1 portion = 22g lactose hydrolysate syrup
Flapjacks
56g Demerara sugar 
84g Margarine 
168g Rolled oats 
56g S.R. flour
llO g  Lactose hydrolysate syrup
Recipe yields 10 fingers 
1 Finger = l l g  lactose hydrolysate syrup
F ru it Cookies
112g Margarine
112g Rolled oats
112g Currants
36g Glace cherries
112g Stale cake crumbs
280g Lactose hydrolysate syrup
Recipe yields 15 squares 
1 Square = 18g lactose hydrolysate syrup
Fudge Biscuits
200g Cooking chocolate 
200g Margarine
2 Small pkts. crushed digestive biscuits 
280g Lactose hydrolysate syrup
Recipe yields 20 squares 
1 Square = 14g lactose hydrolysate syrup
R ice-Crispie Squares
200g Cooking chocolate 
200g Margarine 
320g Rice-Crispies/cornflakes 
280g Lactose hydrolysate syrup
Recipe yields 20 squares
1 Square = 14g lactose hydrolysate syrup
Control Carbohydrate Mix Recipes: 
Grantham Biscuits 
225g Margarine
225g Control carbohydrate mix 
225g Plain flour 
£ tsp. Bicarbonate of soda 
50g Dessicated coconut
2 tsp Ground ginger 
1 Egg
Recipe yields 25 biscuits 
1 Biscuits = 9g control carbohydrate mix
Date Fingers 
2 Eggs
180g Control carbohydrate mix
75g S.R. flour
Pinch of salt
50g A ll bran
50g Chopped mixed nuts
50g Chopped dates
Recipe yields 14 portions 
1 Date finger = 13g control carbohydrate mix
Flapjacks
120g Control carbohydrate mix
84g Margarine
56g Golden syrup
168g Rolled oats
56g S.R. flour
Recipe yields 10 portions 
1 Flapjack = 12g control carbohydrate mix
Cake
175g Margarine
180g Control carbohydrate mix 
175g S.R. flour 
Pinch of salt 
3 Eggs
225g Glace cherries 
L it t le  m ilk to mix
Recipe yields 10 portions 
1 portion = 18g control carbohydrate mix
Chocolate Brownies
225g Control carbohydrate mix
40g Cocoa
75g S.R. flou r
|  tsp. salt
2 Eggs
2 tbs. m ilk
lOOg Margarine
Recipe yields 16 portions 
1 Portion = 14g contro l carbohydrate m ix
Orange Loaf 
50g Margarine
175g Control carbohydrate mix
1 Egg
Grated rind and ju ice of 1 orange 
200g Plain flour
2 tsp baking powder 
^ tsp salt
2 tbs m ilk
Recipe yields 10 portions 
1 Portion = 17.5g control carbohydrate mix
APPENDIX 3
Personal Details of the Test Volunteers fed LHS and the Control
Volunteers fed the Control Carbohydrate Mix
Volunteer Age
(yrs)
Smoking
habits
PRE-STUDY
Sporting Oral 
a c tiv ity  medication
Smoking
habits
POST-STUDY
Sporting Oral 
ac tiv ity  medication
[ - 1 21 NIL Moderate
1/week
None NIL NIL None
2 22 NIL Heavy
1/week
None NIL NIL None
IS)
LU
— I<
3 23 20/day Moderate
1/week
Oral contr. 
"ovranet
20/day NIL Oral contr. 
"ovranet"
Z
LU
LU
4 22 NIL Moderate
2/week
None NIL Moderate
2/week
None
h~IS)
3 22 NIL Heavy
3/week
None NIL Heavy
1/week
None
LU
h- 6 23 NIL NIL None NIL NIL None
7 20 NIL Moderate
5/week
None NIL Moderate
5/week
None
IS)
~ 8 24 NIL Heavy 
3 /week
None NIL NIL None
LU
_l
<
9 23 NIL Heavy
2/week
None NIL Heavy
2/week
None
z
f—IS)
10 23 NIL Heavy
3/week
None NIL Heavy
2/week
None
LU
1— 11 23 NIL Heavy3/week
None NIL Heavy
2/week
None
12 23 6/day Heavy
2/week
None 6/day Heavy
2/week
None
IS )
“  1 24 10/day Heavy
2/week
Oral contr. 
"ovranet"
l l /d a y Heavy
1/week
Oral contr. 
"ovranet"
LU
_J
<
2 23 NIL Moderate
1/week
None NIL NIL None
z
LU
LU
3 25 NIL Moderate
3/week
None NIL Moderate
3/week
None
_J 4 24 2/week Heavy
1/week
Oral contr. 
"neocon"
5/week Heavy
2/week
Oral contr. 
"neocon"
zo
u
3 24 NIL Moderate
2/week
None NIL Moderate
2/week
None
"  6 25 NIL Heavy
2/week
None NIL Heavy
1/week
None
IS)
LU
_l<
7 23 NIL Heavy
4/week
None NIL NIL None
8 21 NIL Moderate
7/week
None NIL Moderate
7/week
None
z 9 21 4/day NIL None NIL NIL None
— I
o 10 23 NIL NIL None - - -L/a:1-Z
11 23 NIL Heavy
2/week
None NIL Heavy
1/week
None
Ou 12 28 10/day Heavy5/week
None 10/day Heavy
4/week
None
APPENDIX 4
The influence o f the sex o f the ind iv idual and o f the m enstrual cycle on 
galactose tolerance. By C e lia  A. W il l ia m s , A lis o n  M . O w ens and 
P a u la  H u n t ,  Department of Biochemistry, University o f Surrey, Guildford, 
Surrey GUi $XH
I t  has been suggested that galactose tolerance is influenced by the sex o f the 
individual, the stage o f the menstrual cycle and by pregnancy; the results are 
conflicting and are based on the excretion o f urinary’ reducing bodies after 
galactose ingestion (Rowe, 1924) or lactose (W atkins, 1928).
T o  investigate the influence o f the menstrual cycle on galactose tolerance, eight 
female volunteers were investigated on four occasions during the ir menstrual cycle. 
Six males were investigated at regular wreekly intervals. A ll females were nullipare 
and had histories o f regular 24-31 day menstrual cycles. Basal body temperature 
and onset o f menstruation were recorded. A ll subjects were considered to  be in 
good health and non-obese, the age range was 18—33 years. A fte r an overnight fast 
each subject was given 0 5 g galactose/kg body-weight (B W ) in  4 m l w ater/kg BW . 
Blood samples were taken before the meal and at 15, 30, 60 and 90 m in  after. 
Serum w’as analysed fo r galactose, glucose and insulin. U rine was collected fo r 6 h 
after galactose ingestion, the volume recorded and a portion  analysed fo r galactose.
Results from  seven female subjects were classified according to  week. The  serum 
response to galactose was found to be consistently greatest during  e ither week 3 or 
4. The mean (w ith  se ) serum galactose concentration at 30 m in  wras 1 92  (0-278) 
mmol/1 in week 4 and 0 99 (01 44 ), 1 3 0  (0 328) and 1 25  (0159 )  mmol/1 in  weeks 
1, 2 and 3 respectively. The mean area under the serum galactose response curve 
was greatest in week 4. The serum glucose and serum insu lin  response to galactose 
and the subsequent u rinary galactose excretion were not influenced by the 
menstrual cycle. There were no differences in the mean serum galactose response 
to  galactose or in  the u rina ry  excretion o f galactose in  the male volunteers during 
repeated galactose tolerance tests. The mean serum galactose level at 30 m in was 
significantly greater in  males when compared w ith  the female response in  week 1 
(P C o -o i) bu t there were no significant sex differences in  the areas under the serum 
galactose or serum insu lin  response curves. The mean area under the serum 
glucose response curve to  galactose was significantly greater in  males than in  
females during wreeks r, 2 and 3 (P < o -o i).
These results show that the serum galactose response to  galactose is no t 
influenced by the sex o f the consumer, although the serum glucose response is 
significantly greater in  males. I t  is possible tha t the elevated serum progesterone 
levels or simultaneously elevated progesterone and oestrogen levels found during  
the pre-menstrual phase influence galactose tolerance. T h is  effect is not mediated 
through an altered urinary loss o f galactose. Differences in  the rate o f gastric 
emptying w hich occur in  the menstrual cycle (Macdonald, 1956) m igh t explain the 
results reported. I t  is possible tha t the hormonal changes in  the menstrual cycle 
can influence the hepatic metabolism  o f galactose.
Macdonald, I. (1956). Gastroenterology 30,602—607.
Rowe, A. W. (1924). Archives of Internal Medicine 34, 388—401.
Watkins, O. (1928). Journal of Biological Chemistry 80, 33-66.
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APPENDIX 7
The D ietary Composition and the Method of Preparation
Used for the Rat and Guinea-Pig Test and Control Diets
INGREDIENT TEST DIET 
A B
CONTROL
DIET
(G) (G) (G)
( Com oil 30 50 50
FAT (
( Hydrogenated 40 40 40
( coconut oil
PROTEIN Casein 400 400 400
( Galactose 500 750 -
CHO (
( Glucose 1400 1150 1900
FIBRE Solkafloc 250 250 250
*V itam ins lg/lOOg mix
**M ine ra ls 7g/100g mix
*V itam ins as supplied by Special D ie t Services fo r ra t and 
guinea pig maintenance diets
**M ine ra ls  as supplied by Special D ie t Services fo r ra t and 
guinea pig maintenance diets
Preparation; 
1. M ix protein, carbohydrate, fib re  and m ineral sources. 
M ix fo r 30 minutes in a food mixer.
2. M elt hydrogenated coconut oil.
3. Add melted coconut oil and corn o il to dry ingredients 
and m ix fo r 30 minutes.
4. D ivide in half and add vitam in mix fo r rats to one ha lf 
and vitam in m ix fo r guinea-pigs to the other.
3. Store in sealed containers un til used.
APPENDIX 8
Mean Daily Food Consumption Per Gram Body Weight by Galactose-Fed Test
Rats and Guinea-Pigs w ith  Standard Errors (SE) 
and P Values when P<0.02
STUDY WEEK
Animal
Group
1 2 3 4 3 6 7 8 9 10
AR
(n=6)
X
SE +
0.23
0.01
0.26
0.02
0.20
0.01
0.18
0.00
0.15
0.00
0.13
0.00
0.10
0.00
0.11
0.00
0.09
0.00
0.09
0.00
BR
(n=6)
X
SE +
O
0.17
0.01
O
0.21°
0.01
O
0.17°
0.00
O
0.16g
0.01
0.14
0.01
0.14
0.01
O
0.12
0.00
0.11
0.00
0.10
0.00
0.11°
0.00
AGP X 0.06A 0.12A 0.15^ 0.13^ 0.13 0.09 0.09 0.10 0.08 0.07
(n=5) SE + 0.00 0.01 0.01 0.01 0.01 0.02 0.02 0.01 0.02 0.01
BGP X 0.09* 0.17# 0.15 0.14 0.10*
•
O .llS
•
0.092
•
0.082 0.07* 0.07*
(n=5) SE + 0.01 0.01 0.01 0.01 0.00 0.01 0.01 0.01 0.00 0.01
O P<0.001 )
Q ) For Comparison of
O P<0.02 ) Groups AR and BR
)
o P<0.01 )
A P<0.001 ) For Comparison o f
A ) Groups AGP and AR
A P<0.01 )
•  P<0.001 )
)
J  P<0.02 ) For Comparison of
2 P<0.01 )
) Groups BGP and BR
